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Abstract 
Haematopoietic stem cells (HSCs) have a huge clinical relevance as they are 
regularly used in bone marrow transplants worldwide. This therapy has profound 
potential to alleviate diseases of the blood and immune system, where others are 
ineffective. However, HSCs cannot currently be cultured long term ex vivo, as 
they rapidly differentiate or senesce. Hence, genetically matched donors must 
often be found for transplant and studies of HSCs require costly animal models.  
Mimicking the microenvironment of the bone marrow, in which they reside, by 
incorporating supportive stromal cells including mesenchymal stem cells (MSCs), 
has the potential to overcome these limitations. This project aimed to create an 
HSC-permissive MSC spheroid culture system using magnetic nanoparticles and a 
collagen gel. An existing spheroid system was optimised for HSC-MSC co-culture 
and then characterised to assess the potential for HSC support. MSC spheroids 
were more quiescent, and expressed higher levels of HSC-supportive genes such 
as nestin and CXCL12.  
Subsequently, additional bone marrow cell types were introduced to the model to 
mimic vascular and endosteal areas of the bone marrow niche. HSC behaviour 
within these models was investigated. MSCs, endothelial cells, and osteoblasts 
exhibited gene expression changes in line with those predicted from examination 
of the physiology of endosteal and vascular regions of the bone marrow: i.e. higher 
activity at the vascular niche (model including endothelial cells), and lower 
activity at the endosteum (model including osteoblasts). However, gene 
transcription and phenotypic analyses of HSCs following culture within the bone 
marrow models produced more inconclusive results. Hence, further optimisation 
of the conditions of the model and repetition of results presented here are 
required to develop the system so that it truly mimics physiological bone marrow.  
The development of such a model has many applications, including in drug 
discovery, modelling disease states, and probing haematopoietic functions. 
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ALP  Alkaline phosphatase 
Ang-1  Angiopoietin 1 
BIT  BSA, insulin, and transferrin 
BM  Bone marrow 
BMI1  B lymphoma Mo-MLV insertion region 1 homolog 
BrdU  Bromodeoxyuridine 
BSA  Bovine serum albumin 
c-Kit  Also known as CD117 
CaR  Calcium sensing receptor 
CAR  CXCL-12 abundant reticular cells 
CD  Cluster of differentiation 
CDK  Cyclin dependent kinase  
CLP  Common lymphoid progenitor 
CMP  Common myeloid progenitor 
CXCL12 C-X-C motif chemokine 12 (also known as SDF1) 
CXCR4  C-X-C chemokine receptor type 4 
DAPI  4',6-diamidino-2-phenylindole 
DMEM   Dulbecco’s modified Eagle’s medium 
DMSO  Dimethyl suphoxide 
DNA  Deoxyribose nucleic acid 
EC   Endothelial cell 
EDTA  Ethylenediaminetetraacetic acid 
ELISA  Enzyme-linked immunosorbent assay 
FACS  Fluorescence-activated cell sorting 
FBS   Fetal bovine serum  
FBXW7 F-box and WD40 repeat domain-containing 7 
FITC  Fluorescein isothiocyanate 
G-CSF  Granulocyte colony stimulating factor 
GMP  Granulocyte-monocyte progenitor 
GvHD  Graft-versus-host disease 
HA   Hyaluronic acid 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HH  Hedgehog 
HHIP  Human hedgehog-interacting protein 
HIF1-α  Hypoxia-inducible transcription factor 1 alpha 
HPSC  Haematopoietic stem or progenitor cell 
HS   Human serum 
HSC  Haematopoietic stem cell 
hTERT  Human telomerase reverse transcriptase 
HUVECs  Human umbilical vein endothelial cells  
ICAM-1 Intercellular adhesion molecule 1 
Ig  Immunoglobulin 
IMDM  Isocove’s modified Dulbecco’s medium 
ISCT  International Society for Cellular Therapy 
Jag-1  Jagged 1 
JAK  Janus kinase 
LDL   Low density lipoprotein 
LFA-1  Lymphocyte function-associated antigen 1 
LSC  Leukaemic stem cell 
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LTR  Long-term reconstitution 
MAPK  Mitogen-activated protein kinase 
MCM  Mini-chromosome maintenance protein 
MEP  Megakaryocyte-erythroid progenitor 
MEP  Megakaryocyte/erythrocyte progenitor 
MG63   Human osteosarcoma cell line 
MLP  Multi-lymphoid progenitor 
MMP  Matrix metalloprotease 
MNC   Mononuclear cells  
MPL  Myeloproliferative leukemia protein, also known as CD110 
MPP  Multipotent progenitor 
MSC   Mesenchymal stem cell 
MTT  4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
NICD  Notch intracellular domain 
NSC  Neural stem cell 
OB  Osteoblasts  
OPN  Osteopontin  
PBS  Phosphate buffered saline 
PCR  Polymerase chain reaction 
PI3K  Phosphoinositide 3-kinase 
RM  Recommended medium 
RNA   Ribose nucleic acid 
ROS  Reactive oxygen species 
RUNX1/2 Runt-related transcription factor 1 or 2 
SCF   Stem cell factor 
SDF1  Stromal derived factor, also known as CXCL12 
SEM  Scanning electron microscopy 
SHH  Sonic hedgehog 
SMO  Smoothened, part of the Hedgehog pathway 
SNS  Sympathetic nervous system  
STAT3  Signal-transducer and activator of transcription 3 
TCP  Tissue culture plastic 
TEM  Transmission electron microscopy 
Tie-2  Tyrosine kinase with immunoglobulin-like and EGF-like domains 2 
TPO  Thrombopoietin 
TRITC  Tetramethylrhodamine 
VCAM-1 Vascular cell adhesion molecule 1 
VLA-4  Very late antigen-4, also known as integrin α4β1 
VLA-5  Very late antigen-5, also known as integrin α5β1 
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Chapter 1 Introduction  
The bone marrow (BM) is a unique organ with multiple vital functions in red blood 
cell production (haematopoiesis) and the lymphatic system (white blood cell 
production) in tetrapods (Sanchez et al. 2014). As the site of haematopoiesis, 
study of the BM and its resident cells has been an area of intensive investigation. 
To this end, recapitulating the BM architecture to allow studies in vitro has huge 
clinical significance, both in terms of supporting artificial haematopoiesis, and as 
a platform for drug discovery and testing in the pharmaceutical industry. This 
chapter will give an overview of the BM, its resident cell types and their clinical 
significance, interactions between the cell types, and the physical and chemical 
characteristics that are fundamental to its function. It will then explore current 
ex vivo BM models, and describe the aims for this project.  
1.1 Bone marrow architecture 
The BM is located in the hollow interior of bones. Initially thought to be a diffuse 
structure in which cells relating to haematopoiesis were randomly distributed, in 
the 1990s structural analysis revealed a highly-ordered architecture, which has 
functional significance for haematopoiesis (Lord 1990), as depicted in Figure 1.1. 
BM with a predominant haematopoietic role is called ‘red marrow’ and is mainly 
located in trabecular bone, in small thin bones, and in the epiphysis of long bones. 
Red marrow is highly vascularised and has a large surface area, mainly due to the 
honeycomb network of trabecular plates.  
Aside from haematopoiesis, an additional function of the BM is fat storage, 
wherein the marrow mainly consists of adipocytic inactive haematopoietic tissue 
termed ‘yellow marrow’. This is found only in the medullary cavities of cortical 
bone (Figure 1.1) and has a poor vascular supply. The proportion of yellow BM 
increases during adulthood and aging to around 50%. In cases of blood cell type 
imbalance or blood loss, yellow marrow can be converted to red to increase blood 
production (Clarke 2008). 
The trabecular region comprises several anatomical features which have an 
influence on haematopoiesis. One of these, the endosteum, is described as a 
“membranous structure covering the inner surface of cortical bone, trabecular 
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bone, and the blood vessel canals present in bone” (Clarke 2008). The endosteum 
is in contact with both the bone marrow and trabecular bone, lining the hollow 
medullary cavity, and has a protective role (Figure 1.1). The endosteum itself is 
comprised of a flattened, quiescent osteoblast (OB) subset (Clarke 2008) and is a 
proposed site for haematopoiesis.  
 
Figure 1.1 Schematic of bone architecture.  
Trabecular bone containing red marrow is located in the bone epiphysis, and yellow marrow 
is situated in the medullary cavity. The endosteum comprises a layer of quiescent 
osteoblasts (orange), with a network of sinusoids located within the epiphysis lined with 
endothelial cells. Original image.  
The BM is also highly vascularised. Internal vessels are connected to the exterior 
via hollow tubes in cortical bone termed ‘Haversian canals’ and ‘Volkman’s 
canals’, which are orientated perpendicularly to each other and form a branching 
network. These vessels play a large role in cellular turnover in the marrow. They 
are highly permeable and made up of endothelial cells which also produce 
regulatory factors that influence the production of blood cells (Itkin et al. 2016).  
As early as 1990, the radial organisation of the BM had been described, indicating 
an organised and distinct architecture (Lord 1990). Colony-forming unit (CFU) 
capacity, a proxy for self-renewal capacity, is greatest in HSCs located in the 
endosteal region and commitment to erythropoiesis triggers movement of cells to 
the centre of the marrow and the sinusoid: showing that these locations are 
related to haematopoietic stem cell (HSC) state and behaviour.  
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1.2 Bone marrow resident cells 
The BM comprises several key cell types that contribute to the process of 
haematopoiesis by interacting directly and indirectly with HSCs. These 
interactions maintain HSCs and trigger haematopoietic events.  
1.2.1 Mesenchymal stem cells 
Mesenchymal stem cells (MSCs) are adult stem cells that reside in many organs of 
the body, including the BM. MSCs are multipotent and produce mesenchymal 
lineage cells, including chondrocytes, adipocytes, OBs, and myoblasts. They are 
important in the healing and regeneration process, have immunomodulatory 
capacity, and are a key support of HSCs (as described later in the text).  
The identification of MSCs is complex as they can be obtained from multiple tissue 
sources, and several subsets exist with subtly different biological activities. A 
position statement from the International Society for Cellular Therapy defined the 
minimal criteria for MSCs as: (1) cells must be plastic adherent under standard 
culture conditions; (2) they must be positive for CD105, CD73, and CD90; negative 
for CD45, CD34, CD14 or CD11b, CD79α or CD19, and HLA-DR surface molecules; 
and (3) they must have the ability to differentiate into osteoblasts, adipocytes, 
and chondroblasts in vitro (Dominici et al. 2006). These properties can be 
validated by quantitative RNA analysis, flow cytometric analysis of functionally 
relevant surface markers, and protein analysis of the secretome (Galipeau et al. 
2015). However, no single marker associated with MSC ‘stemness’ has been agreed 
upon and many ‘proxy’ identifiers for subsets of MSCs with differing functions have 
also been identified (Table 1.1). Markers are often used for identification and/or 
isolation of MSC subsets.  
Many subsets of BM-resident cells with MSC-like properties have been implicated 
in haematopoietic function. For example, CXCL12-abundant reticular cells (CaR) 
cells are located adjacent to sinusoids in the BM, and have been found to have a 
role in haematopoiesis, particularly in the support of B cells (Eltoukhy et al. 2016). 
Similarly, nestin-expressing cells occupy a similar location, are involved in HSC 
support, and have mesenchymal lineage potential (Méndez-Ferrer et al. 2010). 
Although evidence suggests that these cells are not the same cell type, they may 
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overlap with each other and with alarger MSC population. Furthermore, it has 
been suggested that CAR cells may in fact be MSC progenitors.  
MSC 
subpopulation 
Source Biological properties Reference  
STRO-1+ BM Promote angiogenesis. May not support 
HSC engraftment. Also expressed by 
erythroid cells, so STRO-1 may not be a 
suitable marker for multipotent MSCs.  
Mo et al. 2016; 
Lv et al. 2014 
CD271+ BM  
Adipose tissue 
Express higher levels of differentiation-
related genes than cells isolated by 
plastic adherence. Enhanced chondral 
repair. Express higher levels of 
immunosuppressive cytokines. Enhance 
HSC engraftment ability.  
Álvarez-Viejo 
2015; Mo et al. 
2016; Lv et al. 
2014 
CD105+ BM 
Umbilical cord 
blood 
Wharton’s jelly 
Enhanced myogenic differentiation. Mo et al. 2016 
CD146+ BM 
Skeletal muscle 
pericytes  
Enhanced osteogenic differentiation. 
Produce cardiomyocytes and pro-
angiogenic factors. Marker is 
downregulated in differentiated cells.  
Mo et al. 2016 
CD44+ BM Increased proliferation and homing 
capacity. 
Mo et al. 2016 
Nestin+ BM Involved in HSC niche and cellular 
support.  
Mo et al. 2016 
CXCR4+ BM Enhanced migration and engraftment.  Mo et al. 2016 
PDGFRα+ Fetal BM HSC supportive. Express nestin.  Pinho et al. 2013 
CD51+ Fetal BM HSC supportive. Express nestin. Pinho et al. 2013 
CD49f+ BM Multipotent, CFU-Fs. Knock-down 
causes HSC differentiation.  
Lv et al. 2014 
Table 1.1 Subpopulations of human mesenchymal stem cells (MSCs), with markers used for 
identification.  
Details of the cell subsets defined by these markers are given. BM, bone marrow, CD, 
cluster of differentiation; PDGFR, platelet derived growth factor receptor.  
1.2.2 Haematopoietic stem cells 
HSCs are able to differentiate into all cellular components of the blood: 
erythrocytes, lymphocytes, and myelocytes, via a process termed haematopoiesis 
(Wang & Wagers 2011) (Figure 1.2). Their regenerative potential gives them great 
clinical relevance in haematologic diseases, such as leukaemias, anaemias, and 
autoimmune disorders. HSCs are multipotent (they can differentiate into multiple 
but limited cell types) and give rise to oligopotent progenitor cells (which can 
differentiate into just a few cell types). These oligopotent cells subsequently have 
gradually restricted differentiation potentials, resulting in the production of the 
mature cells of the blood system. The term HSPC (haematopoietic stem and 
progenitor cell) collectively describes HSCs and these multipotent and oligopotent 
progenitors. These comprise megakaryocyte-erythrocyte progenitors (MEPs), 
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common myeloid progenitors (CMPs), common lymphoid progenitors (CLPs); and 
granulocyte-monocyte progenitors (GMPs). Except for a subset of HSCs, long-term 
reconstituting HSCs, these progenitors all present the cluster of differentiation 34 
(CD34) glycoprotein on their cell surface.  
 
Figure 1.2 Schematic of haematopoietic development, including emergence of identifying cell 
surface markers.  
HSC, haematopoietic stem cell; MPP, multipotent progenitor; MLP, multipotent lymphoid 
progenitor; CMP, common myeloid progenitor; MEP, megakaryocyte-erythroid progenitor; 
GMP, granulocyte-macrophage progenitor; CLP, common lymphoid progenitor. 
Isolating and distinguishing subsets of HSPCs can be performed using a selection 
of cell surface markers. The basic phenotype used for isolating progenitors is 
CD34+CD38-, however, more specific progenitors can be identified using a more 
comprehensive panel of markers, as described in Error! Reference source not f
ound.. The progenitors do not express markers indicating the various 
haematopoietic lineages: these only appear during terminal differentiation. The 
CD34 marker does remain expressed on progenitors lower in the hierarchy, 
whereas expression of CD38 tends to increase in most of the lineage progenitors. 
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Clinically, purification of BM or mobilised peripheral blood samples is performed, 
normally limited to removal of plasma, removal of donor T lymphocytes, and 
purification of a CD34+ population, which is sufficient for clinical purposes (Antin 
& Raley 2013). However, for detailed investigation of progenitor function and 
location within the BM (the ‘niches’), identification of other progenitor subsets is 
required using the unique combinations of cell surface markers.  
1.2.3 Osteoblasts 
Osteoblasts (OBs) are bone forming cells, responsible for synthesis and 
mineralisation of bone during formation and remodelling. They secrete vesicles 
which concentrate calcium and phosphate, and degrade mineralisation inhibitors. 
OBs arise from MSCs as a result of Wnt/β-catenin signalling, accompanied by a 
morphological shift from spindle shaped to large cuboidal cells with large nuclei, 
extensive endoplasmic reticulum, and enlarged Golgi apparatus. Active OBs 
secrete type I collagen and other matrix proteins towards bone formation. 
Following bone formation activity OBs either apoptose (50-70%), become 
osteocytes, or become flattened bone lining cells that form the endosteum, which 
are thought to be quiescent OBs (Clarke 2008).  
1.2.4 Endothelial cells 
Endothelial cells (ECs) form the lining of all blood vessels, in a sheet termed the 
endothelium. In capillaries and sinusoids, which are abundant in the BM vascular 
system, the vessels consist entirely of endothelial cells, basal lamina, and 
pericytes. As such, they are a major constituent of the BM microenvironment 
(Alberts et al. 2002). Sinusoids are highly fenestrated venous vessels, and are 
hence the main conduit for HSC egress from the BM. Also present are arterioles, 
small vessels that link arteries with capillary networks. These vessels also have 
muscular walls (Crane et al. 2017). BM ECs are phenotypically distinct from those 
found in the microvasculature of other organs, as they constitutively express 
cytokines and adhesion molecules. They also exhibit specific binding affinity for 
CD34+ progenitors and megakaryocytes, indicating a role in regulating 
haematopoiesis (Rafii et al. 1995; Almeida-Porada & Ascensao 1996; Whoriskey et 
al. 1994).  
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1.2.5 Megakaryocytes 
Megakaryocytes represent 1 in 10,000 cells of the BM. They have large nuclei and 
are responsible for platelet production. Mature megakaryocytes are polyploid as 
a result of serial endomitosis. They localise to ECs of sinusoids in the BM, with EC-
megakaryocyte adhesion enhancing survival, maturation, and platelet production. 
Other stromal cell types are inhibitory, so their specific localisation may also 
protect them from such signals (Avecilla et al. 2004).  
1.2.6 Nerve cells  
The sympathetic nervous system (SNS), consisting of various types of nerve fibres, 
is involved in BM structure and function. The SNS controls HSC egress from the BM, 
bone remodelling, and transduction of circadian oscillation signals from the 
suprachiasmatic nucleus (SCN) (Méndez-Ferrer et al. 2009). Large nerve bundles 
enter the BM along with the major arteries at various locations. Nerve terminal 
contact with other BM cells is limited: signal transduction is non-synaptic and 
involves intercellular junctions (Elefteriou et al. 2014). The ubiquity of the SNS 
means that it is present and active in every area of the BM.  
1.3 Bone marrow stem cell transplants 
1.3.1 Summary of stem cell transplants to date 
BM transplants are the original and remain the main stem cell therapy in clinical 
use today. Over 50,000 people are treated with a BM transplant each year and 
over 1,000,000 people had received one by December 2012. The classical 
treatments are for blood disorders such as leukemia, thalassemia, and anaemia. 
Increased knowledge of human leukocyte antigen (HLA) typing and matching 
patients in the 1960s encouraged the development of multiple registries of donors, 
which have expanded in the subsequent decades. However, less than 30% of 
patients have an HLA-identical donor (Copelan 2006), and many patients still 
cannot find a match, due to complex multiple ethnicities. In fact, 40% of patients 
need to be matched by someone in another country (WHO 2013). Fifty percent of 
these patients can find a donor through international databases, but the three-
month duration of this process means that less than half of plausible donors are 
actually used (Copelan 2006). 
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Mobilised peripheral blood is an alternative HSC source to direct BM transplants. 
BM transplants are expensive and as such are limited to wealthy nations. Although 
peripheral blood stem cells (PBSCs) engraft quickly and can be obtained without 
specialist staff and hospitalisation, the rate of graft versus host disease (GvHD) is 
higher and survival is lower. The donor is treated with the mobilisation inducer 
granulocyte colony stimulating factor (G-CSF); Mozobil (pleraxifor hydrochloride), 
a C-X-C chemokine receptor type 4 (CXCR4) agonist; or chemotherapy regimens 
against lymphoma. The blood is collected and processed to remove red cells, 
plasma, and T lymphocytes, and isolate CD34+ cells, before being infused into the 
patient (Antin & Raley 2013). This process has widened the availability of BM 
transplants beyond the Western world (Yoshimi et al. 2016).  
Autologous transplants are a more recent development that has been used to treat 
aggressive cancers, for which there is no other option. A patient’s cells can be 
removed prior to treatment and replaced after myeloablative therapy (high dose 
chemotherapy that kills BM cells), hence eliminating GvHD. However, these 
transplants can be less effective against cancer, with increased relapse rates; as 
there is a graft-versus-tumour effect against tumour stem cells, wherein an 
allogeneic BM transplant immunologically attacks remaining tumour cells. This 
effect is lacking in autologous transplants (Copelan 2006). Cord blood as an 
alternative stem cell source is also promising, as the HLA requirement is less 
stringent and appropriate samples can often be found quickly. However, the 
volume available is limited and slower engraftment increases the probability of 
infection. Combining stem cell sources and expanding CD34+ cells from cord blood 
ex vivo to increase cell number are active areas of research. 
Although HSC transplants are performed routinely, MSCs are also an emerging cell 
therapy for tissue repair and immune disorders. In particular, they can be applied 
alongside HSCs in BM transplants to enhance engraftment and reduce GvHD due to 
their immunomodulatory properties. They do not require HLA matching as they do 
not induce in vivo lymphocyte proliferation, and are hence a much more easily 
obtainable therapy. Prochymal® was the world’s first stem cell ‘drug’ to be 
approved by the Food and Drug Administration (FDA) in 2012 (Wei et al. 2013). 
Investigation into use of these cells for other indications is ongoing.  
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As described above, despite decades of research, there remain several issues 
associated with BM transplants. The ability to sustain and expand an HSC 
population ex vivo has the potential to overcome therapy limitations. 
Furthermore, creating an HSC supportive environment would also allow detailed 
study of the control mechanisms therein, using an in vitro system that is more 
representative of the in vivo situation.  
1.3.2 HSC clinical trials 
Clinical research into HSC therapies is very active. A search on 
www.clinicaltrials.gov for ‘haematopoietic stem cells’ identified 2635 studies 
with the search term, of which 783 are currently active (accessed 22/02/2017, 
Figure 1.3). Although the majority of these studies focus on evaluating the 
outcomes of current practice, improving graft versus host disease (GvHD) and 
infection complications, augmenting transplants with new drugs, and treating 
multiple types of leukemias, the repertoire of HSC-treatable diseases is 
expanding. There are active clinical trials using HSCs to treat kidney disease, 
Crohn’s disease, and other autoimmune diseases.  
 
Figure 1.3 World map illustrating past and current clinical trials involving haematopoietic 
stem cells (HSCs). From www.clinicaltrials.gov.  
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There is also a huge potential for HSCs in gene therapies. The gene editing 
clustered regularly interspaced short palindromic repeats (CRISPR)/Cas91 system 
is a relatively new technique that has only recently gained regulatory approval in 
embryos (Callaway 2016). Given the fact that blood/mobilised peripheral blood 
transplants are an established procedure with extensive infrastructure, one of the 
obvious first targets for CRISPR gene therapies is the blood, using both HSCs and 
terminally differentiated cells. This is in contrast to bulk tissues, where delivery 
of edited cells or the editing machinery itself may be more difficult. Edited HSCs 
could be used to treat patients with disorders such as β thalassemia, Wiskott-
Aldrich syndrome, and adenosine deaminase deficiency (leading to severe 
combined immunodeficiency (SCID). Creating a culture system in which HSCs could 
be maintained and processed for gene editing techniques could accelerate this 
process. The limitations of traditional tissue culture mean that a new system could 
extend the available timeframe for editing whilst a patient is waiting for a 
transplant. It also means that a patient’s own cells can be edited with lower risk 
of GvHD and other complications, compared to obtaining an allogeneic donor. 
Furthermore, editing of HLA markers themselves could circumvent the need for 
identifying a donor. Some proof-of concept studies have begun to investigate the 
feasibility of this technology, although it is still in the early stages (Torikai et al. 
2016; Gundry et al. 2016; Genovese et al. 2014).  
A high-profile use of stem cell transplants that has been recently reported widely 
in the media is the trial for patients with multiple sclerosis. This involved 
autologous HSC transplants given to patients for whom other treatments had 
failed. There was a 2.8% mortality rate in the 100 days following transplant, but 
almost half of the recipients remained free from neurological progression for 5 
years following the procedure (Muraro et al. 2017).  
It is evident that, although a long-established technique, there are several aspects 
of BM stem cell transplants that can be developed. Many improvements have been 
made over the years; for example, stem cell transplants are now often performed 
                                         
1 CRISPR/Cas9 is a prokaryotic adaptive immune system component that recognises foreign (viral) 
DNA and allows it to be destroyed. CRISPR passes on the details of the viral DNA it has 
encountered to its progeny, as a ‘genetic vaccination card’. CRISPR refers to the DNA 
sequence. In targeting gene editing, Cas9 is a nuclease that complexes with synthetic guide 
RNA (gRNA), complementary to the desired cut site in the genome.  
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from mobilised peripheral blood, rather than BM itself, which does not require 
invasive surgery, reducing risks and costs. However, increasing the success of 
autologous transplants, by increasing yields or expanding the HSC population, has 
the potential to widen the treatment to many individuals who do not currently 
have the option of a donor. A platform for gene editing could enhance 
effectiveness and negate the need for matched donors. A deeper understanding 
of HSC biology, and of the environment in which they reside, is fundamental for 
this goal.  
1.3.3 MSC clinical trials  
MSCs, as adult stem cells, have lower regenerative capacity than the alternative 
embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), however, 
ethical issues and the potential to form teratomas during clinical use respectively 
limit these alternatives. MSCs are therefore of key clinical interest as a cell 
therapy and are the most commonly used non-HSC stem cells in clinic. Their 
usefulness as a treatment is due to their regenerative capacity, production of 
growth factors in damaged tissues, and their immunosuppressive properties. 
Furthermore, due to innate tumour homing capabilities, MSCs can be engineered 
to deliver anti-tumour drugs and nanoparticles. Although they have been in 
clinical use since the early 2000s, optimisations including MSC source and route of 
administration need to be addressed (Baldari et al. 2017).  
A similar search on www.clinicaltrials.gov for ‘mesenchymal stem cells’ retrieved 
696 clinical trial studies, of which 243 are currently open (accessed 22/02/2017, 
Figure 1.4). The immunomodulatory capacity of these cells, as well as their 
regenerative potential in multiple organs of the body, means that they are being 
trialled for orthopaedic applications as well as multiple organ diseases such as 
pulmonary fibrosis, Limbus Corneae Insufficiency Syndrome, and polycystic kidney 
disease (Wei et al. 2013). 
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Figure 1.4 World map illustrating past and current clinical trials involving mesenchymal 
stem cells (MSCs). From www.clinicaltrials.gov.  
1.4 The HSC microenvironment within the bone marrow 
The concept of a specialised HSC microenvironment within BM, termed a niche, is 
long established (Schofield 1978) and is the subject of ongoing investigation. The 
niche functions to maintain a quiescent pool of HSCs, which are nevertheless able 
to self-renew, differentiate, and mobilise in the event of haematopoietic injury. 
The niche also protects the cells from overstimulation and prevents inappropriate 
differentiation. Cell-cell interactions, the SNS, and hormonal inputs have all been 
identified as playing a role in the regulation of haematopoiesis. Cell-extracellular 
matrix (ECM) interactions, oxygen tension, and calcium ion concentration are also 
fundamental physical features of the niche (Wang & Wagers 2011). The HSC niche 
is clearly a very complex environment and many features are not yet fully 
understood.  
Examining this niche is necessary in order to recapitulate a suitable HSC culture 
environment ex vivo. In adults, HSCs reside in the BM, predominantly in the 
trabecular rich metaphysis (Ellis et al. 2011). Here, HSCs have been observed in 
contact with the endosteum (the surface of the bone), and localised around 
sinusoids (capillaries which supply the marrow), as shown earlier in Figure 1.1 
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(Kiel et al. 2005). This has given rise to a ‘zoned model’ of the haematopoietic 
niche (Figure 1.5, Suárez-Álvarez et al. 2012). It is hypothesised that the 
endosteum houses quiescent HSCs, with the more active cycling HSCs located 
around the sinusoid (Ehninger & Trumpp 2011). However, with the recent use of 
advanced techniques for imaging HSCs in situ or in large areas of tissue, it has 
been suggested that this model is over-simplified: that in the trabecular bone the 
endosteum and vasculature are in close contact and so HSCs may be interacting 
with both suggested niche components simultaneously (Ugarte & Forsberg 2013; 
Nombela-Arrieta et al. 2013; Ellis et al. 2011). Kunisaki et al. 2013 imaged BM 
from both long bones and the sternum, finding evidence for the sinusoid being a 
proliferative niche, but also identifying a putative arteriolar niche. Arterioles, 
exhibiting characteristic smooth muscle, nerves, and matrix, were associated with 
highly nestin+ perivascular cells, which were also more quiescent and produced 
more HSC-supportive factors than those localised to sinusoids. Quiescent HSCs 
localised to these arterioles.  
 
Figure 1.5 The ‘zoned model’ of the HSC niche.  
HSCs are hypothesised to reside in two separate zones in the bone marrow: the sinusoidal 
niche and the endosteal niche, migrating between the two. Nestin+ MSCs are important for 
HSC support in both zones. Adapted from Ehninger & Trumpp 2011. 
The precise location of HSCs relative to endosteum or elements of the vasculature 
(sinusoids and arterioles), and thus the nature of cellular signals they receive, may 
determine whether the cells proliferate or are quiescent. Different areas of the 
BM or cellular components may serve distinct functions depending on the stage of 
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haematopoiesis, with each lineage progenitor residing in its own specific 
microenvironment (Wang & Wagers 2011; Ding & Morrison 2013).  
1.4.1 Cellular support of HSCs 
Several different cell types have a proposed role in HSC regulation; including 
MSCs, pericytes, ECs, and OBs. The observation that most HSCs are located 
adjacent to bone in the endosteum initially placed osteoblasts as the main 
supporting cell. However, later genetic evidence called this into question, 
concluding that any effect of osteoblasts is indirect (Morrison & Scadden 2014) as 
the endosteum is in such close proximity to the vasculature. Other cell types have 
also been implicated, including C-X-C motif chemokine 12 (CXCL12)-abundant 
reticular (CaR) cells, which functionally overlap in part with MSCs and are located 
both perivascularly and endosteally (Sugiyama et al. 2006). However, the extent 
to which stromal cell subsets are distinct has not yet been established (Wang & 
Wagers 2011).  
More recently, the emphasis has been on nestin+ MSCs, a subset of CaR cells, as 
the main HSC support. They are enriched in several important HSC maintenance 
factors, localise to perivascular regions, and are closely associated with the SNS. 
As osteoprogenitors they have features of both the osteoblastic and the 
endothelial niches, replacing the idea of osteoblasts themselves maintaining HSCs, 
and giving a ‘master’ role to the MSC which can coordinate many other cell types 
(Méndez-Ferrer et al. 2010). These cells are themselves maintained as quiescent 
by the niche and establish gradients of secreted cell products to control HSCs 
(Bianco 2011).  
Although OBs may not be direct regulators of HSCs, they do have several unique 
functions. Firstly, they produce the matrix protein osteopontin (OPN) at the 
endosteum, to which HSCs can bind to via β1 integrins, an interaction which 
promotes HSC quiescence (Janeczek et al. 2015). They also produce 
thrombopoietin (TPO), and angiopoietin-1 (Ang-1) which are both important for 
HSC regulation. However, deletion of the adhesion protein N-cadherin has no 
effect on proliferation or differentiation of HSCs, showing that direct cell-cell 
interactions are not necessary for the role of OBs in the niche (Janeczek et al. 
2015). A further complication arises from the fact that identification of cells of 
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the osteoblastic lineage is not straightforward due to a lack of available cell-
surface markers. Furthermore, the endosteal lining of the marrow is made up of 
active osteoblasts and quiescent bone lining cells, the latter outnumbering the 
former. The positions of these cells in the osteoblastic hierarchy remains to be 
distinguished, and they may have different roles in the HSC niche. In fact, the 
main member of the OB lineage in HSC regulation may be an immature skeletal 
stem cell or pre-osteoblast, which have both been shown to produce HSC-relevant 
cytokines and can be found in perivascular locations (Askmyr et al. 2009).  
ECs form the network of vasculature in the trabeculum. Although this is mostly 
comprised of sinusoids (Kunisaki et al. 2013), several other vessel types are also 
present. As well as providing a mechanical barrier for blood cells and platelets, 
ECs release angiocrine signals that participate in HSC development and regulation, 
and contribute to the sinusoidal HSC niche. In particular, HSCs require stem cell 
factor (SCF) expressed by ECs, but not SCF expressed by OBs or nestin+ cells (Ding 
et al. 2012). Regenerated sinusoidal ECs are required for successful engraftment 
of HSCs following myeloablative therapy (Hooper et al. 2009). Furthermore, the 
integrity of blood vessels may have an effect on HSCs: HSCs close to sinusoids have 
higher ROS levels than arteriolar HSCs, and retention is higher at arterioles. 
Homing and endothelial transmigration are exclusive to sinusoids as they are 
highly permeable (Itkin et al. 2016). Hence, differences between ECs may 
contribute to the heterogeneity of HSC niches. 
1.5 HSC homing, lodgement, and engraftment in the bone 
marrow 
There are three processes that occur to establish HSCs in the niche from the 
circulation, either after recovery or during foetal-to-adult niche transition (Figure 
1.6). The first process is termed ‘homing’, where HSCs enter the BM from the 
circulation and migrate through the endothelium of the vasculature. HSCs are 
chemoattracted to the BM through several mechanisms. The most important of 
these is the CXCR4/CXCL12 interaction. Other chemoattractants include SCF/c-
Kit and prostaglandin E2, whilst CD48 also plays an important role (Heazlewood et 
al. 2014)). The migration of HSCs through the vasculature is similar to that of 
lymphocytes: weak initial adhesion and rolling is mediated by endothelial selectins 
binding to oligosaccharides on the migrating cell. Lymphocyte function-associated 
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antigen 1 (LFA-1) activation in the mobile cell then initiates stronger binding and 
allows the cell to migrate through the endothelium (Papayannopoulou 2003).  
 
Figure 1.6 HSC homing to and migration from the BM niche.  
Multiple signalling molecules are involved in homing, lodgement, and engraftment. Taken 
from Wilson & Trumpp 2006. Permission to reproduce this figure has been granted by 
Springer Nature. 
The second process, lodgement, occurs in the BM and involves the migration of 
HSCs to specific niches within the BM. The membrane bound form of SCF and 
hyaluronic acid (HA) are critical in HSC lodgement. OPN, localised to the endosteal 
surface, is also important for HSC retention in the niche (Heazlewood et al. 2014).  
Finally, engraftment is the ability of the migrated HSCs to respond to the signals 
within the niche to encourage retention (Heazlewood et al. 2014). Megakaryocytes 
release cytokines including insulin-like growth factor 1 (IGF-1), which enhance 
HSC proliferation post-transplant. These cells are important for engraftment in 
the endosteal region (Heazlewood et al. 2013). Cells which are in gap 1 (G1) or G0 
stages of the cell cycle are also better at engrafting than dividing cells (Fleming 
et al. 1993).  
Conversely, HSC mobilisation from the niche is initiated by reduction in adhesion 
and desensitisation to cytokine signalling. Elastase and cathepsin G cleave CXCR4, 
CXCL12, VCAM-1, and very late antigen-4 (VLA-4). Matrix metalloproteases (MMPs) 
cleave c-Kit and degrade OPN. The action of osteoclasts also degrades OPN and 
encourages HSC egress from the BM (Janeczek et al. 2015). Collectively, the action 
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of these enzymes decreases HSC affinity for the niche, provoking migration into 
the blood. Granulocyte colony stimulating factor (G-CSF) and granulocyte 
macrophage colony stimulating factor (GM-CSF) are cytokines that negatively 
regulate the CXCR4/CXCL12 axis and are clinically exploited to mobilise HSCs to 
the blood for transplant (Suárez-Álvarez et al. 2012).  
1.6 Molecular interactions within the HSC niche 
There are many interactions that occur in the niche between HSCs and the 
supporting cells (Figure 1.7). These exchanges act in two ways, which are not 
mutually exclusive. Some facilitate direct attachment, retaining the HSCs in a 
supportive environment. Secondly, they initiate further downstream pathways to 
influence cell behaviour and fate. Changes in these signals can influence HSCs, for 
example causing them to move into the bloodstream or to differentiate. The 
molecules involved can be split into two categories: membrane bound receptors 
(direct adhesion) and cytokines (interaction via secreted factors). The key 
interactions are summarised in Table 1.2.  
 
Figure 1.7 Schematic of the key established interactions between BM niche cells and HSCs. 
Red arrows indicate direct interactions between membrane-bound molecules; black arrows 
indicate interactions via secretion of soluble factors. OBs, osteoblasts; ECs, endothelial 
cells.  
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1.6.1 Membrane bound receptors 
Several classes of membrane bound receptors play a role in HSC homing and 
adhesion in the niche. These include integrins, cadherins, and selectins. They 
recognise counterpart ligands on the opposing cell type and are intimately 
connected to cytoskeleton components (usually actin) via linkage proteins. They 
can also feed in to other signalling pathways through these linkers.  
Integrins are predominantly involved in cell adhesion to the ECM, although they 
are involved in cell-cell adhesion. They are linked to the cell cytoskeleton via 
actin filaments, and initiate intracellular signalling when bound, thus acting as an 
environmental sensing mechanism. Integrins are composed of two transmembrane 
glycoprotein subunits; α and β. In humans, there are 8 varieties of β subunit, and 
18 types of α subunit, reflecting the diversity of integrin heterodimers (Brizzi et 
al. 2012). They also have functional overlap, with several varieties able to bind to 
the same ECM components. The ligands for β2 subunits are immunoglobulin (Ig) 
superfamily counter-receptors, and so are involved in cell-cell binding. They are 
exclusively expressed on haematopoietic cells and include HSC integrin LFA-1, 
which binds to Ig superfamily molecule intercellular adhesion molecule 1 (ICAM-
1) on MSCs (Simmons et al. 1992; Teixido et al. 1992). Alternatively, VLA-4 is a β1 
integrin, which binds to VCAM-1. Blocking β1 using an antibody has been found to 
reduce adhesion of haematopoietic progenitor cells (HPSCs) to a feeder layer of 
MSCs (Jing et al. 2010). Higher expression of fibronectin, cadherin-11, VCAM-1, 
and integrins is associated with greater adhesion (Wagner, Wein, et al. 2007). 
Whether cadherins are involved in HSC adhesion to the niche is controversial. 
Cadherins operate through homophilic adhesion. Some groups have asserted that 
HSCs and niche cells do not express N-cadherin (Kiel et al. 2007; Kiel et al. 2009), 
and deletion studies did not have any effect on cell number and function. 
However, other studies have observed expression of N-cadherin and cadherin-11, 
and found them to mediate HSC-MSC interaction, with a vital role in adhesion to 
the niche (Wein et al. 2010; Hosokawa et al. 2010). This discrepancy may be due 
in part to differences in experimental techniques. It is likely that N-cadherin is 
expressed only at very low levels in a small subset of HSCs, and that its function 
is not essential for HSC maintenance. There may however be redundancy with 
other cadherins (Li & Zon 2010).  
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E-selectin is expressed by the vascular endothelium. The absence of E-selectin 
slows the cycling of HSCs, supporting the hypothesis that sinusoidal HSCs are more 
active than endosteal HSCs (Moore 2012; Winkler et al. 2012). Conversely, the OPN 
negatively regulates HSC proliferation. OPN expression is restricted to the 
endosteum, further supporting the zoned niche model (Nilsson et al. 2005).  
1.6.2 Cytokines 
Cytokines are small proteins that are active in cell signalling, and are produced 
by a broad range of cells. Recognition of cytokines by receptors on the surface of 
cells triggers intracellular signalling cascades, which then induce changes in cell 
behaviour. Cytokines have fundamental roles in immune responses and in 
development, as well as inter-cell communication in the BM niche. Several 
cytokine interactions are important for attracting and retaining HSCs into the 
niche, as explained in section 1.5. These interactions have a combinatorial role: 
both in increasing HSC adherence to cells and ECM, and activating downstream 
pathways that promote quiescence, an immature phenotype, and self-renewal. 
Gradients of these factors can facilitate attraction of HSCs to the niche. 
As described earlier, the CXCR4/CXCL12 axis is vital to HSC communication within 
the BM. The receptor CXCR4 is expressed by HSCs, which recognises the ligand 
CXCL12 that is secreted by CAR cells in the niche. Deletion of the receptor results 
in severe reduction of the HSC population (Sugiyama et al. 2006) and blocking the 
CXCR4 receptor by drugs or antibodies has been shown to mobilise HSCs from the 
niche: a fact that is exploited to harvest HSCs from donors for transplant (Petit et 
al. 2002).  
The c-Kit ligand is expressed by HSCs at all stages of development. The ligand, 
SCF, is expressed in both soluble and membrane bound forms by perivascular niche 
cells, with the membrane bound form facilitating attachment directly, and 
activating c-Kit for a prolonged period. The interaction may also contribute to 
upregulation of the β1 integrins VLA-4 and VLA-5, increasing affinity for 
fibronectin and thus adhesion to the niche (Ashman 1999).  
Angiopoietin-1 (Ang-1)/Tie-2 tyrosine kinase receptor signalling also upregulates 
β1 integrins on HSCs. Activation of the Tie-2 receptor on HSCs via the binding of 
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Ang-1 feeds into the phosphoinositide 3-kinase (PI3K)-AKT signalling cascade. 
Downstream effects of this pathway include cell cycle regulation, leading to 
quiescence and preventing apoptosis. Ang-1 exposure maintains an immature HSC 
phenotype by retaining the expression of c-Kit and Tie-2 cell surface markers, 
which are characteristic of the immature state (Arai et al. 2004). 
Quiescent HSCs express myeloproliferative leukemia protein (MPL), the receptor 
for thrombopoietin (TPO), which is secreted by osteoblastic cells. MPL expression 
in HSCs is closely correlated with cell cycle status, and TPO application affects 
levels of c-Myc, cyclin dependent kinase inhibitors p57, p21, and p27, and Tie2. 
In turn, three major signalling pathways are activated after MPL activation: 
p42/44 MAPK, PI3K-Akt, and Janus kinase (JAK)-signal transducer and activator of 
transcription (STAT) 3 and STAT5 (Yoshihara et al. 2007).  
Interaction 
type 
HSC 
molecule 
Niche 
molecule 
Description Effects Reference 
Membrane 
bound 
 
VLA-4 
 
LFA-1 
VCAM-1 
 
ICAM-1 
Integrin-Ig 
superfamily 
interactions.  
Physically anchors 
HSCs to the niche. 
Wagner et al. 
2007; Simmons et 
al. 1992; Teixido et 
al. 1992 
N-
cadherin 
N-
cadherin 
Homotypic 
adhesion. 
Physically anchors 
HSCs to the niche 
(under 
controversy). 
Li & Zon 2010b 
Not yet 
identified 
E-
selectin 
E-selectin is 
expressed on 
vascular 
endothelium. 
Enhances HSC 
cycling. 
Winkler et al. 
2012, Moore 2012 
CD44, 
multiple 
integrins 
OPN OPN is expressed 
at the endosteum. 
Negatively 
regulates HSC 
proliferation. 
Nilsson et al. 2005 
HA CD44 HSCs synthesise a 
membrane bound 
form of HA. 
Inhibits HSC 
proliferation and 
differentiation.  
Nilsson et al. 2003 
Cytokine 
 
CXCR4 CXCL12 
(SDF1) 
CXCL12 is secreted 
by the niche cell 
and recognised by 
the CXCR4 
receptor on HSCs.  
Direct adhesion. 
Upregulation of 
VCAM-1. Inhibition 
of HSC cycling. 
Sugiyama et al. 
2006; Suárez-
Álvarez et al. 2012 
c-Kit SCF SCF is expressed in 
both soluble and 
membrane bound 
forms.  
Membrane bound 
SCF: direct 
attachment. VLA-4 
and VLA-5 
upregulation, 
increasing adhesion 
to fibronectin. 
Ashman 1999 
Tie-2 Ang-1 Niche cells secrete 
Ang-1. Tyrosine 
kinase signalling 
feeds into 
downstream 
pathways.  
Upregulates β1 
integrins. Cell 
cycle regulation 
leads to 
quiescence, 
apoptosis 
Arai et al. 2004 
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prevention, and 
increased self-
renewal. 
Maintenance of 
immature 
phenotype. 
MPL TPO TPO is secreted by 
MSCs.  
Upregulation of β1 
integrins. Feeds 
into cell cycle 
regulation 
affecting levels of 
c-Myc, p57, p21, 
and p27. Affects 
levels of Tie-2 and 
activates other 
signalling 
pathways.  
Yoshihara et al. 
2007 
Table 1.2 Key molecular interactions established between HSCs and supportive niche cells 
within the bone marrow.  
VLA-4, very late antigen 4; LFA-1, lymphocyte function-associated antigen 1; VCAM-1, 
vascular cell adhesion molecule 1; ICAM-1, intercellular adhesion molecule 1; CXCR4, C-X-C 
chemokine receptor type 4; SCF, stem cell factor; OPN; osteopontin, HA, hyaluronan, CXCL-
12, C-X-C motif chemokine 12; MPL, myeloproliferative leukaemia protein; TPO, 
thrombopoietin.  
1.6.3 Signalling pathways in the niche 
Multiple intracellular signalling pathways act in the niche to facilitate cell-cell 
communication and alter cell behaviour. These can be triggered by adhesive 
interactions, or cytokine signals as described in section 1.6. These pathways 
include Hedgehog, Notch, Wnt, and tissue growth factor β (TGF-β) pathways.  
1.6.3.1 Notch signalling 
The Notch signalling pathway (Figure 1.8) acts during cell-cell communication and 
has multiple functions in development. In particular, during bone development it 
is involved in HSC expansion and participates in osteoblastic lineage commitment. 
As both Notch receptors and ligands are transmembrane proteins, direct cell-cell 
contact is required for activation of the pathway. Notch was initially identified as 
being involved in haematopoiesis as aberrations in Notch can lead to leukaemias 
(Gu et al. 2016). It appears to have a role in both lymphoid and myeloid lineages, 
although there is more evidence from malignancies of the former. 
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Figure 1.8 Schematic of the Notch signalling pathway.  
Interaction of a Notch ligand presented by a signal-sending cell with a Notch receptor 
expressed by a signal-receiving cell initiates cleavage of the recptor by an ADAM family 
member to produce a Notch intracellular domain (NICD) This NICD then translocates to the 
nucleus and complexes with proteins such as MAML to activate transcription of downstream 
target genes such as HES and HEY. NICD, Notch intracellular domain; ADAM, a disintegrin 
and metalloproteinase; MAML, Mastermind-like protein; HES, hairy and enhancer of split; 
HEY, hairy/enhancer-of-split related with YRPW motif.  
Notch 1-4 are transmembrane receptors that require direct cell contact for 
activation, whilst JAG1, JAG2, DLL1, and DLL4 are Notch ligands. Ligand 
interaction induces Notch cleavage, and hence release of activated Notch 
intracellular domain (NICD), which translocates into the nucleus. Binding of NICD 
to CBF1 alters its activity from repressor to an activator, by recruiting coactivators 
such as Mastermind-like (MAML). HEY1 and HES1 are downstream genes, which can 
indicate Notch activation, and induce changes in the expression of other genes.  
Notch activation increases HSC self-renewal. The levels of Notch also direct HSC 
fate in binary decisions throughout all stages of differentiation. The proposed 
mechanism for this influence is via interaction of notch with CBP/p300, a complex 
that is necessary for activity of specific transcription factors, some of which are 
involved in lineage specification (Krause 2002).  
Notch signalling has also been implicated as an intermediary in the interaction 
between HSCs and the endosteal niche. Notch signalling has a role in other stem 
cell niches, giving a precedent for its activity in the BM niche. Although there is 
some contradictory evidence, notch signalling does seem to play a part in HSC 
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maintenance by stromal niche cells (Weber & Calvi 2010). Notch ligands are 
expressed by OBs and CD146+, nestin+ MSCs, which express a high level of Jag-1, 
the ligand for the Notch receptor expressed by HSCs (Corselli et al. 2013). Notch 
signalling pathways are important in embryonic haematopoiesis (Bigas et al. 2010), 
and inhibition of notch decreased the yield of HSPCs from co-cultures of MSCs with 
HSCs, implicating an important role in the BM niche. Although many other 
pathways are important to overall niche function, the requirement for direct cell 
interaction for Notch activation may explain the lack of success for replicating the 
effects of a ‘feeder layer’ in HSC culture. The Notch pathway is spontaneously 
activated in feeder layer systems with direct cell contact, but requires application 
of synthetic Notch ligands when support cells are not present in other models.  
The effects of Notch signalling on MSC differentiation, particularly osteogenesis, 
are ambiguous. Removal of Notch from MSCs induces a short term dramatic 
increase in bone (Hilton et al. 2008). Hence, Notch signalling may maintain a pool 
of MSC progenitors by suppressing osteogenesis. This is supported by evidence 
from Dong et al. (2010), showing that Notch is a general repressor of MSC 
differentiation, without lineage bias. Notch signalling from mature OBs may 
induce further self-renewal through feedback signals. Reduced Notch signalling 
increases CXCR4 expression, hence increasing MSC migratory activity towards 
CXCL12 (Xie et al. 2013). 
1.6.3.2 Hedgehog signalling 
Although the most studied role of HH signalling (Figure 1.9) is in embryonic 
development, there is emerging evidence that HH is active in the adult, implicated 
in the regeneration of tissues from adult stem cells, and metastasis. In particular, 
MSCs constitutively express a high level of HH pathway components (Fontaine et 
al. 2008), and reduction in signalling has been associated with differentiation. 
Hedgehog (HH) ligands bind to the Patched (PTCH) receptor, which, when 
unbound, inhibits Smoothened (SMO). Following binding of Sonic hedgehog (SHH) 
or a homologue, inhibition of SMO is terminated. In turn, SMO activates the 
transcription factors GLI1-3. GLI3 is a repressor, whilst the other two are 
activators. Hedgehog signalling is dependent on the presence of primary cilia, an 
organelle where PTCH and SMO reside.  
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Figure 1.9 Schematic of the Hedgehog signalling pathway.  
Binding of the HH ligand triggers degradation of the PTCH receptor, which in turn alleviates 
inhibition of SMO, allowing it to interact with microtubules in the adjacent primary cilium. 
SMO interaction with microtubules causes dissociation of the GL!/SUFU complex, allowing 
translocation of GLI to the nucleus, where it activates transcription of target genes. HH, 
Hedgehog; PTCH, Patched; SMO, Smoothened; SUFU, Suppressor of Fused; GLI, Glioma 
associated oncogene; GSK3β, glycogen synthase kinase 3 β.  
Evidence for HH signalling involvement in haematopoiesis is contradictory. On one 
hand, loss- and gain-of-function studies have identified no role for HH in 
maintenance and self-renewal of HSCs (Gao et al. 2009), whereas previous reports 
had found a role for the pathway in cell cycle regulation (Trowbridge et al. 2006). 
More certain is the evidence that HH signalling is involved in later stages of 
haematopoiesis and development of some haematological malignancies (Gao et 
al. 2009; Bai et al. 2008).  
1.6.3.3 Wnt signalling 
The Wnt pathway is a highly conserved signalling pathway that acts to promote 
HSC self-renewal and prevent differentiation (Figure 1.10, Reya et al. 2003) 
through both canonical and non-canonical pathways. However, the exact target 
genes of the pathway have not yet been identified. There are 19 distinct Wnt 
proteins in the human genome with speculated functional overlap: these are 
glycoproteins that are secreted from cells and bind to the Frizzled family 
receptor. The canonical Wnt pathway induces changes in gene expression. Two 
non-canonical pathways, the planar cell polarity (PCP) and the Wnt-Ca2+ pathway 
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influence the cell cytoskeleton and regulate internal calcium levels, respectively. 
Activation of the receptor by binding of Wnt ligands allows β-catenin to escape 
degradation and form complexes with downstream transcription factors. These 
include TCF1, TCF4, TCF3, and LEF1 (Staal & Luis 2010).  
 
Figure 1.10 Schematic of the Wnt signalling pathway in the HSC niche.  
OBs express non-canonical Wnt ligands that are recognised by the Frizzled receptor 
expressed by haematopoietic cells. This then influences Ca2+ levels within the cell, in turn 
triggering changes in gene expression. The canonical pathway involves -catenin interacting 
with transcription factors that also cause gene expression changes. Taken from Sugimura et 
al. 2012. Permission to reproduce this figure has been granted by Elsevier. 
Overexpression of Wnt signalling components could enhance HSC self-renewal, 
although may alternatively lead to HSC exhaustion (decline in functionality) (Staal 
& Luis 2010). Canonical Wnt signalling has the potential to activate the cell cycle 
to a greater extent (Sugimura et al. 2012). The supply of cell-extrinsic Wnt signals 
to HSCs originates from niche cells, although the relative contributions of different 
stromal cell types is unknown. Non-canonical Wnt ligands are expressed by OBs, 
Chapter 1  45 
 
which can also suppress canonical Wnt signalling (Sugimura et al. 2012). A putative 
role for Wnt signalling in homing to endosteal niche cells has also been identified. 
Perturbation of the pathway may have an influence on development of LSCs and 
vice-versa (Lane et al. 2011). 
1.6.3.4 Transforming growth factor beta signalling 
TGF-β family members are cytokines, the binding of which to its receptor initiates 
a signalling cascade, most commonly the Smad signalling pathway. They regulate 
a broad spectrum of cell behaviours, including proliferation, differentiation, 
survival, migration, and ECM production. (Vaidya & Kale 2015).  
In terms of haematopoietic progenitors, multiple studies have shown that TGF-β 
potently inhibits proliferation of early progenitors. Downstream Smad4 appears to 
be essential for HSC self-renewal, and preserves immaturity by increasing 
expression of CD34. The possible mechanism for preserving stem cell functions is 
via inhibition of lipid raft clustering, which is required for HSCs to augment 
cytokine signalling and re-enter the cell cycle (Yamazaki et al. 2009). TGF-β 
signalling may act in concert with CXCL12 signals via PI3 and Smad pathways, to 
achieve a balance between quiescence and activation caused by each of the 
cytokines respectively in the niche. However, effects on more mature lineage 
progenitors are dependent of differentiation stage and activation states of other 
cytokines (Vaidya & Kale 2015). 
TGF-β molecules are produced by many niche cell types, including OBs and 
macrophages. However, TGF-β exists with its prodomain in the ECM, requiring 
activation by ECM-modulator enzymes such as plasmin, MMPs, and thrombin to 
interact with receptors (Vaidya & Kale 2015). The niche environment may be a 
facilitative site for latent TGFβ activation, and hence HSC quiescence (Yamazaki 
et al. 2009).  
1.7 Additional factors regulating the niche 
In addition to cellular interactions, the physical and chemical characteristics of 
the BM feed into SC regulation. Some of these, including hypoxia, calcium levels, 
and shear force are examined below.  
Chapter 1  46 
 
1.7.1 Hypoxia  
Despite being highly vascularised, the pO2 levels in the BM are lower than in other 
organs. The extravascular environment, the site of haematopoiesis and 
maintenance, is defined as hypoxic (< 1% O2 (Imanirad & Dzierzak 2013)). These 
hypoxic conditions have implications in haematopoiesis as they induce changes in 
proliferation, survival, and metabolism genes via the action of hypoxia-inducible 
factors (HIFs). Characteristics of physiologically hypoxic cells include low reactive 
oxygen species (ROS) levels, lower oxygen consumption and ATP content, high HIF 
levels, low mitochondrial potential, and reliance on glycolysis rather than 
oxidative respiration, all characteristics observed in long term (LT)-HSCs (Imanirad 
& Dzierzak 2013). A recent study showed that HSC hypoxic status is independent 
of location within the marrow: HIF-1α was stably expressed on a cell-specific 
rather than location specific basis, and is even retained in circulating HSCs. Cell-
autonomous factors rather than environmental conditions may determine a 
hypoxic phenotype (Nombela-Arrieta et al. 2013). 
Hypoxic conditions may also facilitate homing and retention in the niche as CXCR4 
expression is regulated by HIF-1α. Similarly, vascular endothelilal growth factor 
(VEGF) expression is hypoxia-inducible, and its expression by HSCs is related to 
engraftment, survival, and colony formation. HIF-1α also has a role in maintaining 
MSC quiescence, prevents RUNX2 expression (inhibiting osteogenesis), and 
enhances expression of niche factors (Morikawa & Takubo 2016). Studies involving 
HSC support cells clearly indicate that hypoxia is a factor in HSC fate. For 
example, silencing of HIF in murine MSCs favours early expansion of co-cultured 
HSCs, followed by increased differentiation (Guarnerio et al. 2014). In OBs, HIF-
1α expression can affect the progression to MPPs and regulate erythropoiesis by 
increased erythropoietin expression, and in ECs upregulate niche factors. 
Furthermore, oxygen concentration affects the maturation of megakaryocytes, 
which occurs faster in higher oxygen environments. Thus, O2 concentration can 
determine the size of the megakaryocyte population and hence the concentration 
of niche factors (Morikawa & Takubo 2016). Hence, hypoxia acts to augment niche 
functionality via both HSCs themselves and influencing niche constituents.  
There is some evidence to suggest that high levels of O2 lead to deregulation of 
the stem cell niche. The putative mechanism for hypoxia enhancing ‘stemness’ is 
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through HIF-1α, which influences expression of quiescence genes. For example, 
CXCL12 is constitutively expressed in the BM but requires activation of HIF-1α for 
expression in other tissues (Suárez-Álvarez et al. 2012). This mechanism could act 
to attract HSCs to sites of vascular injury, which are generally hypoxic. 
Furthermore, there is evidence to suggest that MSCs grown in 3D hydrogels in vitro 
exhibit a hypoxic phenotype, in concordance with an increase in HSC-supportive 
capacity (Sharma et al. 2012). Hence, these systems allow a degree of hypoxia to 
be maintained.  
1.7.2 Calcium 
HSCs deficient in the calcium sensing receptor (CaR) are able to home to the niche 
but exhibit impaired lodgment. This is due to a reduced ability to adhere to 
collagen I (Drüeke 2006). Artificial stimulation of the receptor enhances CXCR4 
signalling and cell migration toward CXCL12. A proposed model suggests that HSCs 
sense Ca2+ ions released during bone remodelling by osteoclasts when they initially 
enter the endosteal niche. Activation of CaR in turn activates CXCR4 and direct 
adhesion to the niche (Lam et al. 2010). Selectins, integrins, and cadherins are all 
dependent on calcium for their adhesive properties, and so calcium concentration 
in the niche may affect adhesion. 
1.7.3 Shear force  
CD44 (which is expressed on HSCs) attachment to hyaluronan (HA) in the ECM has 
an important role in HSC homing and engraftment. This interaction has been 
shown to be stimulated by flow rate (Christophis et al. 2011). The shear stress 
generated by fluid flow can also affect MSC phenotype, inducing osteoblastic or 
endothelial differentiation (Dong et al. 2009; Yourek et al. 2010).  
1.8 Cellular interactions with extracellular matrix within 
the bone marrow  
In the BM, the extracellular matrix (ECM) is secreted by stromal cells and is mainly 
composed of collagen type I, particularly around the trabecular region. 
Fibronectin is also located both perivascularly and endosteally (Nilsson et al. 1998; 
Leisten et al. 2012), and several other proteins such as laminin, heparin, and 
proteoglycans are present, although only 10-15% of total bone protein is non-
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collagenous (Clarke 2008). The ECM provides a surface for secreted cytokines and 
growth factors and cells to adhere to, enabling gradients to be established. Hence, 
the complex 3D architecture of the BM has fundamental importance for control of 
cell behaviour. Any attempt at physiological replication of the BM must 
incorporate this structure.  
1.8.1 HSC-ECM interactions 
The ECM is an important part of the BM niche, although it has been largely 
neglected in the literature due to HSCs being thought of as non-adherent cells. 
Recently, however, numerous studies have emphasised the importance of cell-
ECM interactions in HSC regulation. HSC-ECM interactions occur via HSC integrins; 
VLA-4 and VLA-5 are specific to fibronectin, α6β1 to laminin, and α2β1 to collagen 
(Celebi et al. 2011). Integrins are intimately linked to the cytoskeleton, and so 
attachments can mediate cell growth, differentiation, and self-renewal. For 
example, myosin asymmetry, mediated by adhesion, regulates asymmetric 
division in hematopoiesis (Shin et al. 2014). The ECM has an influence on cell cycle 
progression; the interaction of integrins with fibronectin and collagen in vitro 
imposed a block on S phase in CD34+ cells (Jiang et al. 2000; Oswald et al. 2006). 
ECM properties such as stiffness may therefore be an important consideration for 
influencing HSC quiescence.  
HA is an abundant ECM polysaccharide that is important for HSC homing as it binds 
to the CD44 receptor on HSCs (Lapidot & Petit 2002). Cytoskeletal linker proteins 
connect CD44 to the actin cytoskeleton, feeding into transduction pathways, 
consequences of which include activation of further adhesion molecules. There is 
also some evidence for cross-talk between CD44 and the CXCR4/CXCL12 axis. CD44 
has several additional ligands such as collagen, laminin, and fibronectin as well as 
integrins. CD44 also stimulates osteopontin secretion, which is chemotactic for 
HSCs (Zöller 2011).  
Cultivating HSCs in an artificial ECM has obvious potential for in vitro control. HSCs 
cultivated in a fibrillar collagen I matrix show reduced expansion but greater 
colony forming unit (CFU-C) potential. RNA analysis has identified many genes 
which were upregulated in the 3D environment compared to control, among which 
were a large number of cytokines and growth factors implicated in HSC regulation, 
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as well as genes involved in the cell cycle (Oswald et al. 2006). Growing cells in 
an artificial ECM made up of more than one constituent may give greater growth 
advantages, as the molecules may have a synergistic effect on HSCs through 
formation of heterotertiary structures (Celebi et al. 2011).  
1.8.2 MSC-ECM interactions  
Several recent studies have shown that MSCs are finely tuned to the BM ECM 
microenvironment. Matrix stiffness, surface mobility, and topography are among 
factors which have been shown to influence the differentiation state of MSCs 
(Kilian et al. 2010; Dalby et al. 2007; Engler et al. 2006; McBeath et al. 2004). 
Exploitation of these parameters could enable MSCs to be maintained in a 
multipotent state in which they can support HSCs. For example, Leisten et al. 
(2012) found that using a collagenous matrix supported clonal proliferation to a 
greater extent than standard liquid culture. Culturing MSCs in a 3D environment 
may also induce nestin expression and hence generate the rare subset of MSCs 
that support HSCs (Lewis et al. 2016). MSCs also secrete collagen type I, 
osteopontin, and fibronectin, thus influencing the BM ECM. 
1.9 In vitro models of the bone marrow 
microenvironment 
Recapitulating the BM niche microenvironment ex vivo requires combination of 
the components described above to preserve functionality. The BM has a complex 
architecture, comprising organ structures such as the endosteum, ECM 
components such as collagen, and vascular structures including sinusoids. 
Furthermore, multiple cell types are involved in maintenance of HSCs and control 
of haematopoiesis. MSCs are critical for support, with cells in various areas of the 
niche (OBs at the endosteum, and ECs in the vasculature), fine-tuning the activity 
of progenitors in these areas. Creating a niche model that is able to replicate all 
of these aspects is a challenging task, and requires a move from traditional 2D 
tissue culture methods to 3D environments that are able to mimic physiology.  
1.9.1 3D MSC culture 
There have been many studies into developing 3D culture techniques for MSCs to 
recapitulate the in vivo state. Requiring a combination of biology, materials 
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science, and engineering, these commonly involve a matrix or scaffold to support 
various cell behaviours. These can be either synthetic, such as polycaprolactone 
and polyethylene glycol, or natural, using constituents of the ECM such as 
collagen, gelatin, or hyaluronan. Alternatively, inorganic materials such as 
nanoparticles and graphene have been investigated. MSCs grown in 3D constructs 
generally demonstrate enhanced differentiation capacities and self-renewal, and 
have potential for scalability (Kyu Hong et al. 2015), clear advantages over 
traditional 2D culture.  
More recently, 3D MSC culture techniques have involved creating aggregates of 
cells termed ‘spheroids’. Spheroids facilitate inter-cell interactions, replicate 
gradients of nutrients and oxygen that would be observed in vivo, and can 
generate their own ECM (Cesarz & Tamama 2016). Traditional methods of spheroid 
generation include hanging drops and culture in non-adherent conditions, but with 
the increase in interest, additional techniques are also being investigated, such 
as formation via magnetic levitation. Table 1.3 summarises results from recent 
studies that have used spheroid systems for MSC culture, and how culture affects 
MSC behaviour and phenotype. A study published from the Centre for Cell 
Engineering used magnetically levitated MSC spheroids, which were subsequently 
cultured within a collagen gel. The MSCs became quiescent and maintained 
expression of nestin and STRO-1, indicating a strong MSC phenotype. In addition, 
MSCs were also capable of injury response, migrating towards co-cultured scratch 
assays and differentiating appropriately to regenerate the injured cell type (Lewis 
et al. 2016).  
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Materials/ 
Technique 
Cells  Application Remarks References 
Hanging drop 
 
Rat MSCs Brain injury Comparison of MSCs derived from monolayer and 3D spheroids Guo, Ge, et al. 2014 
hBM-MSCs Apoptosis Model included fibrin hydrogel. Resistance to apoptosis and 
enhanced proangiogenic potential 
Murphy et al. 2014 
 
mBM-MSCs Cytotoxicity and 
differentiation 
studies 
Cells retained differentiation and clonogenic capacity Banerjee & Bhonde 2006 
hUC-MSCs Elucidate 
pluripotent 
mechanisms 
Relaxation of cytoskeletal tension Is associated with pluripotency Zhou et al. 2017 
hBM-MSCs Investigate 
therapeutic 
potential 
Spheroids enhance anti-inflammatory properties Bartosh et al. 2010 
hUC-MSCs Evaluate efficiency 
for transplantation 
Spheroids have enhanced engraftment and vascularization Bhang et al. 2012 
hBM-MSCs Examine cellular 
anti-inflammatory 
effects 
Conditioned medium from spheroids stimulates macrophages to 
become anti-inflammatory 
Ylöstalo et al. 2012  
hUC-MSCs Probe epigenetic 
changes  
Passage 6 MSCs regained clonogenic and differentiation capacity Guo, Zhou, et al. 2014 
Low adherence 
or forced 
aggregation 
MSCs MSC expansion 
(scale up) 
Serum free media optimised Alimperti et al. 2014 
hBM-MSCs Investigate role of 
the cytoskeleton 
3D aggregation alters mitochondrial function, and induces 
functional activation, and cellular stress response 
Tsai et al. 2015 
hMSCs Investigated the 
effects of preserving 
ECM produced by 
spheroids 
Endogenous ECM enhanced proliferation, differentiation and 
survival 
Kim & Ma 2013 
mBM-MSCs Enhance utility of 
MSCs for therapies 
No necrosis, enhanced multilineage potential Baraniak & McDevitt 2012 
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Rabbit 
MSCs 
Characterise 
spheroids 
Micropatterned wells. Superior neovessel formation and wound 
healing 
Rettinger et al. 2014 
Liquid overlay 
Adipose 
tissue MSCs 
Evaluate as a 
vascularisation 
strategy 
Implanted spheroids induced strong angiogenic host response Laschke et al. 2013 
Chitosan 
  
hUC-MSCs Cell-matrix 
interaction 
Calcium signalling inside spheroid Yeh et al. 2014 
hMSCs/ 
endothelial 
progenitors 
Angiogenesis Sphere morphology influenced by cell-substrate interaction (Hsu et al. 2014) 
Adipose 
tissue MSCs 
Maintain stemness Upregulation of pluripotency genes, enhanced differentiation  Cheng et al. 2012 
Microfluidics, 
‘micromasses’ 
hBM-MSCs ‘Developmental 
engineering’ for 
skeletal tissue 
regeneration 
Exposure to morphogens identified chondrogenic concentrations Occhetta et al. 2015 
Micropatterned 
substrates  
 
hMSCs Assess potential for 
tissue engineering 
Greater differentiation capacity: downregulation of self-renewal 
genes  
Wang et al. 2009 
Chambered 
slides 
Synovial 
CD105+ 
MSCs 
Chondrogenesis Chondrocytes were produced by spheroids Arufe et al. 2009 
Magnetic 
levitation, 
collagen I gel 
hBM-MSCs Probe wound healing 
response 
MSCs migrate from spheroid in response to co-culture wounding Lewis et al. 2016 
hBM-MSCs Characterise MSCs in 
magnetically 
levitated spheroids 
MSCs are more quiescent in spheroids Lewis et al. 2017 
Table 1.3 Summary of several studies using 3D spheroid systems to culture MSCs.  
Adapted from Kyu Hong et al. 2015. hBM-MSCs, human BM-MSCs; mBM-MSCs, murine BM-MSCs; hUC-MSCs, human umbilical cord MSCs. 
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1.9.2 MSC and HSC co-cultures 
It is well established that MSCs are required to support a successful HSC population 
in vitro, indeed, such cultures have been considerably more successful than 
attempts using HSC maintenance factors in the media, such as cytokines, for 
support (Table 1.4). HSCs co-cultured with stromal support cells demonstrate 
higher expansion (McNiece et al. 2004; Salati et al. 2013), improved clonogenic 
capacity (Salati et al. 2013; Wagner et al. 2008), and enhanced engraftment 
(Wagner et al. 2008; Perdomo-Arciniegas & Vernot 2011). Other studies have 
shown that stromal cells influence differentiation (Salati et al. 2013; Cheng et al. 
2000; Perucca et al. 2017), that HSCs also have an effect on MSCs (Perucca et al. 
2017), and allowed preliminary studies into niche structure (Jing et al. 2010). The 
importance of the rare subset of nestin+ MSCs, mentioned previously, was 
demonstrated by Corselli et al. (2013): they cultured nestin+ MSCs together with 
HSCs and showed that a larger self-renewing population of the latter was 
maintained without differentiation, compared to culture with unfractionated 
MSCs. This support occurred through cell-cell contacts and through activation of 
the cell membrane bound Notch protein by direct cell contact, leading to 
downstream signalling (Figure 1.11, Corselli et al. 2013).  
 
Figure 1.11 Schematic of HSC-stromal co-culture systems and mechanisms. 
Typical ‘feeder layer’ culture systems provide a stromal cell sheet over which is overlaid 
haematopoietic lineage cells in suspension. Cytokines (such as CXCL12 and SCF) released 
by the stromal cells encourage migration of the suspension cells to the layer, resulting in 
direct interactions via membrane bound proteins such as integrins and Notch receptors.  
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More recently, attempts have been made to move away from traditional 
monolayer cell culture techniques employed in these co-culture studies. MSCs 
within their niche in the bone marrow exist as discrete cell populations in a 3D 
environment; therefore, it is believed that mimicking such culture conditions in 
vitro may enhance MSC properties, and in turn enhance HSC support. Culturing 
MSCs as adherent cells will impair their ability to secrete vital HSC maintenance 
factors, favouring a move towards 3D culture (Isern et al. 2013). However, MSCs 
cultured as 3D cell aggregates (spheroids or ‘mesenspheres’) are known to 
enhance the self-renewal of MSCs, and indeed have been shown to sustain HSC 
self-renewal and expansion without direct cell contact (Isern et al. 2013). 
Bearing this in mind, there have been several co-culture studies utilising 3D 
scaffolds (Leisten et al. 2012; Sharma et al. 2012; Ferreira et al. 2012). These 
models have been shown to preserve HSC quiescence, expression of stem cell 
markers, and HSC functionality. Microchip systems have produced similar results, 
with the added parameter of fluid flow (Torisawa et al. 2014; Wuchter et al. 
2016). Some of these studies are documented in (Table 1.4). In general, these co-
culture systems replicate the physiological ratios of haematopoietic progenitors 
more closely than culture in isolation.  
Despite these successes, the complexity of the bone marrow niche must not be 
underestimated. Nestin+ MSCs may be the ‘keystone of the niche’ (Frenette et al. 
2013), but the BM environment houses multiple cell types that feed into HSC 
regulation, directly and indirectly. Hormonal and neuronal inputs will also play a 
role. Therefore, co-culture with multiple cell types may be necessary to retain 
niche functionality ex vivo. Some recent studies have begun to develop 3D models 
with more than two niche types, such as in Huang et al. (2016), which included 
ECs in an attempt to model the endothelial niche.  
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System Material Cell types  Remarks Reference 
Co-culture of non-
adherent cells with 
feeder layer 
 
None 
 
Adipose and fetal BM 
MSCs, hUC-CD34+ 
Identification of a specific subset of HSC-supportive MSCs.  Corselli 
et al. 
2013 
hBM-MSCs, hUC-CD34+ CD34+ population increased in culture with MSCs.  McNiece 
et al. 
2004 
hUC-CD34+, BM OBs 23-fold expansion of HSPC population and increase in 
clonogenic capacity. OBs favoured mono/macrophage 
lineage at the expense of erythroid. 
Salati et 
al. 2013 
hBM-MSCs, hUC-
CD34+/CD38- 
HSCs with higher self-renewal capacities also exhibited 
higher adherence to MSCs. 
Wagner 
et al. 
2008 
hUC-CD34+, BM 
adherent cells.  
HSCs cultured with MSCs exhibited higher LFA-1 expression, 
enhanced VCAM-1 dependent migration, and improved 
capacity for engraftment. 
Perdomo-
Arciniegas 
& Vernot 
2011 
hBM-MSCs, hBM-CD34+ MSCs induced megakaryocytic differentiation of CD34+ cells, 
and subsequently platelet formation. 
Cheng et 
al. 2003 
Mobilised peripheral 
blood CD34+, hBM-
MSCs 
Distinct microenvironments observed in the model: HSC 
proliferation at the MSC surface, and maintenance of 
quiescent cells beneath the layer. 
Jing et al. 
2010 
hUC-CD34+, hBM-MSCs MSCs prime HSCs for erythroid differentiation. HSCs direct 
the BM niche towards the vascular compartment, enhancing 
hypoxia and angiogenesis related pathways. 
Perucca 
et al. 
2017 
Co-culture within a gel  
 
Puramatrix gel 
 
Human CD34+, marrow 
or placenta MSCs 
3D MSCs fostered a large pool of quiescent MSCs, combined 
with robust multi-lineage haematopoiesis: only a few stem 
cell clones activated to produce daughters to avoid 
exhaustion.  
Sharma et 
al. 2012 
Chapter 1  56 
 
Co-culture in collagen 
scaffold 
Collagen I/III 
gel 
hBM-MSC or hUC-MSC, 
umbilical cord CD34+ 
hUB-MSCs are unsuitable for HSC maintenance long-term. 
Collagen promotes HSC migration and MSCs enhance 
CD34+CD38- phenotype. MSC-derived fibronectin may 
contribute to increased HSC migration compared to cell-free 
collagen.  
Leisten et 
al. 2012 
Bone marrow-on-a-chip PDMS; collagen 
I containing 
demineralised 
bone powder, 
BMP2, and 
BMP4.  
Populated with host 
cells following 
implantation, 
extracted whole 
engineered bone for 
analysis 
Complex niche physiology and architecture reconstituted, 
HSCs present in similar proportions to in vivo. Also 
integrates effects of flow force.  
Torisawa 
et al. 
2014 
Microcavity arrays: 
perfused microchip 
with microwell cavities 
for high-density 3D cell 
culture. 
Collagen I  hBM-MSCs, hUC-CD34+ 3D co-culture compared to 2D: MSCs formed a network with 
integrated HSCs. Higher expression of stem cell markers 
observed.  
Wuchter 
et al. 
2016 
3D co-culture 
comprising matrix and 
bioceramic scaffold 
3D β-
tricalcium 
phosphate, 
Matrigel or 
collagen I/III 
gels.  
hBM-MSCs, hUC-CD34+ CD34+CD38- HSPCs were maintained in β-TCP scaffold 
containing collagen I/III and Matrigel, including 
haematopoietic recruitment, proliferation and 
differentiation, and ECM remodelling.  
Ferreira 
et al. 
2012 
Spheroids, termed 
‘mesenspheres’ 
None  hUC-CD34+, hBM-MSCs Mesenshperes enhanced HSC expansion.  Isern et 
al. 2013 
Bio-derived bone 
scaffolds, multiple cell 
types 
Decellularised 
bone scaffold, 
collagen I and 
fibronectin gel  
hBM-MSCs, HUVECs, 
hUC-CD34+ 
The system supported HSC expansion, and maintained 
quiescence. HUVECs improved osteogenic differentiation of 
MSCs. Both adherent cell types together were more 
effective that co-culture alone.  
Huang et 
al. 2016 
Table 1.4 Summary of co-culture studies to support HSCs ex vivo.  
hBM, human bone marrow; hUC, human umbilical cord 
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1.10 Conclusion  
From reviewing the literature in this chapter, it is evident that (1) there is an 
obvious clinical need for HSC culture ex vivo, (2) in order to do this, a better 
understanding of HSC biology is required to improve the approach in developing 
models, and (3) the optimal model will include all the major components of the 
HSC BM niche. The HSC niche is an incredibly complex environment, which is only 
beginning to be understood. The many varied facets described in this chapter 
including the supportive cells, 3D architecture, and ECM proteins, as well as 
maintenance factors (cytokines etc.) need to be taken into consideration when 
developing a successful in vitro culture HSC model. This project aims to develop 
a functional, supportive HSC niche environment by co-culturing them with MSC 
spheroids (generated via magnetic levitation), with a type I collagen gel. The 
model will then be extended to include ECs and OBs, to mimic the vascular and 
endosteal niche zones, respectively. During the course of this project the 
interactions between the co-cultured cells will be examined and compared to the 
in vivo interactions.  
1.10.1 Hypothesis and objectives 
The hypothesis of this study is that culture within a in vitro bone marrow niche 
model influences cell phenotype and behaviour in such a way as to more 
accurately represent in vivo cell phenotype and behaviour compared to traditional 
tissue culture. To test this hypothesis, the aims of this project are as follows: 
 Optimisation of various cell culture techniques to allow effective co-culture 
of primary HSCs and MSCs, using an existing magnetically levitated MSC 
spheroid model (Lewis et al. 2016). These include cell isolation and cell 
culture medium. Subsequently, optimisation of techniques for isolation of 
cell populations for downstream analysis. This part of the project is 
described in Chapter 3.  
 Characterisation of the MSC spheroid model in terms of its capacity to 
support HSCs and hence mimic the BM microenvironment. These include 
structural characterisation, evaluation of cell viability, and expression of 
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niche-related genes. The findings from this part of the project can be found 
in Chapter 4.  
 Extension of the MSC spheroid model to include additional BM-resident cell 
types that play a role in different areas of the niche: ECs and OBs to 
replicate the vascular and endosteal niches respectively. This is followed 
by analysis of gene expression by the different cell types and flow 
cytometric analysis of HSCs to determine the influence these environments 
have on the cells. This part of the project is detailed in Chapter 5. 
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Chapter 2 Materials and methods 
This chapter describes the materials and methods used to carry out the studies 
detailed in later chapters.  
2.1 Cell Culture  
A variety of cell types were employed throughout the project, including 
mesenchymal stem cells (MSCs), human umbilical vein endothelial cells (HUVECs), 
osteoblasts (OBs), human osteosarcoma MG63 cells (MG63s), immortalized mouse 
myoblasts (C2C12s), immortalised human dermal fibroblasts (hTERTS), 
mononuclear cells isolated from bone marrow (MNCs), and HSPCs defined as 
expressing the cell surface marker CD34. The details of cell sources and culture 
conditions are given in Table 2.1. Adherent cells were passaged when confluent 
using trypsin according to standard methods. All cells were grown in an incubator 
at 37 C, 5% CO2. MSCs were used between passage 1-4, HUVECs between passage 
1-6, OBs between 1-10, and CD34+ cells were used up to a week after isolation.  
Cell type Source 
Basal 
medium 
Supplements 
MSCs Promocell 
DMEM  
10% FBS with 2% antibiotic mixture, 1% 
Non-Essential Amino Acids (NEAA, 
Sigma), and 1% Sodium Pyruvate 
(Sigma). 
 
2% FBS in PBS (recommended medium, 
RM) used for enrichment.  
MG63s 
Sigma-
Aldrich 
hTERTs 
Clontech 
Laboratories 
MNCs 
Primary 
human 
tissue 
C2C12s 
Sigma-
Aldrich 
OBs Promocell 
10% FBS with 2% antibiotic mixture, 1% 
NEAA, and 1% Sodium Pyruvate, or 
osteogenic media (DMEM containing 0.1 
µM dexamethasone and 350 µM 
ascorbate-2-phosphate). 
HUVECs Promocell EBM  
SingleQuotsTM endothelial growth 
supplement (Lonza) 
CD34+ 
HSPCs 
Primary 
human 
tissue 
IMDM  
20% BIT 9500 Serum Substitute 
(StemCell Technologies), 0.02% 
antibiotic mixture, 20 ng ml-1 IL-3, 20 
ng ml-1 IL-6, 20 ng ml-1 G-CSF, 100 ng 
ml-1 Flt3L, and 100 ng ml-1 SCF. All 
Chapter 2  61 
 
growth factors were obtained from 
Peprotech. 
2% FBS in PBS (recommended medium, 
RM) used for enrichment. 
Table 2.1 Cell types, sources, and culture conditions used for experiments.  
MSCs, mesenchymal stem cells; HUVECs, human umbilical vein endothelial cells; OBs, 
osteoblasts; MG63s, human bone osteosarcoma cells; hTERTs, immortalised human dermal 
fibroblasts; MNCs, mononuclear cells; HSPCs, haematopoietic stem and progenitor cells; 
C2C12s, mouse myoblast cell line; DMEM, Dulbecco’s Modified Eagle’s Medium (Sigma); 
IMDM, Isocove’s Modified Dulbecco’s Medium (Sigma); EBM, Endothelial basal medium 
(Lonza); FBS, fetal bovine serum; BIT, bovine serum albumin, insulin, transferrin. 
2.1.1 Isolation of human serum and mononuclear cells from 
clinical samples 
Mononuclear cells (MNCs) were obtained from clinical samples kindly provided by 
Mr Dominic Meek from patients undergoing routine hip replacement surgery. 
Samples were extracted from femoral heads, transferred into transport media (1% 
phosphate buffered saline (PBS), EDTA), resuspended in 10 ml of PBS, and spun 
for 10 min at 445 × g. The supernatant containing human serum was removed and 
frozen for downstream processing. The pellet was resuspended in cell culture 
medium, and spun once more at the same parameters. Supernatant was discarded, 
the pellet was resuspended in 10 ml of DMEM and then layered onto 7.5 ml of 
Ficoll-Paque PLUS (GE Healthcare), which was spun for 45 min at 445 × g. After 
the spin, the mononuclear cell fraction was removed using a Pasteur pipette. This 
was washed twice in cell culture medium for 10 min at 445 × g. The final cell 
pellet containing MNCs was either: resuspended in cell culture media and 
transferred to a flask for culture; resuspended in PBS, 2% FBS, 1 mM EDTA for 
enrichment; or resuspended in freezing buffer for storage at -80 C.  
2.1.2 Enrichment of mononuclear cell fraction for the CD34 
marker 
Desired cell types were extracted from the MNC fraction using the EasySep™ 
system (STEMCELL Technologies, Vancouver, Canada). The HSPC population was 
taken to be defined by the presence of the CD34 cell surface marker.  
Immediately after processing, MNCs (obtained as described in section 2.1.1) were 
resuspended in 1 ml of RM. Enrichment was performed using an EasySep™ Human 
CD34 Positive Selection Kit (STEMCELL Technologies), according to the 
manufacturer’s instructions. Cells were incubated with 100 µl CD34 positive 
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selection cocktail for 10 min at room temperature. Fifty microlitres of magnetic 
nanoparticles were added for a second 10 min incubation. RM was added to a total 
volume of 2.5 ml, and the tube was placed into the EasySep™ magnet without the 
lid. After 5 min, the excess was transferred to a fresh universal. Two and a half 
millilitres of RM were added and this process was repeated a further 3 times. After 
the last incubation, the remaining cells were resuspended in 4 ml IMDM and 
transferred to a new vented culture flask.  
2.1.3 Freezing cells for storage 
MNCs (obtained as described in section 2.1.1) were frozen and stored at -80 °C in 
FBS containing 20% DMEM and 10% DMSO. Post-enrichment, CD34+ cells were 
frozen in PBS containing 1% human serum albumin (HSA) and 10% DMSO.  
2.1.4 Thawing cells from storage  
Cells were revived by rapidly thawing in a 37 °C water bath. They were then 
transferred into 10 ml of warmed culture media, spun for 5 min at 445 × g, and 
transferred to a flask containing warmed medium.  
2.2  Magnetic cell levitation and spheroid formation 
The 3D model used throughout this project was based upon MSC spheroids 
(aggregates of cells) cultured within a type I collagen gel. The following describes 
the method used for spheroid generation and subsequent culture conditions. 
Adherent cells (Promocell MSCs, MG63s, C2C12s, or hTERTs) were seeded into 24 
well plates at a density of 1 x 104 cells ml-1, with 1 ml suspension in each well. 
After 24 hours, either unlabelled, green, or red fluorescently labelled magnetic 
iron oxide (FeO3) 200 nm diameter nanoparticles (Chemicell) were added to the 
adhered cells at a concentration of 0.1 mg ml-1, and subsequently incubated for 
30 min over a magnetic plate to enhance cellular uptake. Samples were then 
washed with HEPES saline three times to remove excess nanoparticles and 
detached via trypsin. The resulting cell suspension was centrifuged (4 min, 445 × 
g), the supernatant was removed and the cells were re-suspended in fresh 
medium. This suspension was then transferred to 6-well plates at a concentration 
of 2.22 x 103 cells ml-1, with 4.5 ml medium per well, with magnets fixed to the 
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culture plate lid to attract the magnetically labelled cells together. Spheroids 
formed after 24 hours.  
2.2.1 Implanting spheroids into collagen type I gel 
After 24 hours, the cell spheroids were transferred from media into a 24 well 
plate, to each of which 1 ml of fresh collagen gel solution was added. 
Approximately 6 ml of collagen gel solution was generated by addition of 2.5 ml 
2.05 mg ml-1 rat tail collagen (FirstLink, Wolverhampton, UK) to 0.5 ml FBS, 0.5 
ml IMDM/DMEM, and 0.5 ml 10x DMEM (FirstLink), adjusted to pH 8.2 with 0.1 M 
NaOH and prepared on ice. The plate was then returned to the incubator to allow 
gelation to occur. A magnet was placed over each well for the first 24 hours of 
culture.  
 
Figure 2.1 Spheroid formation procedure.   
A: MSC loaded with magnetic nanoparticles. Red, actin; blue, nucleus; green, nanoparticles. 
B: MSC spheroid forms after 24 hours of culture in medium underneath a magnet. Red, STRO-
1; blue, nuclei. C: Schematic of spheroid implanted into collagen gel.  
2.3 Viability staining 
Cell viability was determined using an ethidium homodimer/calcein AM (Life 
Technologies) stain. Medium containing 1 µl ml-1 mix of both stains was added to 
live cells. After 1 hour, the cells were washed, the medium was exchanged for 
fresh, warm medium, and the cells were imaged using a fluorescence microscope. 
Cells fluorescing in the TRITC channel were deemed ‘dead’ and those fluorescing 
in the FITC channel were deemed ‘alive’. Images were processed in ImageJ and 
binomial statistical tests were performed on the live/dead cell counts.  
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2.4 Coomassie blue cell morphology staining 
Cultures were initiated, and cells were grown for a set period of time before being 
fixed for 15 min at 37 °C with 4% formaldehyde, 2% sucrose in PBS. Samples were 
then washed twice in PBS. One millilitre of filtered Coomassie blue solution was 
added to each sample, and incubated for 2 min at room temperature. Samples 
were washed twice more in PBS and then imaged on a light microscope.  
2.5 Immunostaining 
Cultures were initiated, and cells were grown for a set period of time before being 
fixed for 15 min at 37 °C with 4% formaldehyde, 2% sucrose in PBS. If appropriate, 
they were incubated in permeabilising buffer (10.3 g sucrose, 0.292 g NaCl, 0.06 
g MgCl2 (hexahydrate), 0.476 g HEPES, 0.5 ml Triton X in 100 ml PBS, pH 7.2) for 
5 min at 4 °C. Samples were blocked in PBS/BSA and stained with primary antibody 
(Table 2.2) diluted with 1% BSA/PBS for 1 hour at 37 °C. After the incubation, they 
were washed three times in PBS/0.5% Tween 20. They were then incubated with 
biotin conjugated secondary antibody (1:200 in 1% BSA/PBS, Vector Laboratories, 
mouse or rabbit) for 1 hour at 37 °C. After 3 washes in PBS/0.5% Tween 20, 
streptavidin-FITC (1:50 in 1% BSA/PBS, Vector Laboratories) was added, and 
incubated for 30 min at 37 °C. The samples were then washed three more times 
in PBS/0.5% Tween 20 and mounted in DAPI. An Axiovert 200 fluorescence 
microscope was used to image the samples.  
Phalloidin was used to stain actin filaments on fixed samples for fluorescence 
microscopy if appropriate. At the primary antibody incubation stage, phalloidin 
diluted 1:500 in 1% PBS/BSA was added.  
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Primary antibody Manufacturer Dilution Secondary antibody 
BrdU GE Healthcare, 
Chicago, IL, USA 
1:100 Mouse 
Nestin Santa Cruz 
Biotechnologies, 
Dallas, TX, USA 
1:100 Mouse 
STRO-1 Santa Cruz 
Biotechnologies 
1:50 Mouse 
CXCL12 Abcam, Cambridge, 
UK 
1:200 Rabbit 
Table 2.2 Antibodies used for immunohistochemistry. 
2.6 BrdU proliferation assay 
BrdU is a synthetic thymine analogue which can be incorporated into the DNA of 
dividing cells in lieu of thymidine as it is being synthesised. This incorporation can 
be visualised using immunostaining. One millimolar BrdU solution in medium was 
added to cells in culture. After a 6-hour incubation cells were washed in 1x PBS, 
fixed in 4% formaldehyde and permeabilised. The immunostaining procedure 
described in section 2.5 was then applied, using a BrdU antibody (1:100 in DNase). 
Image analysis was performed in ImageJ to assess the percentage of cells 
undergoing S-phase, indicated by nuclear co-localisation of BrdU antibody signal 
and DAPI signal.  
2.7 MTT metabolic activity assay 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) is a yellow 
tetrazolium dye which is reduced to insoluble purple formazan by oxidoreductase 
enzymes involved in metabolic processes in cells. An MTT assay is used to evaluate 
the metabolic activity of cells and can be used as a proxy for viability or 
proliferation tests. After a set period of growth, 20 µl of MTT dye solution (5 mg 
ml-1 MTT (Sigma-Aldrich) in PBS, pH 7.4) was added to each well of a 96-well plate 
and incubated for 2.5 hours. After the incubation, formazan crystals were 
solubilised with 200 µl DMSO (dimethyl sulphoxide). The absorbance of each well 
at 550 nm was read on a Dynatech MR7000 microplate reader. A blank sample 
(culture medium with no cells) was used to calibrate the spectrophotometer to 
zero absorbance.  
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2.8 ELISA assays 
Enzyme-linked immunosorbent assays (ELISAs) were performed to measure the 
amounts of particular cytokines secreted by MSCs. A Human CXCL12 Quantikine 
ELISA (R & D Systems, Minneapolis, USA) was performed according to the 
manufacturer’s instructions. Cell culture supernates were collected at the 
specified time points and stored at 4 C until required. One hundred microlitres 
of Assay Diluent RD1-55 were added to each microplate well, followed by 100 µl 
of standard, sample, or control. The microplate was incubated at 4 C overnight. 
Wells were washed four times in 400 µl wash buffer (provided), then 200 µl of 
Human SDF-1 Conjugate was added to each well. After another incubation at 4 
C overnight, washing was repeated as before. Two hundred microlitres of 
Substrate Solution were added and the plate was incubated for 30 min at room 
temperature in the dark. Fifty microlitres of Stop Solution were added to 
terminate the reaction and the absorbance at 450 nm was measured.  
2.9 Electron microscopy 
Samples were prepared for visualisation via Scanning Electron Microscopy (SEM) 
and Transmission Electron Microscopy (TEM) with the assistance of Margaret 
Mullin, the electron microscopy technician. In brief, samples were fixed in 2.5% 
glutaraldehyde in 0.1 M sodium cacodylate buffer (SC) for 1 hour. Cells were 
washed 3 times in 0.1 M SC, then incubated for 1 h in 1% osmium tetroxide. 
Samples were rinsed 3 times in distilled water before a 1 h incubation in 0.5% 
aqueous uranyl acetate in the dark. They were washed a further two times in 
distilled water, then subjected to dehydration through an alcohol series before 
critical point drying.  
SEM samples were then mounted onto stubs, coated in gold and imaged on a 
scanning electron microscope. TEM samples were embedded in resin and sectioned 
prior to imaging on a transmission electron microscope.  
2.10 RNA extraction and isolation 
RNA extractions from cell pellets were performed using a QIAGEN RNeasy mini kit, 
according to the manufacturer’s protocol. All centrifuge runs were at 8000 × g for 
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15 seconds unless otherwise stated. Pellets were either used immediately after 
cell harvest or after storage at -80 C. Three hundred and fifty microlitres of 
buffer RLT were added to each pellet, and the sample was homogenised by 
vigorous pipetting. Three hundred and fifty microlitres of 70% ethanol were added 
to the lysate, and mixed by pipetting. The sample was immediately transferred to 
an Rneasy MinElute spin column in a 2-ml collection tube, and centrifuged. The 
flow-through was discarded from the collection tube. Three hundred and fifty 
microlitres of buffer RW1 were added to the spin column and centrifuged. Eighty 
microlitres of DNase I in buffer RDD were added directly to the spin column 
membrane, and incubated at 20-30 C for 15 min. Three hundred and fifty 
microlitres of buffer RW1 were added, and the column was centrifuged. The 
collection tube was discarded and replaced, 500 µl buffer RPE was added, and the 
column was centrifuged again. Five hundred microlitres of 80% ethanol was added, 
and the column was centrifuged at 8000 × g for 2 min, after which the collection 
tube was discarded. The spin column was placed into a new collection tube and 
centrifuged at 16,000 × g for 5 min to dry the membrane. The flow-through and 
collection tube were discarded. The column was then placed into a 1.5 ml 
collection tube. Fourteen microlitres of RNase-free water were added to the 
centre of the spin column membrane, and the RNA was eluted by centrifuging at 
16,000 × g for 1 min.  
For samples with low cell numbers, RNA extraction was performed using an 
ARCTURUS PicoPure RNA Isolation Kit (Applied Biosystems), according to the 
manufacturer’s protocol. Cells were pelleted by centrifugation at 3,000 × g for 10 
min. The supernatant was discarded and the pellet was resuspended in 1 ml of 
cell suspension medium (0.9 ml PBS/10% BSA; 0.1 ml 0.5 M EDTA). The sample was 
then centrifuged at 3,000 × g for 5 min. One hundred microlitres of  extraction 
buffer were added and the pellet was resuspended with a pipette. The sample 
was incubated at 42 C for 30 min, then centrifuged at 3,000 × g for 2 min. The 
supernatant was transferred to a new microcentrifuge tube. The RNA purification 
column was preconditioned by adding 250 µl conditioning buffer to the column 
filter membrane and incubating for 5 min at room temperature. The column was 
then centrifuged in a collection tube for 1 min at 16,000 × g. One hundred 
microlitres of 70% ethanol was added to the cell extract, and it was mixed by 
pipetting. This mixture was then pipetted into the preconditioned purification 
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column. To bind RNA to the column, it was centrifuged for 2 min at 100 × g, 
immediately followed by centrifugation at 16,000 × g for 30 seconds to remove 
flowthrough. One hundred microlitres of wash buffer was added and the column 
was centrifuged for 1 min at 8,000 × g. One hundred microlitres of wash buffer 2 
was added and the column was centrifuged at 16,000 × g for 2 min. The 
purification column was then transferred to a new 0.5 ml microcentrifuge kit, and 
11 µl elution buffer was pipetted directly onto the membrane. The column was 
incubated for 1 min at room temperature, then centrifuged for 1 min at 1,000 × g 
to distribute the elution buffer in the column, followed by a spin for 1 min at 
16,000 × g to elute the RNA. RNA content was quantified using a NanoDrop 2000 
spectrophotometer (ThermoFisher Scientific, Waltham, MA, USA). The samples 
were either stored at -80 C or used immediately.  
2.11 Reverse transcription 
Reverse transcription was performed using a QuantiTect® Reverse Transcription 
Kit according to the manufacturer’s protocol. Template RNA samples were thawed 
on ice. The kit reagents (gDNA Wipeout Buffer, Quantiscript® Reverse 
Transcriptase, Quantiscript RT Buffer, RT Primer Mix, and RNasefree water) were 
thawed at room temperature (15–25 C). The solutions were gently mixed and 
centrifuged to collect residual liquid from the sides of the tube. All subsequent 
reactions were prepared on ice. RNA content was normalised to 500 ng total in 
the reaction, if possible. If the total quantity in the sample, determined by 
Nanodrop quantification, was insufficient to yield this amount, the total volume 
of the RNA elute was used. The genomic DNA elimination reaction was set up with 
2 µl of gDNA Wipeout Buffer and the appropriate amount of template RNA to yield 
a total amount of 500 ng, made up to 14 µl with RNase-free water. This reaction 
was incubated for 2 min at 42 C, and then placed immediately on ice. The reverse 
transcription reaction was set up with 1 µl Quantiscript Reverse Transcriptase, 4 
µl Quantiscript RT buffer, 1 µl RT primer mix, and 14 µl template RNA from the 
genomic DNA elimination reaction (total reaction volume 20 µl). This mix was 
incubated for 15 min at 42 C, followed by an incubation for 3 min at 95 C to 
inactivate the Quantiscript Reverse Transcriptase. The reverse transcription 
reactions were stored at -20 C.  
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2.12 Fluidigm Real-Time PCR 
2.12.1 Specific target amplification 
Specific target amplification (STA) reactions were performed to increase the 
mRNA of the gene targets. Primers for the genes listed in Table 2.3 were designed 
using the Sigma online primer design tool. One microlitre aliquots of 100 µM 
forward and reverse primer sets were pooled and diluted in DNA suspension buffer 
to create a 500 nM (10x) primer mixture. Pre-mix solutions were made up for each 
cDNA sample: comprising 2.5 µl TaqMan PreAmp Master Mix (Applied Biosystems), 
0.5 µl 500 nM pooled primer mix, and 0.75 µl water. One and a quarter microlitres 
of cDNA sample was added to this mixture, to a final volume of 5 µl, and the 
reaction was vortexed. The samples were then run on a thermocycler under the 
sequence outlined in Table 2.4.  
Gene Forward Reverse 
ENOX2 GAGCTGGAGGGAACCTGATTT CACTGGCACTACCAAACTGCA 
ALCAM TCCAGAACACGATGAGG GTAGACGACACCAGCAACAAGG 
Vimentin CATCAACACCGAGTTCAAG ATCTTATTCTGCTGCTCCA 
CD63 CCCTTGGAATTGCTTTTGTT TATTCCACTCCCCCAGATGA 
CD271 CCTCATTCCCTGTCTATTGCTCC GTTGGCTCCTTGCTTGTTCTGC 
CD34 CGGAGGAGGTAGAAGTAG AGAGTAAGGATATGTTAGGT 
CXCR4 TTACCATGGAGGGGATCAGT GTAGATGGTGGGCAGGAAGA 
RUNX2 AACAAGACCCTGCCCGTGG CATTCAGCAGAGGCATTCCGG 
Osterix TTCTGCGGCAAGAGGTTCACTC GTGTTTGCTCAGGTGGTCGCTT 
BMP2 AGACCTGTATCGCAGGCACT CCACTCGTTTCTGGTAGTTCTTCC 
VLA4 GCATACAGGTGTCCAGCAGAGA AGGACCAAGGTGGTAAGCAGCT 
VCAM1 TTGGCTCACAATTAAGAAGTT GCAGGTATTATTAAGGAGGATG 
LFA1 CTGCTTTTGCCAGCCTCTCTGT GCTCACAGGTATCTGGCTATGG 
ICAM1 TCCTCAGTCAGATACAACAG TCTTGCTCCTTCCTCTTG 
N-cadherin CTGCTTCAGGCGTCTGTAGA GCCTGTCCTTCATGCACATC 
E-selectin CCTGCTACCTACCTGTGA CGAAGCCAGAGGAGAAAT 
B2M TTGTCTTTCAGCAAGGACTGG ATCCGGCATCTTCAAACCTCC 
OPN AGCTGGATGACCAGAGTGCT TGAAATTCATGGCTGTGGAA 
CXCL12 AGCATCTCAAAATTCTCAACA GGTACTCCTGAATCCACTT 
c-Kit GCATTCAAGCACAATGGCAC CCAATCAGCAAAGGAGTGAA 
SCF AGTGATTGTGTGGTTTCTTC ACTGCTACTGCTGTCATT 
Tie2 CCTCTTGTATCTGATGCTGAA CCTGGTGCTGGTTCATTA 
Ang1 AACATGAAGTCGGAGATGG GCTTTCTGGTCTGCTCTG 
MPL ACTCAGCGAGTCCTCTTTGTGG CATAGCGGAGTTCGTACCTCAG 
TPO AGGGATTCAGAGCCAAGATT AGTCCACGAGTTCCATTCAA 
NOTCH1 TCCACTGTGAGAACAACACGC ACTCATTGACATCGTGCTGGC 
NOTCH2 GCAAAGTGTATCGATCACCCGA TGCAGGTGTAGGAATCAATACCATC 
NOTCH3 TACTGGTAGCCACTGTGAGCAG CAGTTATCACCATTGTAGCCAGG 
NOTCH4 TTCCACTGTCCTCCTGCCAGAA TGGCACAGGCTGCCTTGGAATC 
JAG1 TGGGATTCCAGTAATGACACCG GTAGTCATCACAGGTCACGC 
JAG2 CAAAAACCTGATTGGCGGCT CACACACTGGTACCCGTTCA 
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DLL1 GCCTGGATGTGATGAGCAGC ACAGCCTGGATAGCGGATACAC 
DLL3 CACTCAACAACCTAAGGACGCAG GAGCGTAGATGGAAGGAGCAGA 
DLL4 TCGCTCATCATCGAAGCTTGG CAGTTCTGACCCACAGCTAGG 
MAML GCAACAGCAGTTCCTTCAGAGG GTGAACTGTCCAACCTGCTGTG 
UBE CCATGGCTCTGAAGAGAATCC GATAGGGACTGTCATTTGGCC 
HEY1 CCGTGGATCACCTGAAAATGC GGCATCTAGTCCTTCAATGATGC 
HEY2 GAAGATGCTCCAGGCTACAGG CCTTCCACTGAGCTTAGGTACC 
FBXW7 CCTTCTCTGGAGAGAGAAATGC CTGTCTGATGTATGCACTTTTCC 
NUMB CCAAACCAGTGACAGTGGTGGC CCCAAGGGTTGGTTTCACGC 
LFNG GCCACAAGGAGATGACGTT GAGCAGTTTGTGATGACCACG 
MFNG CTGGTACAGTTCTGGTTTGC ATGTGTCCATGAAACGGGAGC 
VEGF AGAAGGAGGAGGGCAGAATCA AGGGTACTCCTGGAAGATGTCC 
TP53 TTCTTGCATTCTGGGACAGCC GGGGGTGTGGAATCAACCC 
MYC GACTCTGAGGAGGAACAAGA TTGGCAGCAGGATAGTCCTT 
TCF3 TGACCTCCTGGACTTCAGC ACCTGAACCTCCGAACTGC 
TCF4 AATCAAAACAGCTCCTCCGATT CCATCTTGCCTCTTGGCCG 
TCF7 TCAACCAGATCCTGGGTCGC CCTTTCCTTGCGGGCCAG 
SMO CTGACCGCTTCCCTGAAGG CGTCCTCGTACCAGCTCTTGG 
SMAD6 CTCCCTACTCTCGGCTGTCT AGAATTCACCCGGAGCAGTG 
SMAD7 CCATCACCTTAGCCGACTCT CCAGGGGCCAGATAATTCGT 
SHH CGAGCGATTTAAGGAACTCACC GCGTTCAACTTGTCCTTACACC 
PTCH1 ACATTTGTGTTACAAATCAGGAGAGC CTGTCCCAGACTGTAATTTCGC 
PTCH2 TGTGGTGGGAGGCTATCTG GCATGGTCACACAGGCATAG 
ATP TCCATCCTGTCAGGGACTATG ATCAAACTGGACGTCCACCAC 
p38 GAGCGTTACCAGAACCTGTCTC AGTAACCGCAGTTCTCTGTAGGT 
NFKB1 AGATGATCCATATTTGGGAAGGC TTGCTCTAATATTTGAAGGTATGGGC 
NFKB2 CTTCTCTGCCTTCCTTAG GATCTCACTGCTGTCAT 
MPO GCATCATCGGTACCCAGTTC GTGGTGATGCCTGTGTTGTC 
MEIS1 AAGCAGTTGGCACAAGACACGG CTGCTCGGTTGGACTGGTCTAT 
LEF1 CACTGACAGTGACCTAATGC CAACGACATTCGCTCTCATT 
HIF1A TACTCATCCATGTGACCATGAGG TAGTTCTTCCTCGGCTAGTTAGG 
HHIP GCCATTCAGTAATGGTCCTTTGG CCACTGCTTTGTCACAGGAC 
GSK3B CGACTAACACCACTGGAAGCT GGATGGTAGCCAGAGGTGGAT 
GLI1 AGCCAAGCACCAGAATCGG TCTTGACATGTTTTCGCAGCG 
GLI3 CTCCTATGGTCACTTATCTGCAAGT TGAACCTAAGCTCTGTTGTCGG 
GATA1 TATTCCTCTCCCAAGCTTCG CATCTTGTGATAGAGGCCGCA 
GATA2 GCGCAGCAAGGCTCGTT AGCATTGCACAGGTAGTGGC 
GATA3 CGAACTGTCAGACCACCACA GGTTTCTGGTCTGGATGCCTT 
FOS AGGAGAATCCGAAGGGAAAGG TAGTTGGTCTGTCTCCGCTTG 
E2F1 GGACCTGGAAACTGACCATCAG CAGTGAGGTCTCATAGCGTGAC 
E2F2 CTCTCTGAGCTTCAAGCACCTG CTTGACGGCAATCACTGTCTGC 
E2F3 AGCGGTCATCAGTACCTCTCAG TGGTGAGCAGACCAAGAGACGT 
CYCLIN E1 GTCCTGGCTGAATGTATACATGC CCCTATTTTGTTCAGACAACATGGC 
CDKn1A GTGGACCTGGAGACTCTCAG CCTCTTGGAGAAGATCAGCCG 
CD79 GAACGAGAAGCTCGGGTTG TGCCCACATCCTGGTAGGT 
RNF GGTGTCTCTTCAACGGAGGAA TAGTGAGGCATCATCAGTGGC 
BMP10 ACCCACCAGAGTACATGTTGG GCCCATTAAAACTGACCGGC 
BMI1 GCATCGAACAACGAGAATCA GCTGGTCTCCAGGTAACGAA 
AKT1 TGGACTACCTGCACTCGGAGAA GTGCCGCAAAAGGTCTTCATGG 
AKT2 CCAACACCTTTGTCATACGCTGC GCTTCAGACTGTTGGCGACCAT 
ADAM17 CTTCTACAGATACATGGGCAGAG CTCTATCTGTATTCCATAGCCTTTAA 
ADAM10 ATGGCAAAGATGATAAAGAATTATGCC AATCGTTGCAAGGGGATCC 
SUFU CTCCAGGTTACCGCTATCGTCA TGCTCAGGGATGTTGGCAGAAG 
STAT3 CCTAGATCGGCTAGAAAACTGG GGGTCCCCTTTGTAGGAAAC 
RUNX1 CACCTACCACAGAGCCATCAA CTCGGAAAAGGACAAGCTCC 
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SPI1 GTGCCCTATGACACGGATCT AAGCTCTCGAACTCGCTGTG 
MCM4 TGACCGTTACCCTGACTCAA GGGAATCAGCTGGGATGTCC 
CYCLIND1 CAGAAGGAGATTGTGCCATCC GAAGCGGTCCAGGTAGTTCA 
CYCLIND2 CCACCGACTTTAAGTTTGCC CACGTCTGTGTTGGTGATCT 
CD44 GGCAAGAAACCTGGGATTGG GCCTGCTGAGATGGTATTTGA 
HES1 GGAGAAAAATTCCTCGTCCC CGCGAGCTATCTTTCTTCAG 
PML CCGTCATAGGAAGTGAGGTCTTC GTTTTCGGCATCTGAGTCTTCCG 
Nestin GCAGCGTTGGAACAGAGGT GCGATCTGGCTCTGTAGGC 
BMP7 CAGGCCTGTAAGAAGCACGA TGGTTGGTGGCGTTCATGTA 
CYC1 ACTGCGGGAAGGTCTCTACTT GGGTGCCATCGTCAAACTCTA 
Table 2.3 Primers used in Fluidigm analysis.  
Shaded cells indicate genes used as housekeeping controls for normalisation. 
Condition Hold 10-14 cycles Hold  
Temperature 95 ºC 95 ºC 60 ºC 4 ºC 
Time 10 min 15 sec 4 min ∞ 
 
Table 2.4 Thermal cycler protocol for pre-amplification of cDNA samples. 
2.12.2 Exonuclease treatment 
Exonuclease treatment was used to remove unincorporated primers. Exonuclease 
I was diluted to 4 U µl-1 to a volume of 2 µl per reaction (1.4 µl water, 0.2 µl 
Exonuclease I reaction buffer, 0.4 µl Exonuclease I at 20 U µl-1). This 2 µl was 
added to the STA reactions, which were then vortexed, centrifuged, and run in a 
thermal cycler as described in Table 2.5.  
Condition Digest Inactivate Hold 
Temperature 37 ºC 80 ºC 4 ºC 
Time 30 min 15 min ∞ 
 
Table 2.5 Thermal cycler protocol for exonuclease treatment of cDNA samples. 
The products were then diluted 5-fold in TE buffer (TEKnova, PN T0224), and 
stored at -20 ºC or used immediately for on-chip PCR. 
2.12.3 Sample pre-mix preparation 
Two times (2X) SsoFast EvaGreen Supermix with low ORX (Bio-Rad, PN 172-5211) 
was mixed with 20X DNA Binding Dye Sample Loading Reagent (Fluidigm, PN 100-
3738) in an 11:1 ratio. Two point seven five microlitres of this ‘pre-mix’ was added 
to 2.25 µl of the STA and exonuclease treated cDNA sample. This final mixture 
was vortexed for 20 seconds and centrifuged for 30 seconds. All reactions were 
kept on ice.  
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2.12.4 Assay mix preparation 
One hundred micromolar stocks of forward and reverse primers for each assay 
were diluted to a final concentration of 5 µM (2.5 µl 2X Assay Loading Reagent, 
2.25 µl 1X DNA Suspension Buffer, and 0.25 µl 100 µM mixed forward and reverse 
primers). The mixture was vortexed for 20 sec and centrifuged for 30 sec.  
2.12.5 Chip priming and loading 
The 96.96 Dynamic Array IFC was primed with control line fluid, which was 
injected into each accumulator on the chip. The chip was placed into the IFC 
controller MX, and the Prime (136x) script was run. Five microlitres of each assay 
and each sample were pipetted into each respective inlet in the chip. The chip 
was inserted into the IFC Controller and the Load Mix (136x) script was run to load 
the samples and assays into the chip. The chip was then run in the BioMark HD 
system using the protocol described in Table 2.6.  
Segment Type 
Temperature 
(ºC) 
Duration 
(sec) 
BioMark HD Ramp 
Rate (ºC/s) 
1 Thermal Mix 
70 2400 5.5 
60 30 5.5 
2 Hot Start 95 60 5.5 
3 
PCR (30 
cycles) 
96 5 5.5 
60 20 5.5 
4 Melting Curve 
60 3 1 
60-95 1 1 
Table 2.6 Cycling parameters for the 96.96 Dynamic Array IFC.  
Results from the chip analysis were analysed using the 2-ΔΔCT method (Schmittgen 
& Livak 2008).  
2.13 Flow cytometry 
Cells for flow cytometric analysis were harvested from culture models using 
collagenase and/or trypsin, and centrifuged at 400 × g for 10 min. They were 
resuspended in 800 µl 1% FBS in PBS containing 1 mM EDTA (FACS buffer). They 
were washed once more using the same parameters. If required, they were then 
stained with appropriate antibodies (100 µl, 10 µl ml-1) for 30 min at 4 ºC and 
protected from light. They were then centrifugally washed twice more and 
resuspended in 200 µl FACS buffer. They were then run on a BD FACSCantoII 
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analyser, or a BD FACSAria cell sorter. An unstained control sample was used to 
set the voltage for each channel, and an isotype control sample (with cells) was 
also included. Details of antibodies used are presented in Table 2.7.  
Manufacturer Marker Fluorochrome Organism and isotype 
BD Biosciences CD7 BV421 Mouse IgG1 
BD Biosciences CD41a FITC Mouse IgG1 
BD Biosciences CD36 APC Mouse IgM 
BD Biosciences CD14 PE Mouse IgG2b 
BD Biosciences CD45 APC-Cy7 Mouse IgG1 
BioLegend CD44 PE-Cy7 Rat IgG2b 
BD Biosciences CD45 BV421 Mouse IgG1 
BD Biosciences CD34 APC Mouse IgG1 
eBioscience CD13 PE Mouse IgG1 
BD Biosciences CD10 PE-Cy7 Mouse IgG1 
BD Biosciences CD38 V450 Mouse 
BD Biosciences Lineage FITC Mouse 
BD Biosciences CD123 APC Mouse 
BD Biosciences CD135 PE Mouse 
BD Biosciences CD45RA APC-H7 Mouse 
BD Biosciences CD90 PE-Cy7 Mouse 
BD Biosciences CD34 PerCP Mouse 
R&D Biosystems Osteopontin APC Mouse 
Miltenyi  CD31 APC Mouse IgG1 
BD Biosciences 
Mouse IgG1, κ 
Isotype control  
V450 - 
BD Biosciences 
Mouse IgG1, κ 
Isotype control  
PE-Cy7 - 
BD Biosciences 
Mouse IgG2b, κ 
(specific for 
dansyl) Isotype 
control  
APC - 
BD Biosciences 
Mouse IgG2a, κ 
(specific for TNP) 
Isotype control  
APC-H7 - 
BD Biosciences 
Mouse IgG1, κ 
Isotype control  
PE - 
BD Biosciences 
Mouse IgG1, κ 
Isotype control  
PerCP - 
Table 2.7 Antibodies used for flow cytometry.  
2.13.1 Compensation 
To correct for any spectral overlap, a process of fluorescence compensation was 
performed using UltraComp eBeads™ compensation beads (ThermoFisher 
Scientific). For each antibody used, 1 drop of beads in 100 µl FACS buffer was 
stained with 1 µl antibody for 10 min, 4 ºC. The beads were then washed by 
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centrifuging at 600 × g for 5 min and resuspended in 200 µl FACS buffer. Each 
sample was run on the cytometer under the compensation set up, and the spectral 
overlap settings were set automatically.  
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2.13.2 Phenotyping panels 
For phenotyping experiments described in Chapter 3 and Chapter 5, the antibody 
panels listed in Table 2.8 were used.  
Panel 1 Panel 2 Panel 3 
Marker Label Marker Label Marker Label 
CD38 V450 CD7 BV421 CD45 BV421 
Lin FITC CD41a FITC CD41a FITC 
CD123 APC CD36 APC CD34 APC 
CD135 PE CD14 PE CD13 PE 
CD45RA APC-H7 CD45 APC-Cy7 free APC-H7 
CD90 PE –Cy7 CD44 PE-Cy7 CD10 PE-Cy7 
CD34 PerCP free PerCP free PerCP 
Table 2.8 Antibody panels used for phenotyping experiments. 
2.13.3 Gating strategies 
For each panel of antibodies listed in Table 2.8, specific gating strategies were 
used in the analysis of the data. These strategies are described below.  
For all panels, firstly the viable cell population was identified using a forward 
scatter area (FSC-A) versus side scatter area (SSC-A) scatter diagram (Figure 2.2A). 
From within this population, doublets were excluded using an FSC-A versus FSC-H 
(height) scatter diagram (Figure 2.2B).  
For panel 1, viable, single cell CD34+CD38+ and CD34+CD38- populations were 
then identified (Figure 2.2C). Within these subsets, progenitors as listed in Table 
2.9 were identified using the remaining four markers (Figure 2.2D&E). A 
hierarchical overview of this process is show in (Figure 2.2F). The process for 
identifying subsets of progenitors using antibody panel 1 is depicted in Figure 2.2. 
Phenotypes of the progenitors investigated are listed in Table 2.9. 
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Figure 2.2 Gating strategy used for analysis of data obtained using antibody panel 1. 
Sample data is from the isotype control. A, Forward scatter vs. side scatter plot used to 
identify viable cells; B, Forward scatter (area) vs. forward scatter (height) plot used to identify 
the population of single cells; C, CD34 vs. CD38 scatter plot; D, CD45RA vs. CD90 scatter 
plot; E, CD123 vs. CD135 scatter plot; F, diagram of gating strategy used to identify progenitor 
subsets using combinations of markers.  
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Progenitor/Marker CD34 CD38 CD45RA CD90 CD135 CD123 
HSC + - - + - - 
MPP + - - - - - 
CMP + + - - + + 
MEP + + - - - - 
GMP + + + - + + 
MLP + - + -   
CLP + -/low + +   
Table 2.9 Phenotype profiles for haematopoietic progenitor subsets. 
HSC, haematopoietic stem cell; MPP, multipotent progenitor; CMP, common myeloid 
progenitor; MEP, megakaryocyte-erythroid progenitor; GMP, granulocyte-monocyte 
progenitor; MLP, multi-lymphoid progenitor; CLP, common lymphoid progenitor.  
For cell samples stained with antibody panels 2 and 3, subsets were identified 
from within the single cell fraction individually for each marker. Gates were drawn 
simply to identify positive and negative cells for each antibody (Figure 2.3 & Figure 
2.4), which were then quantified in terms of percentage of single cells.  
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Figure 2.3 Gating strategy used for analysis of data obtained using antibody panel 2.  
Sample data is taken from the isotype control. A, Forward scatter vs. side scatter plot used 
to identify viable cells; B, Forward scatter (area) vs. forward scatter (height) plot used to 
identify the population of single cells; C-H, gates used for identification of cells positive or 
negative for CD45, CD7, CD14, CD36, CD41a, and CD44, respectively.  
A B
C D E
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Figure 2.4 Gating strategy used for analysis of data obtained using antibody panel 3. 
Sample data is taken from the isotype control. A, Forward scatter vs. side scatter plot used 
to identify viable cells; B, Forward scatter (area) vs. forward scatter (height) plot used to 
identify the population of single cells; C-G, gates used for identification of cells positive or 
negative for CD45, CD41a, CD10, CD13, and CD34, respectively.  
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2.14 Conclusion  
The procedures described above were used to carry out many of the experiments 
and analyses elaborated on in the following chapters. More detailed information 
about materials and methods relevant to each chapter are provided if appropriate. 
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Chapter 3 Model development and optimisation 
3.1 Introduction 
As previously described, both MSCs and HSCs have great importance in paving the 
way for regenerative medicine. Both cell types are well studied, and HSCs in 
particular have been used as a cell therapy for decades (Gratwohl et al. 2015; 
WBMT 2013). MSC therapies are also beginning to obtain regulatory approval and 
enter the clinic (Wei et al. 2013). However, culturing them in combination 
requires the consideration of optimal conditions for each cell type.  
MSCs are traditionally cultured as adherent, in medium containing some sort of 
serum supplement. Common basal media are DMEM, DMEM F-12, or α-MEM 
supplemented with 10% FBS. Batch variability is often circumvented by using 
commercial serum supplements, autologous serum, platelet-rich plasma, or serum 
free media using growth factor supplementation (Bara et al. 2014). However, 
there is extensive variation between disciplines and even lab groups on the 
formulation and supplements used. These may also differ depending on the 
intended application of the cells. For example, fibroblast growth factor and 
lithium both promote MSC proliferation, and inclusion of synthetic glucocorticoid 
dexamethasone induces osteogenic differentiation (Both et al. 2007). 
Furthermore, initial seeding density has an influence on MSC behaviour: at lower 
seeding densities proliferation is rapid, and slows when the cells reach confluence. 
Passaging the cells, the process by which cells are removed from the surface of 
the culture vessel (usually enzymatically) and seeded into a new vessel at a lower 
density to allow further expansion, also influences multipotency. Higher passage 
cells can be characterised by lower expression of typical MSC cell surface markers 
(Both et al. 2007). Nevertheless, maintaining a true naive MSC phenotype may be 
impossible, as gene expression changes occur immediately after isolation and 
accumulate throughout prolonged culture (Bara et al. 2014). 
Similarly, there is no standard culture method for HSCs/HSPCs2, and the selected 
medium may be specific for a particular function or for a particular subset of 
                                         
2 HSPCs, identified by the presence of the CD34 cell surface marker, are used throughout this 
project as a proxy for the true HSC population. HSPC is generally used when describing 
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progenitors. Commonly used basal media are RPMI, α-MEM, and IMDM, which can 
be supplemented with either serum or cytokines. Culture of HSPCs is proceeding 
towards serum-free systems to remove the presence of xenogenic compounds that 
are not appropriate for clinical use, meaning that the media must be 
supplemented with cytokines. However, this does increase the expense of the 
system, especially for scale-up (Zainal Ariffin et al. 2016). Cytokines that promote 
modest HSPC maintenance and proliferation have been identified using functional 
genomics and proteomics to identify compounds in HSPC supportive cells that are 
absent in non-supportive cells (Verfaillie 2002). They usually include a 
combination of EPO, IL-6, Il-3, Flt3L, G-CSF, SCF, GM-CSF, and TPO in various 
concentrations (Choi et al. 2010; Andrade et al. 2010). However, these cytokines 
in isolation do not allow cell division without loss of repopulation ability, as the 
effect of cytokines is modulated by the ECM. Furthermore, direct cell contact 
through integrins and Notch signalling may be required for synergistic effects of 
cytokines (Tisdale et al. 1998).  
Therefore, MSC and HSPC co-culture in a collagen gel may be able to circumvent 
the issues encountered with exogenous cytokine application, promoting HSPC 
proliferation without a loss of repopulation capacity. As described in Chapter 1, 
several such systems are already in existence. These comprise both simple feeder 
layer systems and more complex systems that incorporate extracellular matrix 
and/or organoid structures. This project aims to extend an existing MSC spheroid 
model (Lewis et al. 2016) to include HSPCs. However, addition of HSPCs into the 
model requires optimisation of certain aspects of the system. For example, the 
different cell types require provision of different exogenous substances in the 
media for culture. Furthermore, analysis of cell populations within the model 
requires development of a multiple-stage protocol for separation.  
  
                                         
procedures and results of this study. However, HSC and CD34+ may be used interchangeably 
when these terms are more appropriate for the context.  
Chapter 3  84 
 
3.1.1 Objectives  
This chapter aims to extend an existing magnetically-levitated MSC spheroid 3D 
model developed in the Centre for Cell Engineering (Lewis et al. 2016; Lewis et 
al. 2017) to include HSPCs, and to develop methods to analyse cell behaviour 
within the model. This will be achieved by addressing the following issues in turn. 
1. Cell culture optimisation: optimisation of cell culture techniques such as 
freezing and thawing cells will be evaluated.  
2. Optimisation of growth media formulations to allow successful co-culture 
of MSCs and HSPCs. 
3. Development of protocols for the 3D co-culture model deconstruction, to 
allow cell retrieval for downstream analysis of individual cell populations. 
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3.2 Materials and Methods 
3.2.1 Cells and cell culture 
HSPCs were isolated from BM and enriched for the CD34 cell surface marker as 
described in section 2.1.2 C2C12s, MG63s, and h-TERTS were used as a substitute 
for primary patient MSCs for optimisation of physical aspects of the model. 
Promocell MSCs were used for MSC functional studies in the model.  
3.2.2 Viability staining 
Viability staining was performed as described in section 2.3. Viable cells and non-
viable cells were counted separately. For some images for which individual cells 
could not be discerned, percentage green signal area within the cell layer was 
taken as a proxy for viability. Percentage viability was calculated using the 
formula: 
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑣𝑖𝑎𝑏𝑙𝑒 𝑐𝑒𝑙𝑙𝑠
𝑡𝑜𝑡𝑎𝑙 𝑐𝑒𝑙𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 
 ×  100. The average percentage viability from several 
images was calculated and statistical analyses were performed in GraphPad Prism.  
3.2.3 MTT assay  
MTT assays were carried out as described in section 2.7. The metabolic activity of 
MSCs grown in IMDM (HSPC optimal media) was compared to that of MSCs grown 
in DMEM (MSC optimal media) using an MTT assay. Although an MTT assay evaluates 
the metabolic activity of cells, it is often used as a proxy for viability or 
proliferation tests. Samples were analysed at 24, 48, and 72 hours after culture 
within IMDM or DMEM (control).  
3.2.4 BrdU incorporation assay 
A BrdU assay was performed as described in section 2.6 to ascertain the level of 
cell proliferation. MSCs were seeded in DMEM, following which they were cultured 
in IMDM (or fresh DMEM as a control) for either 24, 48, or 72 hours. Images were 
collected for each condition and time point and analysed in ImageJ. Data collected 
was processed in Microsoft Excel.  
The binomial test was performed to evaluate whether the number of BrdU-
negative cells in IMDM was equal to the number in DMEM. This test was performed 
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for each time point, taking the DMEM result as the base probability for comparison. 
The binomial test was performed using the BINOM.DIST function in Excel to 
evaluate the probability of successes in the control condition compared to the 
probability in the test condition. Ninety five percent confidence intervals for the 
proportions were calculated using the Agresti-Coull method, using the online 
calculator provided by GraphPad3.  
3.2.5 Collagenase digestion  
Following culture within a collagen gel, cells were extracted using collagenase at 
2 mg ml-1 for 90 min. Following this period, the resulting cell suspension was 
centrifuged at 400 × g to pellet the cells.  
3.2.6 Flow cytometry 
Flow cytometric analysis was used to characterise the cells extracted from BM, 
investigate the effectiveness of loading cells with NPs, and for separation of cells 
following incubation in the model. Following collagenase digestion, cell samples 
harvested from culture for analysis were washed three times in 2% FBS in PBS by 
centrifugation at 190 × g for 10 min. Cells were then stained for 30 min in the dark 
with a 1:100 solution of antibody, if appropriate. Following staining, cells were 
centrifuged once more with the same parameters. They were then suspended in 
2% FBS in PBS containing 1 mM EDTA. Samples containing adherent cells were 
passed through a filter before being run on the flow cytometer. Antibodies and 
additional procedures used for phenotyping are listed in Table 2.8 and sections 
2.13.2 and 2.13.3.   
                                         
3 http://www.graphpad.com/quickcalcs/confInterval1/  
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3.3 Results 
3.3.1 Cell culture optimisation 
Several methods not yet in use in the Centre for Cell Engineering were optimised 
for use with HSPCs. The feasibility of banking cell samples for later use once 
extracted from BM, or once enriched via magnetic selection, was tested. This is 
important because CD34+ cells differentiate and die rapidly in culture, meaning 
that they have to be used experimentally as soon as possible after isolation. Being 
able to control the timing of isolation can relieve experimental time pressures.  
3.3.1.1 Viability of cells following freeze-thawing 
Freezing mononuclear cells (MNCs) after isolation and before sorting can affect 
percentage viability of the HSPC subpopulation. To investigate this, cell viability 
was determined in previous frozen cell samples that were (i) isolated and enriched 
for CD34+ prior to freezing; (ii) isolated, frozen, then enriched for CD34+ post-
freezing; and (iii) isolated, frozen, CD34- fraction from enrichment post-freezing 
(Figure 3.1). The average viability was above 50% for all cell groups. The CD34+ 
(F/T MNCs) population, enriched post-freezing, had the highest viability with 
approximately 78% retrieval. This was significantly higher than either the enriched 
pre-freezing F/T CD34+ or the CD34- (F/T MNCs) populations. Viability was similar 
in the latter two groups, at approximately 55%.  
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Figure 3.1 Percentage viability of cells following freeze-thawing.  
F/T CD34+, freeze-thawed CD34+; CD34+, F/T MNCs, CD34+ population from freeze-thawed 
MNCs; CD34-, F/T MNCs, CD34- population from freeze-thawed MNCs. Statistical significance 
was tested using one-way ANOVA. **p < 0.01; ***p < 0.001. 
Interestingly, the CD34+ enriched pre-freezing sample had a much lower retrieval 
rate in terms of cell number when compared to the MNC populations, as indicated 
in Figure 3.2. Collating the cell viability and cell number retrieval following 
freeze-thawing, it is evident that optimum recovery and viability arose from 
enriching for CD34 post-freezing from MNCs, rather than from a frozen CD34+ 
enriched population.  
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Figure 3.2 Average cell number per microscopic field.  
F/T CD34+, freeze-thawed CD34+; CD34+, F/T MNCs, CD34+ population from freeze-thawed 
MNCs; CD34-, F/T MNCs, CD34- population from freeze-thawed MNCs. Statistical significance 
was tested using one-way ANOVA. *p < 0.05; **p < 0.01; ****p < 0.0001. 
3.3.2 Co-culture model development and optimisation 
A co-culture system requires the culture conditions to be suitable for all cell types. 
HSPCs and MSCs are typically cultured very differently, in part due to the fact that 
the former are non-adherent, and are more susceptible to differentiation and 
death in culture. The standard method of MSC culture already utilised in the 
Centre for Cell Engineering is described in section 2.1. For culture of HSPCs, advice 
was kindly given by Dr Jo Mountford and her lab. The following describes the 
various methods used to optimise the conditions of the co-culture system to 
accommodate both cell types.  
3.3.2.1 Phenotypic characterisation of the CD34+ population extracted from 
the bone marrow 
Phenotypic analysis was performed to identify the proportions of haematopoietic 
progenitor subsets present within the HSPC (CD34+) population following isolation 
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from the BM according to the procedure described in Section 2.1.2. One 
representative patient sample was used. Following analysis on a flow cytometer, 
further gating of populations was used to identify progenitor subsets within the 
viable, single cell population (Figure 2.2). Using antibody panel 1 (Table 2.8), 84% 
of the cells were identified as CD34+, reflecting the success of the magnetic 
enrichment technique. The proportion of HSCs within this sample was 7.96%, with 
the proportion of MPPs at 7.88%, giving a total of approximately 16% (HSCs and 
MPPs). Presence of lineage progenitors was comparatively low, with CMPs, CLPs, 
GMPs, and MLPs all at or below 1%. The one exception was for MEPs, which were 
present at 18.5%.  
 
Figure 3.3 Analysis of percentages of progenitor subsets in freshly isolated CD34+ cells. 
HSC, haematopoietic stem cell; MPP, multipotent progenitor; CMP, common myeloid 
progenitor; MEP, megakaryocyte-erythroid progenitor; GMP, granulocyte-monocyte 
progenitor; MLP, multi-lymphoid progenitor; CLP, common lymphoid progenitor.  
A separate panel of antibodies was used to identify cells of various haematopoietic 
lineages within the sample (Figure 2.3, Figure 2.4). Here, the percentage of CD34+ 
cells (identified using a different antibody), was 96.5%, again reflecting the 
success of enrichment. The markers CD7, CD14, and CD41a were all expressed by 
between 2 and 5.2% of cells. CD36, CD10, and CD13 were all expressed on 
approximately 20-30% of cells.  
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Figure 3.4 Percentages of viable cells expressing haematopoietic lineage markers. 
3.3.2.2 Co-culture media survey 
To ascertain the appropriate medium for MSC/HSPC co-culture, a literature survey 
was conducted (Table 3.1). The complexity of this task is highlighted by the fact 
that, of a survey of 19 co-culture studies, 19 different formulations were used. 
The most common basal medium was IMDM, followed by RPMI. These were 
variously supplemented with cytokine cocktails, antibiotics, and human or bovine 
serum.  
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Basal medium for co-
culture 
Author, 
Date 
Title Supplement(s) Serum Comments 
Commercial 
CellGro 
SCGM 
medium 
(CellGenix, 
Freiburg, 
Germany) 
Jing et al. 
2010 
Haematopoietic stem cells in 
co-culture with mesenchymal 
stromal cells - modeling the 
niche compartments in vitro 
10 % FBS, 15 ng ml-1 Flt3-L, 
150 ng ml-1 SCF, 50 ng ml-1 
IL-3. 
y 
In some cultures, HSCs were grown without MSCs but 
with cytokines. 
HPC 
Expansion 
Medium DXF 
(PromoCell 
proprietary 
medium) 
Rödling et 
al. 2017 
3D models of the 
haematopoietic stem cell 
niche under steady-state and 
active conditions 
Cytokine Mix E (containing 
TPO, SCF, FLT3L, and IL-3 
at unspecified 
concentrations) and 1% 
(v/v) 
penicillin/streptomycin.  
n Perfused system. 
QBSF-60 
serum-free 
medium 
Andrade 
et al. 
2010 
Systematic delineation of 
optimal cytokine 
concentrations to expand 
hematopoietic 
stem/progenitor cells in co-
culture with mesenchymal 
stem cells 
SCF, Flt-3L, bFGF, TPO, and 
LIF (leukaemia inhibitory 
factor protein).  
n 
Cytokines were tested in different combinations 
and/or concentrations. For the validation studies (14 
day cultures), two controls were performed: (i) 
without exogenously added cytokines, with a stromal 
layer (No Cyt), and (ii) without stromal layer, using 
the most successful cytokine cocktail optimized by 
the experimental design approach (No Stroma). 
StemSpan 
Zhang et 
al. 2006 
Co-culture of Umbilical Cord 
Blood CD34+ Cells with Human 
Mesenchymal Stem Cells 
40 mg ml-1 LDL, 100 ng ml-1 
SCF, 100 ng ml-1 FL, 50 ng 
ml-1 TPO, and 20 ng ml-1 IL-
3. 
n   
StemSpan 
(StemCell 
Technologies 
proprietary 
medium) 
Alcayaga-
Miranda 
et al. 
2015 
Characterization of menstrual 
stem cells: angiogenic effect, 
migration and hematopoietic 
stem cell support in 
comparison with bone marrow 
mesenchymal stem cells 
10 ng ml-1 FGF-1, 10 ng ml-1 
SCF, 20 ng ml-1 TPO, 100 ng 
ml-1 IGFBP2, and 100 µg ml-1 
penicillin/streptomycin.  
 
n 
CD34+ HSPCs were co-cultured with, without, and 
without direct contact (using a Transwell) with 
menstrual MSCs.  
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StemSpan-
ACF 
(StemCell 
Technologies 
proprietary 
medium) 
Sieber et 
al. 2017 
Bone marrow-on-a-chip: Long-
term culture of human 
haematopoietic stem cells in a 
3D microfluidic environment 
25 ng ml-1 FLT3-L, 10 ng ml-
1 TPO, 1% 
penicillin/streptomycin.  
n Perfused system. 
DMEM 
de Barros 
et al. 
2010 
Osteoblasts and Bone Marrow 
Mesenchymal Stromal Cells 
Control Haematopoietic Stem 
Cell Migration and 
Proliferation in a 3D In Vitro 
Model 
10% FBS and antibiotics y   
Fischer's medium 
Teixido et 
al. 1992 
Role of B1 and B2 Integrins in 
the Adhesion of Human CD34hI 
Stem Cells to Bone Marrow 
Stroma 
25% FBS, 0.00005 M 
hydrocortisone. 
y   
IMDM 
Kedong et 
al. 2010 
Simultaneous expansion and 
harvest of hematopoietic stem 
cells and mesenchymal stem 
cells derived from umbilical 
cord blood 
SCF 15 ng ml-1, Flt3L 5 ng 
ml-1, thrombopoietin (TPO) 
6 ng ml-1, IL-3 15 ng ml-1, 
GM-CSF 5 ng ml-1, G-CSF 1 
ng ml-1. 
y/n 
Isolated MSCs cultured in Dulbecco’s Modified Eagle’s 
Medium (DMEM, Gibco) with 10 % FBS. Cells were also 
cultured in induction media to produce chondrocytes, 
adipocytes, and osteoblasts.  
Wagner 
et al. 
2008 
Adhesion of human 
hematopoietic progenitor cells 
to mesenchymal stromal cells 
involves CD44. 
20 % FBS, penicillin 1,000 
U/ml, and streptomycin 100 
U/ml. 
y   
Li et al. 
2007 
Human mesenchymal stem 
cells improve ex vivo 
expansion of adult human 
CD34+ peripheral blood 
progenitor cells and decrease 
their allostimulatory capacity 
10% FBS and 100 U/mL 
penicillin, 100 mg ml-1 
streptomycin, in the 
presence of SFT or 6-SFT. 
10 ng ml-1 TPO, 50 ng ml-1 
FL, 50 ng ml-1 SCF, and 10 
ng ml-1 IL-6. 
y 
Cytokine cocktails were used in these studies as a 
combination of 3 factors (SCF, FL, and TPO), named 
SFT, or 4 factors (IL-6, and SCF), named 6-SFT 
combination. 
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Cheng et 
al. 2000 
Human Mesenchymal Stem 
Cells Support Megakaryocyte 
and Pro-Platelet Formation 
From CD34+ Hematopoietic 
Progenitor Cells 
BIT (10 mg ml-1 BSA, 10 µg 
ml-1 human insulin, and 200 
µg ml-1 human transferrin, 
final concentration), plus 
100 µmol L-1 2-
mercaptoethanol and 40 µg 
ml-1 low-density 
lipoprotein. 
n 
Cells were cultured for up to 21 days. If CD34+ cells 
were plated in the absence of hMSCs, few cells (less 
than 3% of input cells, either adherent or in 
suspension) survived after 7 days under the previous 
culture conditions. Most hMSCs were aggregated and 
were removed by a 30 µm nylon filter; FACS analyses 
also indicated that most hMSCs were eliminated  
Kedong 
Song et 
al. 2011 
Co-culture of hematopoietic 
stem cells and mesenchymal 
stem cells derived from 
umbilical cord blood using 
human autoserum 
20% HAS-(Human Autologous 
Serum) or FBS. 
y 
HAS compared with FBS in this paper using different 
concentrations. HAS was isolated from peripheral 
blood samples using Ficoll-Paque gradients. After 
growth in test conditions, MSCs were grown in IMDM 
with 10 % FBS. 
Sharma et 
al. 2012 
Mimicking the functional 
hematopoietic stem cell niche 
in vitro: recapitulation of 
marrow physiology by 
hydrogel-based three-
dimensional cultures of 
mesenchymal stromal cells. 
10 % FBS, SCF 50 ng ml-1; IL-
6, 50 ng ml-1, and IL-3, 20 
ng ml-1. 
y   
Wuchter 
et al. 
2016 
Microcavity arrays as an in 
vitro model system of the 
bone marrow niche for 
hematopoietic stem cells 
12.5% FCS, 12.5% horse 
serum. 2 mM L-glutamine, 
100 U/ml 
penicillin/streptomycin, 
0.05% hydrocortisone 100.  
y Perfused system: HSPCs maintained CD34+ expression.  
Mixture 
1:1 mix of 
IMDM and 
DMEM/F12 
Salati et 
al. 2013 
Co-Culture of Hematopoietic 
Stem/Progenitor Cells with 
Human Osteblasts Favours 
Mono/Macrophage 
Differentiation at the Expense 
of the Erythroid Lineage 
20% FBS, SCF 5 ng ml-1, Flt3 
5 ng ml-1, TPO 2 ng ml-1, IL-
3 1 ng ml-1 and IL-6 1 ng ml-
1, streptomycin 100 mg ml-
1, penicillin 100 mg ml-1, 
and L-glutamine 2 mM. 
n 
In order to assess erythroid and megakaryocytic 
differentiation, cells were cultured in serum free 
medium consisting of a 1:1 mix of IMDM and 
DMEM/F12 supplemented with 20% BIT, growth factors 
and antibiotics. 
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Mixture 
50:50 mix of 
EBM-2 and 
DMEM 
Huang et 
al. 2016 
Co-cultured hBMSCs and 
HUVECs on human bio-derived 
bone scaffolds provide support 
for the long-term ex vivo 
culture of HSC/HPCs 
Endothelial basal medium 
(EBM-2) supplemented with 
endothelial growth 
supplement SingleQuots 
(EGM-2). DMEM 
supplemented with 10% 
FBS, 100 U/ml penicillin, 
100 µg ml-1 streptomycin, 
0.29 mg ml-1 glutamine and 
3 mg ml-1 HEPES buffer. 
y Triple co-culture of HUVECs, MSCs, and HSCs. 
RPMI 
Bug et al. 
2002 
Rho family small GTPases 
control migration of 
hematopoietic progenitor cells 
into multicellular spheroids of 
bone marrow 
stroma cells 
10% FCS, IL-3, and GM-CSF; 
10 ng ml-1 each. 
y 
Before co-cultivation, cells were washed with medium 
and subsequently resuspended in IMDM/10% FCS. Co-
culture was performed in IMDM. 
Perdomo-
Arciniegas 
& Vernot 
2011 
Co-culture of hematopoietic 
stem cells with mesenchymal 
stem cells increases VCAM-1-
dependent migration of 
primitive hematopoietic stem 
cells. 
SCF, Flt-3L, and TPO 
cytokines; all used at 50 ng 
ml-1. 
n 
Two conditions were used for the experiment: 1. Co-
culture with MSC plus cytokines (HMC); 2. MSC-free 
culture with cytokines (HC). 
MNCs were enriched and suspended in IMDM 
supplemented with 10% FBS and 1 mM sodium 
pyruvate. 
Wagner 
et al. 
2007 
Molecular and secretory 
profiles of human 
mesenchymal stromal cells 
and their abilities to maintain 
primitive hematopoietic 
progenitors. 
10% FBS y   
Table 3.1 Survey of media used in MSC/HPSC co-culture studies to identify the optimal formulation. 
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3.3.2.3 Testing cell metabolic activity and proliferation in different media 
formulations 
Firstly, the capacity for the chosen medium formulation to support basic MSC 
functions in culture compared to standard DMEM was tested. These activities 
included metabolic activity and viability.  
3.3.2.3.1 Metabolic activity of MSCs 
An MTT assay was used to assess the metabolic activity of MSCs when cultured in 
standard DMEM medium compared to the HSPC-optimal IMDM medium. Differences 
between the groups were analysed using two-way ANOVA. There was no significant 
difference in metabolic activity between MSCs grown in IMDM or DMEM at any time 
point (p > 0.05). Indeed, contrary to expectations, the cells exhibited higher 
metabolic activity in IMDM compared to DMEM at all time points.  
 
Figure 3.5 Optical density at 550 nm from MTT assay performed on MSCs grown in either 
DMEM or IMDM media for 24, 48, and 72 hours.  
Absorbance expressed as mean ± 95% confidence interval. Two-way ANOVA was used to 
analyse differences between the groups. 
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3.3.2.3.2 Proliferation of MSCs  
A BrdU assay was used to test whether the reason for the increase in metabolic 
activity in IMDM was due to increased MSC proliferation. This assay was performed 
in monolayer culture. The percentage of cells that were non-proliferative (do not 
exhibit BrdU signal in the nucleus) remained above 90% for all time points in both 
media conditions (Figure 3.6).  
 
Figure 3.6 Graph of the percentages of BrdU-positive cells after culturing MSCs in DMEM or 
IMDM for either 24, 48, or 72 hours.  
Bars show average percentage of BrdU positive nuclei ± 95% confidence interval of the 
proportion. 
For each time point, p > 0.05 (Table 3.2), indicating that there was no significant 
difference in the number of proliferating MSCs in the two media types at any time 
point. The slight differences detected in metabolic activity may be due to random 
fluctuations in cell number, rather than differences in proliferation.  
Time (hrs) 24 48 72 
p-value 
(binomial test) 
0.997866796 
 
0.366694938 
 
0.551528855 
 
Table 3.2 Table showing the p-values for the binomial tests performed for each time point.  
p > 0.05 at all time points.  
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3.3.3 Model Deconstruction  
Following a set period of time in the model, cell retrieval from the 3D model for 
separate downstream analysis of different cell types was necessary. A series of 
experiments was performed to optimise cell extraction from the model and 
subsequent cell separation to isolate individual cell populations.  
3.3.3.1 Collagenase optimisation 
The initial stage of cell retrieval from a 3D type I collagen gel is gel digestion. On 
Vivek Mudera’s recommendation (UCL), lyophilised collagenase D was used for gel 
digestion, allowing total cell retrieval. Cell populations (ie. MSCs and HSPCs) were 
subsequently separated via flow cytometry. It is essential for the cells to be 
isolated from the gels without compromising viability. For flow cytometry, 
obtaining a suspension of single cells is of particular importance to obtain discrete 
data for each cell, and to prevent damaging the machine during analysis.  
Lyophilised collagenase type D (Roche) was reconstituted in PBS to a stock 
concentration of between 25 and 50 mg ml-1, stored at -20 °C. This was thawed 
and diluted at point-of use to create working solutions. The volume of collagenase 
solution used was equal volume to the gel being digested. As collagenase is not 
inhibited by serum, an equal volume of 10 mM EDTA in PBS was used to quench 
the reaction after the given incubation time.  
3.3.3.1.1 Testing collagenase on cell free gels 
To ascertain the range of concentrations and incubation times that could be used 
for this protocol, digestion of cell-free collagen gels was tested. The manufacturer 
recommended a working concentration between 0.5-2.5 mg ml-1. Initial trial 
concentrations of 0.5 mg ml-1, 1 mg ml-1, 2 mg ml-1, and 2.5 mg ml-1 were therefore 
used. To each 500 µl volume of gel, an equal volume of collagenase was added. 
The incubation times chosen were 15 min, 30 min, and 60 min in accordance with 
manufacturer recommendations. The same volume of EDTA was added to quench 
the reaction after the allotted incubation time. The liquid in the digested wells 
was then removed to a new well plate to observe the extent of fragmentation. 
From Table 3.3 it is evident that even the highest concentration and incubation 
time was insufficient to digest the gel. Hence, the lowest concentration was 
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discarded and the incubation time was increased for subsequent viability tests in 
3.3.3.1.2.  
 Time min-1 
Concentration 
mg ml-1 
15 30 60 
0.5 Gel intact Gel intact 
Gel fragmented 
but mostly intact 
1 
Gel visible in 
removed media 
Gel visible in 
removed media 
Gel visible in 
removed media 
2 
Gel visible in 
removed media 
Gel visible in 
removed media 
Gel partially 
intact 
2.5 
Gel visible in 
removed media 
Gel visible in 
removed media 
Gel intact 
Table 3.3 Table showing state of collagen gels after digestion with collagenase of varying 
concentrations and durations.  
Gels that could not be easily removed from the wells are indicated by shaded cells.  
3.3.3.1.2 Testing cell viability after collagenase digestion 
MG63 cells were seeded as a cell suspension (i.e. not a pre-formed spheroid) into 
collagen gels at approximately 8 × 104 cells per gel, resulting in a dispersed cell 
population throughout the gel. Collagenase at concentrations of 1 mg ml-1, 2 mg 
ml-1, or 2.5 mg ml-1 was added to each gel and incubated for 30, 60, or 90 min. 10 
mM EDTA was added at the end of the allotted incubation time to quench the 
reaction. Subsequently, the cells were stained with a calcein AM/ethidium 
homodimer solution to assess the viability of the cell population after the 
digestion.  
Cells were observed floating in the media after 30 minutes of digestion; the 
number of floating cells increased with digestion time. At longer incubation times 
and higher concentrations, cells were observed beginning to adhere to the surface 
of the well plate, having been freed from the collagen matrix. Viability stained 
cells were imaged after a 1-hour incubation with the stain. Cells were counted 
and the percentage viability is indicated in Figure 3.7.  
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Figure 3.7 MG63 cell viability after digestion of collagen gels with collagenase at different 
concentrations.  
A calcein/ethidium homodimer viability test was performed following digestion and samples 
were imaged on a fluorescence microscope. The numbers of cells exhibiting green (live) and 
red (dead) fluorescence were counted, and percentage viability determined for each image. 
Values are mean percentage viability  95 % confidence interval (CI). Mean percentage 
viability was tested between the concentrations of collagenase at each time point using two-
way ANOVA. *p < 0.05; **p < 0.01; ***p < 0.001. 
Two-way ANOVA was used to compare the percentage viabilities to the 0 mg ml-1 
control at each time point. Statistically significant differences from the control 
were observed for 2 and 2.5 mg ml-1 at 30 min and 1, 2, and 2.5 mg ml-1 at 60 min. 
However, at 90 min viability was not significantly different from the control at 
any concentration. As the viability of cells at all time points and concentrations 
remained above 80%, this was considered sufficient to obtain a large enough 
number of cells for RNA extraction and subsequent Fluidigm analysis. A 
concentration of 2.5 mg ml-1 collagenase D and an incubation time of 90 min were 
therefore used for all subsequent digestions. 
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3.3.3.1.3 Spheroid dissociation after collagen digestion 
As the MSCs were to be cultured as spheroids within the collagen gel, an effective 
method of dissociating the spheroids post-collagenase digestion was investigated. 
As cell-cell contacts within the spheroid are not easily dissociated, both enzymatic 
and mechanical methods were tested. Spheroids were removed from the 
supernatant following digestion by centrifugation, and then subjected to 
dissociation. Two methods of mechanical dissociation and incubation with trypsin 
were tested (Figure 3.8): 
1. Needle: spheroids were taken up into a 21-gauge 40 mm needle and 
vigorously agitated up and down. 
2. Pipette tip: spheroids were taken up into a 200 µl pipette tip and vigorously 
agitated up and down.  
3. Trypsin: spheroids were enzymatically digested for either 2 or 5 min.  
Following this treatment, the spheroids were seeded into a fresh tissue culture 
vessel. After 24 hours, they were stained with Coomassie Blue and imaged on a 
light microscope (Figure 3.8).  
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Figure 3.8 Methods for dissociation of spheroids after digestion of collagen gels.  
Spheroids were subjected to mechanical or enzymatic dissociation, and the resulting cell 
suspension was seeded onto a fresh surface. After 24 hours, these were stained with 
Coomassie Blue. Scale bar = 200 µm. 
Successful dissociation was indicted by small size of nanoparticle/cell clumps 
(dark areas in the images) and confluence of the cell monolayer. The pipette tip 
method was the least effective, with a disperse cell layer and multiple large cell 
aggregates. The 2-min trypsin digestion was slightly more effective but also 
produced large aggregates. No differences were observed between the 5-min 
trypsin incubation and the needle method: both produced a confluent cell layer, 
with multiple small aggregates. For the remainder of the project, a needle was 
used for resuspension, as it does not involve chemical treatment of the cells.  
3.3.3.1.4 Investigating the effects of collagenase on a monolayer 
For dissociation of the eventual triple co-culture model (Figure 5.2), ensuring that 
human umbilical vein endothelial cells (HUVECs) or osteoblasts (OBs) can be 
isolated from the model in addition to MSCs and HSPCs is important, so that they 
can be analysed separately. If collagenase has no effect on a monolayer beneath 
a gel, then once the digested gel containing spheroids and HSPCs has been 
removed, the co-cultured HUVEC/OB monolayer beneath can be extracted using 
needle pipette tip
trypsin 2 min trypsin 5 min
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trypsin. Therefore, the effect of collagenase on a test cell monolayer was 
assessed.  
C2C12 cells were seeded as monolayers onto wells of a 24 well plate at 1 × 104 
cells well-1. After the cells had attached to the surface, a collagen gel was 
overlaid. After 24 hrs of incubation to allow the pH to equilibrate, the gels were 
digested with 2.5 mg ml-1 collagenase for 0, 30, 60, or 90 min, which was quenched 
with EDTA at the incubation end point. The supernatant containing digested gel 
was removed from each well, transferred to a fresh well, and stained with a 
viability kit to determine whether any C2C12 cells were captured during gel 
digestion, whilst the remaining monolayer was also stained, to ascertain the 
extent of damage, and whether it remained intact.  
The FITC fluorescence area (µm2) was measured for each image and converted into 
a percentage of the total image area (measured as 551623.228 µm2 for each image 
using ImageJ) as a proxy of monolayer integrity. The percentages were analysed 
using one-way ANOVA to compare the integrity of the monolayer during each 
collagenase incubation to that of the control (0 min). No significant differences 
were observed for any time point (p > 0.05). A qualitative analysis of the images 
is summarised in Table 3.4. 
 
Figure 3.9 Percentage of FITC signal from images taken of monolayers below gels treated 
with collagenase (0 min, n = 2; 30, 60, and 90 min, n = 4).  
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Collagenase test using C2C12 monolayers 
Incubation time Monolayer Media/gel digest fraction 
0 min Monolayer largely intact, 
with some peeling from 
the surface visible. High 
viability. 
Some cell growth from 
(presumably) transferred cells in 
suspension. High viability.  
30 min Monolayer largely intact, 
with some peeling from 
the surface visible. High 
viability. 
Cell clumps visible, presumably 
from cells interacting with the 
collagen. Some cell growth on 
tissue culture surface. Low 
viability.  
60 min Monolayer largely intact 
with a few gaps visible. 
High viability.  
Cells all in clumps, with no 
growth on the tissue culture 
surface. Very low viability. 
90 min Monolayer largely intact 
with a few gaps visible. 
High viability.  
Cells all in clumps, with no 
growth on the tissue culture 
surface. Very low viability. 
Table 3.4 Qualitative analysis of collagenase digestion.  
Analysis used images taken of C2C12 monolayers (beneath collagen gels) following 
incubation with collagenase, and images of culture media/gel digest supernates containing 
cells and gel following digestion.  
3.3.4 Separation of cell populations using FACS 
Isolation of individual cell populations (e.g. MSCs, HSPCs, OBs, and ECs) for 
downstream analysis following culture within the model is important to elucidate 
the status and behaviour of the cells. Therefore, a series of experiments was 
conducted to develop FACS methods to achieve isolation.  
3.3.4.1 Loading HSPCs with NPs  
As MSCs in the model were labelled with gNPs, the inherent fluorescence can be 
used to identify the MSC population; similarly, loading CD34+ HSPCs isolated from 
BM with rNPs was investigated. HSPCs in suspension were incubated for 24 hours 
with rNPs, added into the cell culture medium. They were then seeded into a 
collagen gel as described previously, stained with calcein AM after 24 hours of 
culture (viability stain) and imaged on a fluorescence microscope (Figure 3.10). 
Co-localisation of green and red signals indicates internalisation or interaction of 
HSPCs with the NPs; no signal overlap was observed in the sample, and so no 
interaction was occurring.  
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Figure 3.10 Fluorescence image of HSPC incubated with rNPs seeded onto a collagen gel 
and stained with a calcein viability stain.  
Green, live cells; red, nanoparticles. Scale bar = 10 µm. 
A separate sample was stained with DAPI and run on a BD FACS Canto II to look at 
effectiveness of rNP internalisation and the effect on the cells (Figure 3.11). 
Figure 3.11A shows the total sample loaded into the flow cytometer on a forward-
scatter (FSC) versus side-scatter (SSC) plot. Panels B and D show this population 
on a DAPI (Comp-Pacific Blue) versus SSC plot, with gates drawn identifying the 
DAPI-positive (79.2%) and DAPI-negative (16.5%), respectively. DAPI-positive cells 
were considered dead, as internalisation of the dye indicates disruption of cell 
membranes. Panels C and E show the red (PE) fluorescence of these live and dead 
cell populations, plotted against SSC, respectively. Both populations are mostly 
negative for this tag, as emphasised by the histogram in Panel F, which depicts 
the frequency of red (PE) fluorescent particles in the live and dead populations 
combined (31.9% positive). The largely negative population indicates that the rNPs 
were not taken up into the cells.  
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Figure 3.11 Flow cytometric analysis of CD34+ HSPCs incubated with rNPs.  
A: Flow cytometric signature of NPs in isolation (FSC vs. SSC). B: Flow cytometric analysis 
(DAPI vs. SSC) of CD34+ HSPCs incubated with rNPs. Gate represents DAPI positive (dead) 
cell population. C: Red fluorescence signal in the dead cell population (PE vs. SSC). D: As 
part (B). Gate represents DAPI negative (live) cell population. E: Red fluorescence signal in 
the live cell population (PE vs. SSC). F: Histogram depicting frequency of red-positive cells 
in both live and dead populations combined.  
A
B C
D E
F
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3.3.4.2 Separation of MSCs loaded with gNPs from HSPCs 
Following collagenase digestion, the digested gel was removed from the Transwell 
and all resultant cells (MSCs and HSPCs) were pelleted. They were then separated 
into population cell types using fluorescence activated cell sorting (FACS) on a BD 
FACSCalibur flow cytometer. MSCs from spheroids were separated from CD34+ 
cells based on the inherent green fluorescence of the nanoparticles (Figure 3.12). 
The cell suspension including both cell types was stained with a CD34 antibody 
conjugated to allophycocyanin (APC) to extract the HSPC population. Cells 
remaining on the Transwell membrane surface (ECs or OBs) were trypsinised and 
pelleted. These were processed by FACS to eliminate any FITC-positive cells 
(containing nanoparticles).  
Figure 3.12 is a representative image of one FACS run following model 
deconstruction. The gating process below was followed to separate MSCs from 
HSCs in several samples. Figure 3.12A shows the full population analysed by the 
flow cytometer, with a gate drawn to isolate cells identified as ‘live’ by their SSC 
versus FSC profile (64.3% of particles). Figure 3.12B shows the gate used to identify 
single cells and exclude doublets using the forward-scatter height (FSC-H) versus 
forward-scatter area (FSC-A) profile of the cells within the gate drawn in panel A. 
Figure 3.12C shows the fluorescence in the FITC channel plotted against 
fluorescence in the APC channel of the cells within the resulting population from 
panel B. This plot was used to identify a FITC-positive, APC-negative population, 
i.e. the MSC population containing FITC-fluorescent nanoparticles (49.7%). A 
separate gate was used to identify cells that were CD34-APC-positive, FITC 
negative, i.e. HSCs (3.87%). Nanoparticle uptake influences cell granularity, 
indicated by SSC, meaning that the live cell population is skewed with respect to 
the expected location of live cells: they appear in a location normally representing 
dead cells. This was taken into account during the gating process. 
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Figure 3.12 Flow cytometry data from FACS sort of MSCs from CD34+ cells after model 
deconstruction.  
MSCs are labelled with green fluorescent NPs (FITC), cell sample is also stained with a CD34+-
APC antibody (APC). A: Forward-scatter (FSC) versus side-scatter (SSC) of initial cell 
population, gated on live cells. B: Single cell population identified from A. C: APC 
fluorescence versus FITC fluorescence; gates indicate NP-FITC labelled cells and CD34+-APC 
cells.  
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3.4 Discussion 
3.4.1 Viable CD34+ cell yield is higher when cells are enriched 
following freezing 
Freezing of the whole BM MNC fraction enhances survival of CD34+ cells following 
thawing (Figure 3.1, Figure 3.2). Enrichment before freezing results in around 50% 
viability, whereas selection after freezing gives a survival rate of nearly 80%. 
Viability of the CD34- fraction is also lower. Therefore, to maximise viability of 
CD34+ cells for experiments, it is optimal to freeze the MNC fraction and perform 
an enrichment shortly before use in culture. This sequence also vastly increases 
the total cell yield.  
3.4.2 Bone marrow enrichment produces a primitive population 
highly expressing the CD34 marker  
From both Figure 3.3 and Figure 3.4 it is evident that magnetic CD34 enrichment 
is successful and gives a high purity: the percentages of CD34+ cells is 84% and 
96.4% respectively. The difference in these values can be attributed to the 
differences in antibodies (discussed in more detail in Chapter 5 (page 184)). The 
population of HSCs is at around 8%, as is the population of MPPs, meaning that 
around 16% of the population is primitive and CD34+CD38-. MEPs are present at an 
even higher proportion, at 18.5% of the CD34+ population. In contrast, the 
remainder of the progenitor subsets are present within the population at very low 
levels. Hence, this shows that a high proportion of the enriched cells are either 
HSCs, MPPs, or early MEPs. The lack of progenitors further on in the hierarchy 
shows that very little differentiation has occurred and few lineage progenitors 
were isolated in the original sample.  
In contrast, expression of some lineage markers was observed in more than 20% of 
the CD34+ population. Expression of the megakaryocyte-erythroid lineage marker 
CD41a (Choi et al. 2009), indicates a frequency of around 5% megakaryocytic-
erythrocytic cells. However, CD36 expression, which emerges on the earliest MEPs 
(Ward et al. 2016), is observed on around 20% of cells. This may be evidence that 
the population are relatively primitive rather than mature erythroid cells 
(including platelets).  
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Similarly, there is variation in expression of the two lymphoid markers examined. 
CD10 is general lymphoid lineage marker (Kohn et al. 2012), which is expressed at 
23.4%. CD7, which is expressed on early and mature T cells (Shukla et al. 2017), 
is expressed by 2.04% of the cells. Again, this may show that a greater number of 
the cells are primitive and few mature lymphoid cells are present.  
Lastly, myeloid lineage cells represented by CD13 (Winnicka et al. 2010) are 
present at near 30% of the population. CD14 is expressed by cells later in the 
myeloid differentiation process, i.e. monocytes and macrophages (Monzen et al. 
2013) and is expressed by around 5% of the cells. Again, this suggests a higher 
level of early myeloid cells compared to terminally differentiated cells.  
3.4.3 There is no consensus regarding the optimal medium 
formulation for co-culture of MSCs and HSPCs 
An extensive literature survey of existing MSC-HSPC co-culture systems revealed 
no consensus on an optimal medium to balance MSC and HSPC requirements (Table 
3.1). These formulations vary in basal medium, whether they contain serum from 
human or bovine sources, and the growth factors and supplements used. 
The medium used for culture of MSCs and HSPCs separately depends on the 
purpose of the experiment or culture. For example, the formulation may differ 
depending on whether the intention is to expand, differentiate, or maintain the 
cells. Medium for MSCs typically is DMEM supplemented with serum or equivalent, 
with antibiotic. There are several commercial media formulations available, 
although the contents of these are not often released. Non-adherent cells 
including HSPCs are typically cultured in IMDM or RPMI media without serum 
supplement (BIT or HSA is sometimes used). Growth factor addition is also 
common.  
Within this project, the culture medium used in Prof. Jo Mountford’s lab was used 
for HSPC culture, on her advice. The basal medium is IMDM, supplemented with 
20% BIT, 0.02% penicillin/streptomycin, 20 ng ml-1 IL-3, 20 ng ml-1 IL-6, 20 ng ml-1 
G-CSF, 100 ng ml-1 Flt3L, and 100 ng ml-1 SCF. There is some evidence that G-CSF 
and IL-3 improve the attachment of adherent cells, whereas SCF and Flt3L may 
depress MSC proliferation, whilst having a positive effect on HSCs (Fan et al. 
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2009). Before beginning experiments, the effect on MSC viability and activity when 
they are grown in serum free IMDM (SFM) was assessed using a viability stain and 
an MTT assay. Relevant results from these tests are summarised below.  
3.4.4 MSCs maintain their metabolic activity and proliferation in 
serum free medium 
MTT assay results suggest that MSCs maintain the same or higher levels of 
metabolic activity in SFM as compared to standard DMEM (Figure 3.5). However, 
this result could be obtained by a fall in cell number accompanied by an increase 
in metabolic activity, as previously described by Pieri et al. (2011), resulting in a 
higher level of proliferation. Nonetheless, results from the BrdU proliferation 
assay show that most cells grown in either medium formulation are non-
proliferative (Figure 3.6). Observed differences are not statistically significant at 
any time point, and the level is maintained over the duration of the experiment. 
This demonstrates that media formulation does not have an effect on MSC 
proliferation.  
Results from these two assays (MTT and BrdU) suggest that MSC activity and 
function are not affected extensively by IMDM. Although this medium does affect 
production of key niche cytokines (as discussed in section 4.4.8), it was therefore 
considered appropriate for the model.  
3.4.5 Collagenase treatment successfully isolates cells from the 
gel matrix and does not significantly affect cell viability of 
spheroids or underlying monolayers 
Collagenase D was used to digest the applied collagen ECM and isolate cells. 
However, as this is a new procedure, optimisation of incubation length and 
collagenase concentration was required (Table 3.3). The gel was not digested 
completely and remained partially intact at all concentrations up to 2.5 mg ml-1 
and incubations up to 60 min. Therefore, all subsequent tests were performed 
with a maximum time period of 90 min. 
Secondly, the concentration and time at which the gel was digested without 
compromising cell viability was determined. Cell viability of cells suspended 
within the gel remained above 80% for all concentrations tested (0-2.5 mg ml-1, 
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Figure 3.7). In addition, the integrity of a monolayer beneath the gel following 
collagenase treatment remained similar regardless of time period or 
concentration, where viability was maintained above 60% even at the longest 
incubation duration (Figure 3.9). It was therefore concluded that collagenase 
digestion did not affect the monolayer to an extent that will compromise the 
efficacy of cell recovery and separation.  
The optimal method for spheroid dissociation following digestion was also 
investigated. Comparison of mechanical and enzymatic dissociation methods 
showed minimal differences between using a needle and a 5 min incubation with 
trypsin (Figure 3.8). As enzymatic treatment is undesirable, the method taken 
forward was re-suspension using a needle. Prior to analysis on a flow cytometer, 
the sample was also passed through a filter, further dissociating the cells.  
3.4.6 Individual cell populations can be separated following 
culture within the model by digestion and subsequent FACS 
Separation of distinct cell populations from the model is required for downstream 
analysis (e.g. for Fluidigm qPCR). Therefore, techniques for isolation involving 
FACS were tested and optimised. Firstly, loading HSPCs with NPs was investigated, 
due to concern that the abundance of the CD34 surface marker could be 
compromised by treatment with collagenase, and the cell population may have 
changed and hence lost the marker in culture. Using NPs provides a stable 
fluorescent signal and allows tracking of a specific cell population from its 
introduction to the model.  
3.4.6.1 Loading HSPCs with NPs is ineffective and causes high levels of cell 
death  
Several observations can be made from Figure 3.11 to inform the process of 
separation. Firstly, the NP signature in Part A shows that the NP population has a 
similar FSC-SSC signature to dead cells (indicating high ‘granularity’ and small 
size). This may not have an effect on live cell populations but does have an effect 
on the voltage required and hence the scatter plots that are produced.  
Secondly, approximately 80% of the particles in the sample are DAPI-positive 
(dead), suggesting that the NPs influence HSPC viability. Dead cells are almost 
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without exception negative for PE. This suggests that the dead cells have not 
internalised the NPs, but they have still had an effect on viability externally. 
Looking at the live cell population, which is 16.5% of the total, these cells are also 
mostly negative for PE, also indicating that these cells have not internalised the 
NPs. However, part of the population shows increased granularity, accompanied 
by a slight increase in PE fluorescence. This subset of cells may have internalised 
NPs but they are not a large enough population to justify using this technique. 
Looking at the total number of particles in the sample that are PE-positive gives 
a percentage of 31.8%, however, this segment probably represents excess NPs that 
were not included in the live or dead populations.  
Analysis of NP uptake by HSPCs shows that the cells have decreased viability and 
do not take up the particles (Figure 3.10). This is sufficient data to eliminate this 
method as a procedure for HSPC labelling.  
3.4.6.2 Cell populations can be separated from the model using FACS 
following collagenase digestion 
Following the above results (labelling CD34+ cells with rNPs), the CD34+ HSPCs 
were labelled instead with a fluorescent CD34 antibody for separation. The 
resulting cell suspension was processed using a FACS machine to produce a CD34+ 
population and a FITC-positive population (Figure 3.12). Any double positive cells 
were discarded. Finally, trypsin was used to extract the monolayer cells (HUVECs 
or OBs) from the model and remove them from the Transwell surface. Purity was 
ensured by eliminating any FITC-positive cells (MSCs) and small cells 
(haematopoietic cells).   
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3.5 Conclusion 
In this chapter, several key aspects of the existing model have been optimised, 
both in terms of set-up and analysis. SFM was determined to be appropriate for A 
protocol for extraction of separate cell populations from the model for 
downstream analysis was also optimised. 
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Chapter 4 The development of an HSC-
permissive bone marrow niche model 
4.1 Introduction 
Chapter 3 described the optimisation of culture methods for the current 3D MSC 
spheroid bone marrow (BM) niche model with a view to including HSCs. This 
chapter gives an overview of the characterisation of this MSC spheroid model, 
firstly in structural and then in biological terms.  
As described in Chapter 1, MSCs are increasingly important in tissue engineering 
and regenerative medicine. Their capacity to differentiate into several cell types, 
including osteocytes, chondrocytes, and adipocytes (Pittenger et al. 1999), 
promotes their use for orthopaedics applications in particular. Within the BM, 
MSCs also act as crucial stromal support to HSCs, where both cell types co-reside 
in the niche microenvironment. There is a growing understanding of the niche 
interactions, with several signalling axes being identified as fundamental to 
MSC/HSC communication and co-support. Such signalling molecules, including 
soluble growth factors and cytokines, are released from nestin+ MSCs and are 
central to HSC homing, maintenance and retention in the BM. The inclusion of 
nestin+ MSCs are therefore key in the development of an in vitro model aimed at 
supporting HSCs. 
MSCs are typically isolated from BM and are traditionally expanded in culture on 
tissue culture treated polystyrene in a 2D monolayer. However, major limitations 
in utilising MSCs ex vivo are that they lose their differentiation potential or 
undergo replicative senescence after a certain number of population doublings 
(Bonab et al. 2006; Banfi et al. 2000). Therefore, fundamental stem cell properties 
such as quiescence and multipotency are gradually lost in culture, limiting their 
usefulness (Lin et al. 2014). There is a growing need to develop MSC culture 
systems to circumvent these issues. 
Multicellular spheroids are one such 3D culture system which has been used to 
generate embryonic bodies and artificial tumours for cancer studies for decades 
(Carlsson et al. 1983; Mueller-Klieser 1987; Hirschhaeuser et al. 2010). Spheroids 
are aggregates of cells, that can self-organise and behave more akin to cells in 
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vivo, replicating tissue organisation and developing concentration gradients of 
nutrients and cytokines. For example, as spheroids closely mimic tumour 
architecture, mirroring pathophysiologically relevant cytokine and nutrient 
gradients, generating 3D ECM features, and promoting secondary central necrosis 
(Hirschhaeuser et al. 2010), they represent a more reliable test platform for anti-
tumour drugs.  
Spheroids can be formed via several techniques, including spinner flasks (Mueller-
Klieser 1987), hanging drops (Banerjee & Bhonde 2006), and culture in low-
adherence vessels (Dontu et al. 2003), However, these methods are often costly 
and time consuming. Magnetic cell levitation (Souza et al. 2010) is a recently 
developed technique, which offers an alternative method for spheroid generation. 
During magnetic levitation cells are pre-loaded with magnetic nanoparticles and 
encouraged to form multicellular spheroids within several hours via an external 
magnetic field. The resultant spheroids are easily manipulated by virtue of their 
magnetic qualities, and this method also confers benefits in cell tracking and 
imaging.  
The ECM is an important part of the MSC niche (Gattazzo et al. 2014). This network 
of proteins is comprised of collagen type I, III, and IV, fibronectin, laminin, 
thrombospondin, haemonectin, and proteoglycans (Gordon 1988; Nilsson et al. 
1998). In particular, collagen type I localises to the endosteal surface and 
endosteal marrow, the proposed stem cell niche site, and is the most abundant 
type of collagen in the marrow (Nilsson et al. 1998). These ECM molecules present 
topographical and biological signals to the cells, and allow for enhanced cell 
adhesion (Chen et al. 2007). The incorporation of these proteins into a 3D culture 
system may further encourage maintenance of MSC phenotype. In addition, the 
3D fibrous network better mimics small molecule diffusion through the bone 
marrow, an important factor to consider when assessing drug delivery 
mechanisms.  
4.1.1 Objectives 
In this chapter, the spheroid culture system in which MSCs are labelled with 
magnetic nanoparticles, multicellular spheroids are generated, and subsequently 
implanted into a type I collagen gel with a similar stiffness (modulus of 36 Pa, 
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Lewis et al. 2016) to the in vivo bone marrow microenvironment (modulus of 100 
Pa, Metzger et al. 2014; Sobotková et al. 1988) is characterised in terms of 
physical features and cell phenotype. Aspects explored in this chapter are as 
follows.  
1. Spheroid formation in terms of nanoparticle uptake, morphology, and 
central necrosis will be investigated using electron microscopy and viability 
studies. 
2. The capacity of MSCs in the model to differentiate into multiple stromal 
lineages will be evaluated using directed differentiation and histology.  
3. Expression of key niche cytokines at the gene and protein levels in 
monolayer and spheroid culture will be examined using 
immunohistochemistry and RT-qPCR. 
4. The expression of genes involved in cell-cell signalling pathways, niche 
interactions, stem cell phenotype, and MSC differentiation into stromal 
lineages will be compared between the two models using RT-qPCR.  
5. The effect of spheroid culture on MSC proliferation will be evaluated using 
a BrdU assay and analysis of cell cycle gene expression.  
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4.2 Materials and methods 
4.2.1 Cell culture 
In this chapter, MSCs were cultured in the format described in Section 2.2, i.e. a 
magnetically levitated spheroid implanted into a collagen gel, unless otherwise 
stated. MSCs cultured in monolayers were used for the histology assay and as 
controls for gene expression analysis. 
4.2.2 Electron microscopy 
Electron microscopy was used to examine the ultrastructure and formation of the 
spheroids. Samples were prepared for visualisation via scanning electron 
microscopy (SEM) and transmission electron microscopy (TEM) as previously 
described (section 2.9).  
4.2.3 ELISA assays 
Enzyme-linked immunosorbent assays (ELISAs) were performed to measure the 
amounts of particular cytokines secreted by the MSC population. A Human CXCL12 
Quantikine ELISA kit (R & D Systems, Minneapolis, USA) was performed according 
to the manufacturer’s instructions, as described previously (section 2.8).  
Standards were assayed from 2 technical replicates and experimental samples 
were assayed from 3 biological replicates. A standard curve was created from the 
standard absorbance measurements and used to interpolate the concentrations of 
the experimental samples. Measurements were normalised to the base reading 
obtained from the respective cell-free sample (DC1 & IC1) to control for the 
background concentrations in the different media formulations. This is of 
particular importance as one of the media formulations is serum free.  
Duplicate readings from the standard samples were similar, indicating accuracy. 
Linear regression was used to fit the standard curve to the average standard 
readings. The equation of the line was y = 0.4666 + 0.000155x, indicating high 
correlation between CXCL12 concentration and absorbance reading, as expected. 
For some of the biological replicates, no interpolated value was obtained. This is 
because the absorbance readings were outside the range of the standard curve, 
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i.e. the readings were below that of the 0 standard. This has decreased the sample 
size for some of the conditions. n = 3 for all conditions, except for DMEM 
monolayer day 2 (n = 1), DMEM spheroid day 2 (n = 1), DMEM spheroid day 9 (n = 
2), and IMDM spheroid day 2 (n = 2).  
4.2.4 Viability staining 
Spheroids were stained to assess central necrosis and general survival using 
calcein/ethidium homodimer staining, as described in section 2.3. Central 
necrosis was evaluated by taking a cross-section through the spheroid and 
assessing the intensity of red and green signal indicating dead and live cells, 
respectively. Cell numbers were also estimated using these signals.  
4.2.5 Histology 
Histological analysis was used to observe the deposition of terminally 
differentiated cell products, and hence assess the differentiation potential of 
MSCs. MSCs were cultured as spheroids, both implanted into collagen gel and 
maintained in media only. After 7 days, the spheroids in gel were treated with 
collagenase as described previously (90 min, 2 mg ml-1, equal volume to the gel). 
All spheroids were then dissociated using resuspension with a needle and re-
seeded onto sterilised glass coverslips. The following day, the media was changed 
to either adipogenic, osteogenic, or chondrogenic induction media (DMEM with 
10% FBS and 2% antibiotics, with supplements as listed in Table 4.1), and the cells 
were grown for 30 days, with media changed twice a week. Cells were fixed and 
stained with Oil Red O, Alizarin Red, or Safranin O stains respectively. MSCs grown 
in monolayers for 30 days were used as a control.  
Induction media Supplements  
Osteogenic 350 µM ascorbate-2-phosphate, 0.1 µM 
dexamethasone 
Adipogenic 1 µM dexamethasone, 1.7 nM insulin, 200 µM 
indomethacin, 500 µM isobutylmethylxanthine 
Chondrogenic 10 ng ml-1 TGFβ1, 100 nM dexamethasone, 6.25 µg 
ml-1 insulin, 50nM ascorbate-2-phosphate, 100 mg L-1 
sodium pyruvate 
Table 4.1 Supplements used for induction media formulations.  
Chapter 4  121 
 
4.2.5.1 Oil Red O staining 
Oil Red O staining was used to observe the deposition of neutral triglycerides and 
lipids, indicating adipogenesis. Samples were rinsed in 60% isopropanol and 
stained in Oil Red O for 15 min. They were then rinsed in isopropanol until 
colourless, followed by a wash with water. The nuclei were counterstained with 
Weigert’s haematoxylin for 10 min, washed again with water, and mounted onto 
slides with an aqueous mountant.  
4.2.5.2 Alizarin Red staining 
Alizarin Red identifies calcium-containing osteocytes in culture. The samples were 
washed in graded alcohols to water, then stained with Alizarin Red solution for 5 
min. The samples were blotted with filter paper, then rinsed in acetone for 30 
sec. They were then rinsed in a 1:1 solution of acetone-xylene for 15 sec, followed 
by a wash with xylene only. They were then mounted onto slides with aqueous 
mountant.  
4.2.5.3 Safranin O staining 
Safranin O is an indicator of chondrogenesis. Samples were taken to water through 
3 changes of graded alcohols. They were then stained with Weigert’s haematoxylin 
for 10 min, followed by a wash in water for 10 min. they were then stained with 
0.001% Fast Green for 5 min, rinsed in 1% acetic acid for 10 sec, and stained with 
0.1% Safranin O solution for 7 min. This was followed by a wash with water. The 
samples were dipped in 1% acetic acid, then dehydrated and mounted onto slides 
with aqueous mountant.  
4.2.6 Quantification of immunohistochemistry  
Immunohistochemistry was carried out as described in section 2.5. Images were 
processed in ImageJ and signals were quantified as follows:  
 Cell number was obtained by using a threshold to isolate nuclei in the DAPI 
channel. Particle analysis, of particles with a size greater than 3 µm, was 
used to count the number of nuclei.  
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 Signal in the FITC channel (representing STRO-1, nestin, or CXCL12) was 
quantified by setting a threshold to isolate areas of green signal. The total 
area of green signal (µm2) was obtained using the ‘Measure’ function in 
ImageJ.  
 The amount of FITC signal per cell nucleus was calculated using the 
formula: signal per cell = FITC area / total cell number.  
 These values were obtained for several cell images for each culture 
condition at two time points (day 3 and day 7). Significant differences 
between culture systems at different time points were evaluated using 
multiple heteroscedastic t-tests.  
4.2.7 Gene expression analysis  
To examine changes induced in cell behaviour by the spheroid culture system, 
expression of several genes including those related to cell cycle regulation, MSC 
differentiation, and signalling pathways was analysed. MSCs were cultured in 
spheroids or monolayers for 7 days, at which point the cells were harvested and 
RNA was extracted according to the procedure described in section 2.10. Reverse 
transcription was performed according to the protocol detailed in section 2.11. 
Fluidigm analysis was performed according to section 2.12.  
Fold change in spheroids compared to monolayers was calculated using the 2-CT 
method (Schmittgen & Livak 2008). Briefly, for each technical replicate the values 
of the housekeeping genes were averaged. These were then subtracted from the 
value of each test gene. Technical replicates were averaged. The biological 
replicates for the results obtained from monolayers were averaged and subtracted 
from each biological replicate for spheroids. These values were converted into 
fold change by raising 2 to the power of the negative CT.  
The non-parametric Kruskal-Wallis test, followed by Dunn’s multiple comparisons 
test, were performed on the CT values to evaluate differences between 
spheroids and monolayers (n = 3 per gene). p < 0.05 was considered statistically 
significant. Statistical analysis was performed using Microsoft Excel (Microsoft, 
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Redmond, WA, USA) and GraphPad Prism (GraphPad Software Inc., La Jolla, CA, 
USA).  
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4.3 Results  
4.3.1 Spheroid morphology and ultrastructure via electron 
microscopy 
Transmission and scanning electron microscopy were used to evaluate 
nanoparticle uptake, spheroid formation, morphology, and ultrastructure at 
different cell seeding densities. The SEM images indicate that the spheroids, once 
formed, developed into spherical structures made up of multiple cellular domains 
(Figure 4.1). This general spheroid shape did not differ between the different 
seeding densities, although larger aggregates of several spheroid structures were 
observed at the higher densities. These images confirm that spheroid formation 
remained constant regardless of cell number. Multiple cellular projections were 
visible on the cell surface, reflecting cellular interaction with the 3D spheroid 
environment.  
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Figure 4.1 Scanning electron micrographs of spheroids formed at different cell seeding 
densities.  
A, B, C, scale bar = 200 µm; D, E, F, scale bar = 10 µm; G, H, I, scale bar = 5 µm; J, K, L, scale 
bar = 2 µm.  
The TEM images clearly show nanoparticle internalisation into the MSCs, located 
in vesicles within the cytoplasm (Figure 4.2). There was no apparent difference in 
cellular uptake of nanoparticles between the different seeding densities.  
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Figure 4.2 Transmission electron micrographs of spheroids formed at different cell seeding 
densities.  
A-F, representative TEM images from spheroids seeded at different initial cell densities. G, H, 
representative higher magnification images taken of spheroids at the 5 x 104 seeding density.  
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4.3.2 MSC spheroid size 
MSC spheroids generated using different seeding densities, stained with a calcein 
AM/ethidium homodimer viability stain, were measured in terms of their cross-
sectional area (CSA) in FIJI (Figure 4.3). The difference in spheroid size at 1 × 104 
and 5 × 104 cells ml-1 was not statistically significant, however, a large significant 
increase in size was observed in spheroids seeded at 1 × 105 cells ml-1. The range 
of sizes at this higher density was varied, with many smaller spheroids apparent, 
similar to those at the lower seeding densities. When considered with the SEM 
images in Figure 4.1, this suggests that there may be a limit on spheroid size when 
formed via magnetic levitation, and the larger structures that were observed 
result from amalgamation of several smaller ones. There was also a strong 
correlation between spheroid size and cell number (Figure 4.4), with correlation 
coefficients of 0.98206805, 0.880558, and 0.9755847 for seeding densities 1 × 104, 
5 × 104, and 1 × 105 respectively.  
 
Figure 4.3 Spheroid size variation at different seeding densities.  
Spheroid cross-sectional area in µm2 was measured for all spheroids imaged at each time 
point: 1 × 104, n = 11; 5 × 104, n = 37; 1 × 105, n = 17. Statistical significance is based on results 
of the Kruskal-Wallis test followed by Dunn’s multiple comparisons test. ****P < 0.0001. 
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Figure 4.4 Spheroid size increases with increasing cell number.  
Spheroids are plotted by cell number against size. The Pearson Product-Moment Correlation 
Coefficient between spheroid area and cell number was calculated for each seeding density 
using the CORREL function in Excel: 1 × 104, 0.98206805; 5 × 104, 0.880558; 1 × 105, 0.9755847. 
4.3.3 Spheroid viability 
MSC viability was determined using a calcein AM/ethidium homodimer viability 
stain as described in section 4.2.4. The percentage of pixels producing signal 
above a given threshold in the FITC channel as compared to those producing signal 
in the TRITC channel was calculated as a proxy for percentage viability for each 
spheroid. There was no statistically significant difference in percentage viability 
in spheroids seeded at the different densities (Figure 4.5A). The relationship 
between percentage viability and spheroid size is shown in Figure 4.5B.  
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Figure 4.5 MSC spheroid viability varies with initial seeding density and spheroid size.  
A: Percentage viability of spheroids seeded at different cell densities. The green signal (FITC 
channel) indicated calcein stained live cells and red signal (TRITC channel) ethidium 
homodimer stained dead cells. Percentage FITC signal was calculated to give a proxy for 
percentage viability. The Kruskal-Wallis test followed by Dunn’s multiple comparison test was 
used to compare the means of all three groups; no statistically significant differences were 
detected (p > 0.05). Mean percentage viability ± 95% confidence interval. B: MSC spheroid 
viability in relation to spheroid size. Percentage FITC signal detected for each spheroid is 
plotted against spheroid cross-sectional area in µm2. The Pearson Product-Moment 
Correlation Coefficient between spheroid size and percentage viability was calculated for 
each seeding density using the CORREL function in Excel: 1 × 104, -0.145204; 5 × 104, 
0.0885486; 1 × 105, 0.4547947. 
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Central necrosis in the spheroids was evaluated by taking measurements of FITC 
and TRITC signal from cross-sections of spheroid images (Figure 4.6). The TRITC 
signal remained at a lower level than the FITC signal across the spheroid, with a 
few intermittent peaks indicating dead cells. Basal grey value (as a proxy for 
fluorescence intensity) for FITC remained at around 4500, and for TRITC around 
2000 for all spheroids. The values of the peaks in the FITC channel, indicating live 
cells, varied depending on strength of absorption of the stain and location in the 
spheroid. There was a larger number of viable cells compared to dead cells, and 
a suggestion of central necrosis that increased with spheroid size, as the TRITC 
signal peaks appeared in the central area of the spheroid.  
 
Figure 4.6 MSC spheroid cross-sectional viability via FITC and TRITC signal across 
spheroids with different cell seeding densities.  
Green, FITC; Red, TRITC. Scale bar = 200 µm. 
4.3.4 Differentiation capacity of MSCs following spheroid culture  
MSC differentiation capacity when cultured as spheroids was evaluated by 
histological staining (Figure 4.7). Adipogenic differentiation was clearly visible in 
all three types of cells. Oil Red O stains neutral triglycerides and lipids red, and 
several cells exhibiting partial or total staining, as well as adipose cell 
morphology, were visible. However, the staining observed in cells grown in 
osteogenic and chondrogenic media was more ambiguous, as it was confounded 
by the presence of nanoparticles, which have a similar colour to the stain. A small 
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amount of red staining was observed in the corresponding monolayer controls, 
indicating the presence of calcific deposits and chondrogenic cells, respectively.  
 
Figure 4.7 Histological analysis of cells grown in adipogenic (A-C), osteogenic (D-F), or 
chondrogenic (G-I) induction media formulations.  
A, D, G, MSCs grown in monolayers; B, E, H, MSCs extracted from spheroids grown in media; 
C, F, I, MSCs extracted from spheroids grown in collagen type I gel. A-C, stained with Oil Red 
O; D-F, stained with Alizarin Red; G-I, stained with Safranin O. Scale bar = 100 µm. 
4.3.5 Gene expression analysis  
Fluidigm high-throughput RT-qPCR was used to evaluate the expression of several 
gene groups in spheroids compared to monolayers. These included genes involved 
in the cell cycle, MSC differentiation, niche microenvironment interactions, and 
cell-cell signalling pathways.  
4.3.5.1 Cell cycle genes 
The expression of most of the cell cycle genes investigated (Figure 4.8) decreased 
in spheroids when compared to monolayers. The greatest decreases were observed 
in p53 and cyclin D2 expression (both approximately 0.31-fold change, p < 0.05). 
The expression of two genes, cyclin D1 and FOS, increased, although neither of 
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these increases were significant. Cyclin D1 expression increased 2.5-fold, and FOS 
expression increased 6.2 times in spheroids over monolayers, a significant increase 
(p < 0.05).  
 
Figure 4.8 Fold-change in expression of genes involved in the cell cycle in MSC spheroids 
compared to monolayers.  
Values presented as mean fold change ± standard error of the mean, n = 3. *p < 0.05. 
4.3.5.2 MSC differentiation and phenotype 
Several genes were included in the panel that relate to MSC differentiation into 
bone, fat, and cartilage stromal lineages. They include both early and late 
indicators of differentiation. Increased expression of osteogenesis related genes 
osterix, BMP2, and osteopontin was observed in spheroids compared to monolayers 
(Figure 4.9). The greatest, statistically significant (p < 0.05), increase was 
observed for BMP2, of 55.6 times the amount in monolayers. Osterix and OPN 
expression were increased 8.8- and 4.9-fold, respectively. GATA2 expression was 
also increased 4.7-fold (p < 0.05). SMAD7 and VEGF were upregulated by 2.2 and 
1.7 times, respectively.  
Chapter 4  133 
 
Expression of RUNX1 and SMAD7 remained essentially unchanged in spheroids 
compared to monolayers (expression levels of between 0.8 and 1.0 times that of 
the monolayer for each). The rest of the genes related to MSC differentiation were 
downregulated, although not to a degree of magnitude similar to the upregulated 
genes. TCF3, PML, and RUNX2 expression levels in spheroids were more than half 
the levels of the monolayer (ranging between 0.63 and 0.7 times the expression). 
STAT3, TCF4, NFKB1, NFKB2, and LEF1 mRNA levels were lower than half the 
amount observed in monolayers (range 0.45-0.55 times).  
 
Figure 4.9 Fold-change in expression of genes involved in MSC differentiation in MSC 
spheroids compared to monolayers.  
Values presented as mean fold change ± standard error of the mean, n = 3. *p < 0.05. 
Examining the expression of genes involved in MSC phenotype can indicate 
whether stem cell properties are maintained (Figure 4.10). CD79, MEIS1, and CD63 
mRNA abundance were 0.3, 0.4, and 0.5 times the levels observed in monolayers. 
CD271 and HIF1α levels remained constant. The rest of the MSC markers, CD34, 
CXCR4, and nestin, were upregulated. Although these changes were not 
significant, they are of a high magnitude, at 7.9, 9.7, and 31.0 times the levels of 
the control, respectively.  
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Figure 4.10 Fold-change in expression of genes involved in MSC phenotype in MSC spheroids 
compared to monolayers.  
Values presented as mean fold change ± standard error of the mean, n = 3.  
4.3.5.3 Niche microenvironment interactions 
Genes involved in cell adhesion and cytokine interactions were examined to 
evaluate the extent of cell interactions in the model compared to standard 
culture. All genes involved in direct cell adherence were either downregulated or 
remained the same in spheroids compared to monolayers (Figure 4.11). In 
particular, VCAM1 was significantly downregulated (p < 0.05, 0.03 times that of 
control, equivalent to ~32-fold difference). ALCAM and CD44 expression remained 
similar to the levels in monolayers, and VLA4, ICAM1, and N-cadherin were all 
significantly downregulated to approximately 0.25-fold (p < 0.05).  
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Figure 4.11 Fold-change in expression of genes involved in cell-cell or cell-ECM adhesion in 
MSC spheroids compared to monolayers.  
Values presented as mean fold change ± standard error of the mean, n = 3. *p < 0.05.  
One gene (SCF) involved in cytokine interactions was significantly downregulated 
to 0.15 times the level in spheroids compared to monolayers (p < 0.05). Tie-2 was 
also downregulated by 0.17 times the level in the control, although this change 
was not significant. The expression of CXCL12, Ang1, and TPO all remained 
approximately the same in spheroids compared to monolayers.  
 
Figure 4.12 Fold-change in expression of cytokines and receptors in MSC spheroids 
compared to monolayers.  
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Values presented as mean fold change ± standard error of the mean, n = 3. *p < 0.05.  
4.3.5.4 Notch signalling 
Notch signalling is both a regulator of osteogenesis and a mediator of HSC-stromal 
interactions in the niche: the major components of this pathway have been 
analysed here. HEY2 and Notch4 were significantly downregulated by 0.017-times 
and 0.26- times (p < 0.05) in spheroids, respectively. All other genes of the Notch 
pathway have remained relatively constant in spheroids, with the majority 
exhibiting slight downregulation. DLL4 has increased to the greatest extent, with 
an 8.28-fold increase.  
 
Figure 4.13 Fold-change in expression of genes involved in Notch signalling in MSC 
spheroids compared to monolayers.  
Values presented as mean fold change ± standard error of the mean, n = 3. *p < 0.05. 
4.3.5.5 Hedgehog signalling 
Hedgehog (HH) signalling is also involved in both differentiation and proliferation 
of MSCs. All components of the HH signalling pathway decreased in expression or 
remained constant. GLI1 and 3 exhibited the smallest difference. PTCH2, SMO, 
and SUFU decreased to around 0.5-times. The significant decrease in PTCH1 
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expression is slightly greater at 0.32-times the level of that observed in 
monolayers (p < 0.05).  
 
Figure 4.14 Fold-change in expression of genes involved in Hedgehog signalling in MSC 
spheroids compared to monolayers.  
Values presented as mean fold change ± standard error of the mean, n = 3. *p < 0.05. 
4.3.6 Protein expression of MSC markers and key cytokines 
4.3.6.1 Immunohistochemistry 
Immunohistochemistry was used to evaluate the protein levels of the HSC-
supportive cytokine CXCL12, and the MSC markers STRO-1 and nestin. Expression 
of all three gene products was increased in spheroids compared to monolayers, in 
accordance with the results obtained from genetic analysis.  
Expression of STRO-1, indicated by green fluorescent signal, was not evident in 
cells grown in monolayers at either day 3 or day 7 (Figure 4.15). However, 
expression was clearly visible in spheroids at both time points, with an increased 
frequency of cells expressing the marker at day 7. The differences at both time 
points were statistically significant (day 3, p = 0.032; day 7, p = 0.015).  
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Figure 4.15 STRO-1 staining in MSCs grown in either monolayer or spheroid culture systems 
for 7 days.  
A: Fluorescence microscopy images, DAPI (blue) = DNA/nuclei, TRITC (red) = phalloidin 
(actin); FITC (green) = STRO-1. Scale bars = 200 µm. B: Average STRO-1 signal (µm2) in 
relation to cell number (nucleus number) for each image, mean ± SEM, n ≥ 3, *p < 0.05. 
A small amount of expression of CXCL12 was evident in monolayers at day 7 (Figure 
4.16). However, none can be seen in monolayers at day 3. In spheroids, there was 
a small signal at day 3, with no difference observed compared to monolayers (p = 
0.51). By day 7, CXCL12 levels increased significantly in spheroids compared to 
monolayers (p = 0.0093). This indicates that cells in culture do not initially express 
day 3 day 7
0
100
200
300
400
Time point
S
T
R
O
-1
 s
ig
n
a
l 
 µ
m
2
/c
e
ll Monolayer
Spheroid
*
*
A
B
Chapter 4  139 
 
CXCL12 and require a conditioning period of time in spheroids before they begin 
to express this cytokine.  
 
Figure 4.16 CXCL12 staining in MSCs grown in either monolayer or spheroid culture systems 
for 7 days.  
A: Fluorescence microscopy images, DAPI (blue) = DNA/nuclei, TRITC (red) = phalloidin 
(actin); FITC (green) = CXCL12. Scale bars = 200 µm. B: Average CXCL12 signal (µm2) in 
relation to cell number (nucleus number) for each image, mean ± SEM, n ≥ 3, **p < 0.01.  
Nestin expression exhibited a difference between the two culture systems at an 
early time point (Figure 4.17). Green staining was only observed in one cell in 
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monolayer culture at both time points. However, staining was widely distributed 
throughout spheroids at both day 3 and day 7, with the protein being almost 
ubiquitous at day 7. This difference was not significant at day 3 (p = 0.086), but 
at day 7, nestin was significantly increased in spheroids above the level in 
monolayers (p = 0.0023).  
 
Figure 4.17 Nestin staining in MSCs grown in either monolayer or spheroid culture systems 
for 7 days.  
A: Fluorescence microscopy images, DAPI (blue) = DNA/nuclei, TRITC (red) = phalloidin 
(actin); FITC (green) = nestin. Scale bars = 200 µm. B: Average nestin signal (µm2) in relation 
to cell number (nucleus number) for each image, mean ± SEM, n ≥ 3, **p < 0.01. 
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4.3.6.2 Quantitative analysis of CXCL12 concentration 
Further analysis of CXCL12 was conducted using an ELISA, as it is a secreted 
cytokine. Two different media formulations were used: standard DMEM containing 
FBS; and serum-free IMDM suitable for HSCs. In DMEM (Figure 4.18), CXCL12 
concentration in the media evidently increased with time, with the highest 
expression in both monolayers and spheroids at day 14. However, the level in 
spheroids was significantly lower (p < 0.01). In IMDM, the expression increased 
more quickly, with a higher level at day 1 in both monolayers and spheroids. 
However, this level was maintained throughout the period of cell culture (14 
days). The concentration remained below 100 pg ml-1 at every time point, whereas 
in DMEM the level was above 100 pg ml-1 by day 14. There was also no difference 
between the two culture systems, with spheroids maintaining similar levels at all 
time points.  
 
Figure 4.18 CXCL12 concentrations in cell culture supernates from MSCs cultured either in 
monolayers or spheroids in DMEM or IMDM media formulations.  
**p < 0.01, n = 3.  
4.3.7 Proliferation analysis 
A BrdU assay was performed to evaluate MSC proliferation in the two culture 
systems (Figure 4.19). Proliferating cells are indicated by an overlap of the DAPI 
stain (blue, nuclei), and the BrdU stain (green, replicating DNA), as the cells 
integrate the thymine analogue into the DNA strand during replication. Here, this 
is represented by a turquoise colour. These stains overlapped to a greater extent 
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in cells in monolayers at day 3. At day 7 the green stain was also more prevalent, 
but whether these overlapped was more ambiguous. The DAPI stain was less 
effective in the spheroids; possibly due to the presence of the collagen gel. Hence, 
elucidating the extent of proliferation is problematic. However, less BrdU was 
detected in the spheroid samples in general, indicating that it was not integrated 
into the cell DNA.  
 
Figure 4.19 MSCs in monolayers and spheroids stained with anti-BrdU antibody following 
treatment with BrdU.  
DAPI (blue) = DNA/nuclei, TRITC (red) = phalloidin (actin); FITC (green) = nestin. Scale bar = 
200 µm. Proliferating cells are indicated by overlapping blue and green signals (white arrows).   
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4.4 Discussion 
This chapter aimed to evaluate MSC spheroid formation, and the behaviour of cells 
grown in the 3D model, in terms of gene expression, protein expression, and 
cytokine release. Behaviours such as quiescence, differentiation, and expression 
of HSC-supportive cytokines that are relevant to HSC support were included in the 
analysis.  
4.4.1 Confirmation of nanoparticle uptake and spheroid formation  
SEM analysis allows visualisation of gross spheroid morphology and cell surface 
activity. As evident from high magnification images, spheroid morphology and size 
vary considerably, although this is not dependent on initial cell seeding density. 
Looking more closely at the cell surface, excess nanoparticles are clearly visible 
with a ‘grainy’ texture above the smoother cell surface, surrounding multiple 
filopodia. These filopodia may have greater importance for cell spreading 
dynamics in a 3D environment, compared to a flat environment wherein 
lamellopodia formation is important (Albuschies & Vogel 2013). The appearance 
of the abundant projections may be a response to the presence of the NPs, 
although filopodia have also been observed to a lesser extent in HeLa spheroids 
formed by the liquid overlay technique (Ma et al. 2012). SEM analysis of these 
HeLa cell spheroids showed individual spherical cells with distinct junctions, 
however, this is less clear with the MSC spheroids developed here. 
TEM images clearly show NP uptake into endosomes, as has been observed in 
previous studies (Smith et al. 2010). These endosomes are of varying shapes and 
sizes, contain varying amounts of NPs, and localise among other organelles. Figure 
4.2G also depicts an endosome either fusing with or being formed from the outer 
cell membrane, confirming that this is a continuing dynamic process even 
following spheroid formation. Excess NPs are also visible surrounding the cells, 
and in contact with the filopodia. Here, cellular junctions are more distinctive, 
demonstrating that cells are in close contact with each other within the spheroid.  
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4.4.1.1 Magnetic MSC spheroids within collagen gel culture do not exhibit 
increased cell-cell or cell-ECM adhesion 
Cell-cell and cell-ECM adhesion are important during formation of spheroids. 
Magnetically levitated spheroids are initially generated in culture media over 24 
hours, after which time they are cultured within a type I collagen gel, to 
recapitulate the BM niche microenvironment. It is expected that both integrins 
(cell-ECM interactions) and cadherins (cell-cell interactions) play a key role. 
Following the formation of loose aggregates via integrin-ECM binding, cadherin 
expression increases followed by formation of compact spheroids by homophilic 
cadherin-cadherin interactions (Figure 4.20, Bartosh et al. 2010). In addition, cell-
cell interactions are also important for HSC retention in vivo. Therefore, the gene 
expression of a selection of adhesion molecules in MSC spheroids was investigated, 
although all genes appeared to be either decreased or similar to monolayer 
controls.  
Expression of activated leukocyte-cell adhesion molecule (ALCAM)4, a 
transmembrane glycoprotein involved in cell-cell adhesion (Nakamura et al. 2010), 
and CD44, which is involved in cell-cell and ECM adherence (Wagner et al. 2008), 
both remained unchanged in spheroids compared to monolayers. Although higher 
expression was expected due to the increased adhesion to the collagen in the 
model, this may have occurred through separate mechanisms.  
Integrins are fundamental components of focal adhesion complexes, which form 
during cell-ECM and cell-cell adhesion. They interlink ECM proteins with the actin 
cytoskeleton, transmitting information about the cellular microenvironment to 
the cytoskeleton and the nucleus, triggering changes in cell gene expression and 
behaviour. β1 integrins (including α1β1 and α1β2) are the main receptors for 
collagen binding (Jokinen et al. 2004). The integrins analysed here are very-late 
antigen 4 (VLA-4), an α4β1 integrin, which binds to vascular cell adhesion 
molecule 1 (VCAM-1); and lymphocyte-associated antigen 1 (LFA-1)5, a β2 integrin 
normally expressed on leukocytes. Whilst results for LFA-1 were not obtained, the 
                                         
4 ALCAM is also known as CD166.  
5 An extreme value was obtained for LFA-1 in this analysis, with n=1 due to sample failure. 
Therefore, it has been removed from the results.  
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significant decrease in expression of VLA-4 was unexpected, as enhanced cell-cell 
interactions in spheroids were expected to upregulate integrins.  
Aside from cell-ECM interactions, cell-cell interactions are crucial to spheroid 
formation. In this case, cadherins, a major class of cell-cell adhesion molecule, 
have been implicated in the latter stages of spheroid compaction. Indeed, MSC 
spheroid formation from umbilical cord-derived cells clearly requires E-cadherin 
(Lee et al. 2012). In addition, a paper published after this experiment was 
conducted (Zhou et al. 2017) showed that spheroid formation is associated with 
an increase in homotypic cell-cell adhesion via N-cadherin and E-cadherin, rather 
than through integrin mediated interactions. Although their study did not apply 
exogenous ECM to hanging drop spheroids, this indicates that cell-cell adhesion, 
rather than cell-ECM adhesion, is important in spheroid culture. In this 
magnetically levitated system, however, N-cadherin was significantly 
downregulated, therefore implying that this mechanism is not predominant in this 
spheroid system.  
 
Figure 4.20 Schematic of the stages involved in spheroid formation. 
The recent study by Zhou et al. (2017) also noted that 3D spheroid culture was 
accompanied by an increase in transcription of genes associated with 
pluripotency, particularly Nanog. Similar phenomena were observed in the gene 
expression analysis study presented here, with, for example, nestin, CD79, and 
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CD63. In the previous year, Zhou et al. (2016) investigated the mechanisms for the 
changes in gene expression in spheroids compared to monolayers, implicating 
cytoskeletal changes as the causative mechanism. The presence of an F-actin6 
network in the nucleus was observed in spheroid MSCs, which may influence gene 
expression by regulating chromatin organisation, as Nanog expression is associated 
with loose chromatin structure (Miyamoto et al. 2011). It is possible that a similar 
mechanism is acting in the spheroids described here, where actin is reorganised 
during spheroid formation and throughout culture.  
High expression of the VLA-4 ligand VCAM-1 has been used to identify a self-
renewing, rapidly proliferating, and differentiating MSC population (Mabuchi et 
al. 2013). However, in this study expression of VCAM-1 has been significantly 
downregulated to a level that equates to a 32-fold decrease. The downregulation 
may simply reflect that the MSC spheroids are non-proliferating and quiescent. 
ICAM-17 is also a glycoprotein that binds to integrins, including LFA-1, and is 
upregulated in BM MSCs upon the addition of nucleated umbilical cord blood 
(Romanov et al. 2017): rather than participating in MSC-MSC adhesion, ICAM-1 may 
have a role in facilitating MSC-HSC interactions. Again, ICAM-1 has been 
significantly downregulated in spheroids compared to monolayers, contrary to 
expectations.  
The adhesion molecules examined in this study are mainly focused on cell-cell 
adhesion. Further work could examine molecules such as VLA-1 and VLA-2, which 
are known to interact with collagen specifically. Vimentin expression, another 
component of focal adhesions, was included in the gene panel, but no results were 
obtained for this gene.  
4.4.2 MSC spheroid size increases relative to cell number 
Compared to other MSC spheroid systems generated using different methods, 
these spheroids are smaller than expected, given the seeding density used. For 
example, Bartosh et al. 2010 reported MSC spheroids, generated through the 
                                         
6 F-actin = filamentous actin.  
7 ICAM-1 is also known as CD54.  
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hanging drop method, of approximately 400 µm diameter, equivalent to a CSA of 
approximately 0.13 mm2, when cells were seeded at a density of 10,000 cells per 
drop. This is compared to a median cross-sectional area (CSA) of around 0.025 
mm2 for magnetically levitated spheroids when seeded with the same number of 
cells. Similarly, spheroids seeded at 100,000 cells per hanging drop had an 
approximate CSA of around 0.64 mm2 (diameter of around 900 µm, Bartosh et al. 
2010), compared to 0.2 mm2 for the magnetically levitated spheroids. Notably, 
however, the hanging drop method causes formation of numerous small aggregates 
which gradually coalesce into a single spheroid. This spheroid does not then grow 
in size but progressively compacts between 48 and 96 hours (Bartosh et al. 2010).  
Rossi et al. 2005 used a non-adherent surface to generate MSC spheroids. 
Similarly, the spheroids from this system were larger than those created through 
magnetic levitation (50,000 cells produced spheroids of 0.26 mm2, compared with 
0.025 mm2 in the present study), although they were more comparable to those 
that were magnetically levitated. This ten-fold difference may be partly due to 
cell loss during the levitation process, in addition to the formation of several 
different spheroids.  
Zimmermann & Mcdevitt (2014) produced spheroids that were slightly smaller but 
comparable in size to the magnetically levitated spheroids, using forced 
aggregation followed by centrifugation. However, given that these were initiated 
with an order of magnitude fewer cells than with the magnetic levitation method, 
this again suggests that the latter method produces smaller spheroids than those 
generated by alternative methods. A possible explanation for these size 
differences is that in a hanging drop system especially, the cells are forced to 
aggregate into a single structure. In the magnetic levitation method, cells are 
forced together, but this results in a collection of smaller aggregates each of under 
1000 cells individually (Figure 4.4). These smaller spheroids may be more similar 
in structure to collections of cells within the BM compared with larger spheroids, 
as the diameter of BM sinusoids around which MSCs are found is up to 60 µm (Itkin 
et al. 2016), equivalent to a CSA of 2800 µm2. Although the smallest spheroids 
produced through the method described here produced are larger than BM 
sinusoids, their conformation may be more similar to MSC clusters in vivo than the 
bigger spheroids.  
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Strong positive correlation was observed between spheroid size and spheroid 
number at all densities, in accordance with expectations (Figure 4.4). The largest 
spheroids were made up of over 500 cells individually. It is worth noting that the 
larger spheroids were less spherical and more cylindrical in shape compared to 
the smaller ones, due to the non-uniform properties of the magnetic field, as 
characterised previously in the Centre for Cell Engineering (Dejardin et al. 2011; 
Smith et al. 2010). A cylindrical shape may contribute to preventing central 
necrosis by decreasing the distance in one plane from the cells in the centre to 
the edge of the spheroid, maintaining diffusion of nutrients and oxygen. This may 
be reflected by the reduced expression of HIF1α in the spheroids.  
4.4.3 MSC spheroid viability is maintained with increasing cell 
density  
Many spheroid systems suffer from central necrosis when they reach a certain size 
threshold, due to increased diffusion distance for vital nutrients and potential 
internal hypoxia (Hirschhaeuser et al. 2010; Souza et al. 2010; Banerjee & Bhonde 
2006). To assess the extent of necrosis in this magnetic MSC spheroid system, 
cross-sectional signals in the TRITC and FITC channels following viability staining 
were taken to identify clusters of dead and live cells, respectively. Figure 4.6 
displays these cross-sections alongside fluorescence microscope images of 
spheroids formed from cells seeded at different initial seeding densities. For all 
densities, the TRITC signal is maintained at a low level with limited elongated 
peaks, which would indicate clusters of dead cells (central necrosis). On the other 
hand, the FITC signal is maintained at a high level, indicating consistent high 
viability across the spheroid.  
As best as can be determined, given the often-irregular spheroid shapes 
generated, the diameter of the spheroids generated from this magnetic levitation 
method range between 200 µm and 360 µm (median size for the lowest and highest 
seeding densities, respectively). Areas of central necrosis were not detected in 
these spheroids. It has been reported that spheroids of diameters greater than 
400-600 µm will exhibit central necrosis, at twice the thickness of the viable cell 
rim (Groebe & Mueller-Klieser 1996). As the magnetically levitated spheroids are 
below this threshold, they conform to this model, and do not exhibit excessive 
central necrosis.  
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4.4.4 MSCs grown in spheroids retain differentiation capacity 
One of the defining features of MSCs is the capacity to differentiate into cell types 
of various lineages. MSCs have been documented as producing cells of the 
osteoblastic, chondrocytic, fibroblastic, myoblastic, and adipocytic lineages 
(Caplan & Correa 2011). Hence, MSC capacity for differentiation was assessed 
following an extended period of growth in spheroids, as shown in Figure 4.7.  
Although MSCs grown in spheroids evidently retain adipogenic differentiation 
capacity, as evidenced by cells clearly stained with Oil Red O, the differentiation 
results are more ambiguous for chondrogenesis and adipogenesis. Although 
staining is observed, the nanoparticles contained in the cells confound the 
red/orange stains that indicate deposition of chondrogenic cells and calcific 
deposits, respectively. However, previous studies of this model have confirmed 
the differentiation potential of spheroids grown in media using a combination of 
histology and immunofluorescence (Lewis et al. 2016).  
4.4.5 Spheroid culture maintains MSCs as quiescent 
MSC quiescence within the bone marrow is important for retention of niche 
functionality. Therefore, the expression of certain key cell cycle genes in MSCs 
and MSC proliferation (via BrdU incorporation) were compared in the monolayer 
and spheroid culture systems.  
With regards to the gene expression study, the results generally show that the cell 
cycle is downregulated and the MSCs are more quiescent in spheroids compared 
to monolayers. A large number of these genes are involved in the G1/S phase 
transition, all of which indicate a downwards trend or have remained similar to 
controls, suggesting that DNA replication is not triggered. Whilst none of these 
differences were statistically significant, this trend supports a previous study in 
the Centre for Cell Engineering, in which genes across different phases of the cell 
cycle were found to be reduced in spheroid culture (Lewis et al. 2017). There are 
several differences in the cyclins and main regulators of the cycle. The genes 
studied are summarised in Figure 4.21, indicating their role in the cell cycle, with 
further discussion of gene changes compared to monolayer controls below.  
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TP53 expression has significantly decreased in MSC spheroids compared to 
monolayers. TP53, also known as p53, is a tumour suppressor gene, which acts 
through multiple mechanisms to repair DNA and slow the cell cycle at the G1/S 
checkpoint. Loss of p53 in MSCs increases growth rate (Armesilla-Diaz et al. 2009), 
promotes senescence, chromosomal instability, and resistance to apoptosis 
(Velletri et al. 2016). Differentiation into osteogenic lineages is repressed by TP53 
expression (Velletri et al. 2016), and both adipogenic and osteogenic 
differentiation are accelerated by p53 knockdown (Armesilla-Diaz et al. 2009), 
hence a reduction in p53 may indicate potential to differentiate. 
 
Figure 4.21 Schematic of the cell cycle including changes in gene expression in MSC 
spheroids identified from this analysis.  
Green arrows, increased expression; red arrows, decreased expression.  
The D-type cyclins phosphorylate Rb, freeing E2F for cell cycle activation. Cyclin 
D2 increases MSC proliferation, and may be a biomarker for MSC transformation 
(Kono et al. 2013). Cyclin D2 expression has significantly decreased in MSC 
spheroids compared to monolayers, indicating that cells have decreased 
proliferation in the model. In contrast, Cyclin D1 levels increased in spheroids, 
although this change was not significant.  
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Significantly increased FOS expression in spheroids indicates suppression of cell 
cycle gene expression, and increased progression to osteoblastic differentiation. 
FOS is a proto-oncogene and a TF. It forms a heterodimer with c-Jun, forming 
activator protein 1 (AP-1), a complex that binds DNA to influence gene expression. 
c-FOS is a negative regulator of cell growth, and prolonged expression suppresses 
entry into the cell cycle by HSCs. AP1 is a positive regulator of OB differentiation. 
(Matsumoto et al. 2012; Kushibiki et al. 2015; Liu et al. 2016). The large increase 
in FOS expression may be related to the increased expression of osteogenic 
markers observed (Figure 4.9).  
As none of the expression changes between cell cycle genes in monolayers and 
spheroids are significant, it is hard to draw definitive conclusions. However, 
upregulation of c-FOS, and general downregulation of cyclins and TFs indicates a 
general trend towards MSC quiescence in spheroid culture. The BrdU assay further 
supports this conclusion (Figure 4.19), where a higher number of MSCs in 
monolayer cultures were proliferating compared to MSCs in spheroids. This is again 
consistent with a reduction in BrdU noted in magnetic MSC spheroids in results 
obtained from previous studies in the Centre for Cell Engineering (Lewis et al. 
2016).  
4.4.6 Spheroid culture maintains primitive MSC phenotype  
As HSCs are supported by primitive MSCs within the bone marrow niche, 
maintenance of MSC phenotype is key to the success of generating a HSC 
permissive BM niche model. The expression of several genes that are key in 
maintaining MSC state as a regenerative, self-renewing pool of progenitors were 
therefore examined in both monolayer and spheroid culture. The results were 
encouraging, with a decrease recorded in CD79, which is a qualifying criterion of 
the identification of true multipotent MSCs (Dominici et al. 2006), and increased 
trends noted in nestin, CXCR4, and CD34, although none of these changes were 
significant. In addition, MSCs grown in either monolayers or spheroids for 7 days 
were analysed using immunohistochemistry to investigate both STRO-1 and 
nestin, both key MSC features within the BM niche; results indicated increased 
levels of protein expression in spheroids compared to corresponding monolayer 
controls.  
Chapter 4  152 
 
As previously described, nestin is a cytoskeletal component that potentially 
defines the HSC-supportive subset of MSCs in the BM (Méndez-Ferrer et al. 2010; 
Pinho et al. 2013). Nestin gene expression has increased 31-fold and demonstrated 
an increased level of staining in spheroids compared to monolayers. This is 
encouraging as it indicates that spheroid cultures are more able to support HSCs 
than monolayers. Whether nestin expression is merely retained to a greater extent 
in the spheroid culture, or whether this is a case of ‘reversal’; i.e. the MSCs are 
induced by the 3D model conformation to begin expressing nestin following loss in 
the monolayer culture, is unknown. If expression is due to reversal, this is 
particularly interesting as it means that MSCs may be able to revert to a more 
primitive state simply by changing culture system and/or conformation. These 
results also suggest that MSCs require presence of gel/ECM, 3D culture, and/or 
intimate cell-cell interactions to express nestin and hence support HSCs. Nestin is 
an intermediate filament protein, originally observed in primitive cells of the 
nervous system. MSCs have been shown to express several specific neural proteins 
prior to differentiation, one of which is nestin (Tondreau et al. 2004), and 
subsequently nestin+ BM cells were shown to possess the fundamental properties 
of MSCs: self-renewal, trilineage differentiation, and colony-forming unit activity; 
as well as co-localising with HSCs within the niche (Méndez-Ferrer et al. 2010; 
Kunisaki et al. 2013). This nestin+ subset is more quiescent, and although nestin+ 
cells participate in endochondrogenesis during development, in the adult marrow 
they preferentially contribute to the HSC niche rather than ossification (Isern et 
al. 2014; Ono et al. 2014).  
STRO-1 is a marker used to isolate MSC colony forming units (CFU-C) (Kolf et al. 
2007). However, MSCs in standard 2D culture gradually lose STRO-1 expression 
(Gronthos et al. 2003). The results presented here show that MSCs in spheroid 
cultures retain high STRO-1 expression for up to 7 days in culture, which increases 
over time, whereas it is lost in corresponding MSC monolayer cultures. Retention 
of STRO-1 suggests that the spheroid model system prevents differentiation and 
maintains the stem cell population. 
Overall, the expression of primitive stem cell marker genes suggests that MSCs in 
spheroids are retaining their undifferentiated, stem cell-like properties to a 
greater extent compared to monolayers. These results are encouraging, as 
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maintaining self-renewal capacity is essential for niche formation and 
preservation and is key to the development of a HSC-permissive niche model.  
4.4.7 Whilst maintaining phenotype, spheroid cultures may also 
induce bone marrow remodelling and differentiation 
Many genes are involved in determining MSC fate, maintaining a pool of self-
renewing progenitor cells, and thus maintaining HSC support functionality. 
Therefore, a selection of relevant genes involved in MSC differentiation were 
investigated. The majority of genes were noted as being similar between 
monolayers and spheroid culture. However, significantly increased expression of 
BMP2 (55.6 times higher in spheroids compared to monolayers) and significantly 
decreased expression of NFκB1 (0.45 times the level of monolayers observed in 
spheroids). In addition, both osterix and osteopontin (OPN) had large increases in 
expression.  
The increased expression of osteogenic differentiation regulator bone 
morphogenetic protein 2 (BMP2) is interesting. BMP2 stimulates osteogenic 
differentiation, chondrogenic differentiation, and endochondral ossification in 
MSCs (Zhou et al. 2016). Other osteogenic genes such as osterix8 (the ‘secondary 
master regulator’ of osteogenesis, Nakashima et al. 2002) are activated by BMP2 
signalling, which is reflected in the increased osterix expression recorded. In 
contrast, most of the genes involved in differentiation have either decreased 
slightly or remained constant. As BMP2 can act in a non-cell autonomous manner, 
this may indicate that MSCs are secreting signals to remodel the BM niche, as they 
would in vivo, by inducing osteogenesis in surrounding cells.  
Osteopontin (OPN) is a matrix glycoprotein that is involved in the calcification of 
bone and is a classic marker of osteoblastic differentiation in MSCs. OPN has 
slightly increased in the MSC spheroid cultures compared to monolayer. Although 
this may indicate a number of cells progressing to the osteoblastic lineage, the 
presence of OPN may also indicate an increase in quiescent HSC-supportive ability 
in the spheroids: it negatively regulates HSC number in vivo, and thrombin-cleaved 
OPN (tcOPN) is a chemoattractant for HSCs (Stier et al. 2005; Storan et al. 2015). 
                                         
8 Also known as SP7. 
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In fact, it has been speculated that the abundant presence of OPN in the 
endosteum may be the mechanism behind the varying cell cycle status of the HSCs 
in the different environments within the niche. However, this increase is not 
significant, and conclusions cannot be drawn.  
Despite the gene expression results leaning towards an increase in bone marrow 
remodelling and osteogenesis, the expression of genes involved in osteogenic 
signalling are either not changed or slightly decreased in spheroids compared to 
monolayers. However, NFκB1 has been significantly downregulated. As part of the 
platelet-derived growth factor (PDGF) pathway, which may be required for 
osteogenic differentiation, it may have  a role in osteogenic signalling (Goff et al. 
2008). Therefore, this decrease may indicate a lower level of osteogenic 
differentiation in the spheroid model.   
Several genes linked to chondrogenesis were also analysed, LEF1 (Paik et al. 
2012), SMAD7 (Iwai et al. 2008), and RUNX1. However, no significant changes were 
observed in these gees, suggesting that the model environment has little effect 
on chondrogenic differentiation. This is also the case for GATA2, which can also 
be a marker of adipogenic differentiation (Kamata et al. 2014).  
Analysis of differentiation markers on the whole suggests that MSCs in spheroids 
culture are retaining MSC phenotype, with a general decrease in differentiation 
into the chondro and adipo lineages. The increases noted in osterix and 
osteopontin are likely due to the large significant upregulation of BMP2. As many 
of the other genes involved in differentiation have not increased, this suggests 
that MSCs in spheroids are producing BMP2 in order to remodel the niche.  
4.4.8 Spheroid culture enhances CXCL12 expression and 
secretion 
The interfaces between cell types in the BM niche are not simply mediated by 
direct adhesion. Secreted cytokines and chemokines and their ligands also have a 
large role in facilitating entrance, retention, and maintenance in the 
microenvironment. CXCL12 is fundamental to appropriate BM niche function. 
Expression by early MSCs is required for HSC maintenance (Greenbaum et al. 
2013), is involved in HSC homing to the niche, and is necessary for HSC quiescence 
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(Tzeng et al. 2011). Therefore, expression of this chemokine is very important to 
evaluate. CXCL12 expression has slightly increased in spheroids compared to 
monolayers, although not to a large extent at day 3 (Figure 4.16). However, the 
levels of CXCL12 have dramatically increased at day 7, suggesting that a period of 
time in culture is required to stimulate production. 
The secretion of CXCL12 was further investigated using an ELISA assay, performed 
in both serum-free IMDM medium and DMEM, to probe the effect of medium 
formulation on cytokine output. The statistically significant difference in CXCL12 
expression between monolayers and spheroids at the 14-day time point could be 
due in part to (i) the greater proliferative potential of MSCs in monolayers, with 
an increased signal from an increased number of cells, and/or (ii) a retention of 
the cytokine within the collagen gel matrix with spheroid culture due to reduced 
diffusion of chemokines into the culture supernate, resulting in a lower detectable 
concentration. Therefore, a more helpful measurement to consider in the future 
would be CXCL12 output per cell. 
There was a clear difference in CXCL12 levels secreted in monolayer and spheroid 
cultures in the different media, with serum containing DMEM stimulating higher 
secretion values. The maximum concentration measured was around 300 pg ml-1 
in DMEM, whereas all measurements for IMDM samples were below 150 pg ml-1, 
implying that CXCL12 is more highly expressed by cells grown in the presence of 
serum. However, in serum-free medium, spheroids and monolayers produce 
comparable levels of CXCL12, suggesting that MSCs in spheroids produce large 
amounts of CXCL12, especially given the diffusion and cell number issues 
mentioned above. Production by spheroids in both media formulations are also 
comparable, suggesting that spheroids produce CXCl12 without the presence of 
serum. There is some evidence to suggest that serum-free media reduces 
immunoregulatory potential in MSCs (Menard et al. 2013; Zimmermann & Mcdevitt 
2014). Therefore, HSC-supportive serum-free media may undermine the 
supportive capability of MSCs in monolayers but not in spheroids. For cells grown 
in IMDM, there was no significant difference between the culture methods at any 
time point. Conversely, SFM may simply reduce the proliferative capacity of MSCs, 
with the observed differences instead indicating a higher output of CXCL12 from 
spheroids in comparison to cell number. 
Chapter 4  156 
 
This corroborates the results obtained from immunohistochemistry, in which 
CXCL12 expression is increased in spheroid culture compared to monolayer, and 
also suggests that a longer time in culture is required for expression (as expression 
levels were higher at day 7 compared to day 3). 
4.4.9 Spheroid culture does not enhance additional cytokine gene 
expression levels.  
As explained with CXCL12 above, secreted cytokines, chemokines, and their 
ligands play a large role in maintenance of the niche microenvironment. 
Therefore, the gene expression of several other potentially interesting cytokines 
in both monolayer and spheroid culture was investigated, including stem cell 
factor (SCF), Tie-2 (angiopoietin receptor), Ang1 (angiopoietin 1) and TPO 
(thrombopoietin). Both SCF and Tie-2 were significantly decreased in spheroid 
culture, whilst Ang1 and TPO remained unchanged.  
SCF is expressed by niche cells and has an important role in HSC migration. It is 
alternatively spliced into transmembrane and soluble forms. The transmembrane 
form has a role in HSC adherence to the niche (Driessen et al. 2003). SCF 
expression has been significantly downregulated, unexpectedly. Its receptor is c-
kit9, and c-kit positive MSCs have greater colony forming potential rather than 
differentiation potential. c-kit/SCF signalling may downregulate lineage specific 
genes (Suphanantachat et al. 2014), maintaining the MSC undifferentiated state.  
Genes involved in niche interactions have, in general, decreased rather than 
increased as would be expected with enhanced inter-cell interactions and ECM 
binding. This may reflect that fact that the genes chosen are not in fact involved 
in spheroid formation, and another mechanism is acting. Furthermore, the cells 
may require the presence of HSCs and/or other cells to produce niche cytokines 
via a positive feedback loop.  
                                         
9 C-kit is aso known as CD117.  
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4.4.10 Spheroid culture influences major signalling pathways 
Major signalling pathways play a role in cell-cell interactions within the niche. 
Two of these pathways, Notch and Hedgehog, are investigated here to evaluate 
whether spheroids influence signals between cells.  
4.4.10.1 Spheroid culture decreases notch signalling 
Notch signalling has a role in bone osteoblastic development and haematological 
development. It has also been implicated as a potential intermediary in the 
interaction between HSCs and the osteoblastic niche component, which also 
requires direct cell-cell interaction. Genes encoding components of the notch 
pathway are all decreased or unchanged in spheroid culture compared to 
monolayer controls, except for DLL4. HEY2, a downstream regulatory target of 
Notch, has been significantly downregulated. The effects of notch signalling on 
osteoblastic differentiation are ambiguous. In vitro and in vivo studies have 
produced contradictory results, possibly due to the divergent roles of notch at 
varying stages of differentiation. Removal of notch from MSCs induces a short term 
dramatic increase in bone (Hilton et al. 2008), hence, notch signalling may 
maintain a pool of MSC progenitors by suppressing osteogenesis. This is supported 
by evidence from Dong et al. (2010), showing that notch is a general repressor of 
MSC differentiation, without lineage bias.  
Notch signalling has also been found to have a role in other stem cell niches, giving 
a precedent for its activity in the BM niche. Although there is some contradictory 
evidence, Notch signalling does seem to play a part in HSC maintenance by stromal 
niche cells (Weber & Calvi 2010). In addition, reduced Notch signalling increases 
CXCR4 expression, as is also seen in the magnetically levitated spheroids, hence 
increasing MSC migratory activity towards CXCL12 (Xie et al. 2013). 
Notch 1-4 are transmembrane receptors that require direct cell contact for 
activation. JAG1, JAG2, DLL1, and DLL4 are Notch ligands. Ligand interaction 
induces Notch cleavage, and hence release of activated Notch intracellular 
domain (NICD), which translocates into the nucleus. Binding of NICD to CBF1 alters 
its activity from repressor to an activator, by recruiting coactivators such as 
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Mastermind-like (MAML). HEY1 and HES1 are downstream signals. A schematic of 
the Notch signalling pathway is depicted in Figure 1.8.  
Notch signalling may inhibit osteoblastic differentiation via Hairy and Enhancer of 
Split (HES) and/or Hairy/enhancer-of-split related with YRPW motif (HEY) 
proteins, as they directly interact with RUNX2 to decrease its activity (Hilton et 
al. 2008). HES1 protects cells from differentiation and senescence (Liu et al. 2015; 
Sang et al. 2010) and is important for MSC maintenance and suppression of 
chondrogenesis (Dong et al. 2010). However, levels in MSC spheroids are 
essentially unchanged from cells in monolayers, indicating no change in notch 
signalling. Although it has multifactorial effects, the significant HEY2 expression 
decrease indicates an decrease in osteoblast related genes (Sharff et al. 2009). 
In summary, the evidence from the notch signalling pathway gene expression study 
indicates that differentiation is decreased in spheroids and it may be increasing 
expression of HSC-supportive markers. This conclusion is drawn from the 
significant downregulation of its main target gene HEY2, indicating a general 
decrease in activity, and the decreased expression of the Notch4 receptor.  
4.4.10.2 Spheroid culture does not influence hedgehog signalling  
All the genes involved in the HH signalling pathway (Error! Reference source not f
ound.) have been minimally downregulated or remain unchanged in spheroids 
compared to monolayer, save for PTCH1, which has been significantly 
downregulated. This may indicate decreased progression through the cell cycle, 
which would corroborate with analysis of the cell cycle genes examined (Figure 
4.8), and possibly an increase in osteogenesis, confirmed by increased BMP2 and 
osterix (Figure 4.9).  
Sonic hedgehog (SHH) is the best-studied human homologue of HH. Unfortunately, 
the qPCR in this study has not generated results for this gene. Therefore, the 
extent of SHH signalling is unknown. However, the signalling state can be inferred 
from the other components of the pathway that results have been obtained for. 
SHH increases ALP expression, osteocalcin expression, and triggers the BMP 
pathway in rat cells (J. Q. Cai et al. 2012). Applying recombinant SHH to rat BM-
MSCs enhances MSC proliferation, as indicated by FACS and MTT assays (J. Q. Cai 
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et al. 2012). However, contradictory results in human MSCs were obtained by 
Plaisant et al. (2011), suggesting that the effects of HH signalling on MSCs are 
species-specific. The Plaisant study also showed that inhibited HH signalling 
decreases MSC proliferation, via arresting the cells in G1/G0 phases of the cell 
cycle, which is also observed in spheroid cultures (i.e. a decrease in HH signalling 
and a decrease in MSC proliferation).  
PTCH1/2 are transmembrane receptors for HH ligands. They are located in 
primary cilia on the surface of almost all mammalian cells. When HH ligands bind, 
PTCH is displaced in the cilium by SMO, which then interacts with downstream 
elements to activate GLI family members (Error! Reference source not found.). T
he two PTCH receptors examined here have both been slightly downregulated in 
spheroids. Alone, this would indicate an increase in HH signalling. However, the 
concomitant decrease in other pathway constituents suggests a general decrease 
in HH signalling. Osteoblastic differentiation is associated with a 60% decrease in 
SMO expression in adipose-derived MSCs, accompanied by a decrease in the 
number of cells exhibiting primary cilia (Plaisant et al. 2009). SMO expression 
remains at a similar level in spheroids compared to monolayers, again indicating 
that HH signalling is decreased and potentially that osteoblastic differentiation is 
more likely to occur.  
Evidence from individual components of the HH pathway is conflicting. However, 
none of the genes have altered expression greater than four-fold in either 
direction. Hence, the trend is towards a slight decrease in signalling but with 
overall minimal change.  
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4.5 Conclusion 
MSC spheroids within a 3D collagen gel culture have been evaluated in terms of 
structure and size. They express higher levels of stem cell markers at both the 
gene and protein levels, whilst genetic and BrdU analyses showed that spheroids 
are more conducive to quiescence than standard monolayer culture. An interesting 
result also indicates that the MSC spheroids may be progressing towards the 
osteoblastic lineage, as indicated by upregulation of genes involved in 
osteoblastogenesis. These results may indicate that they are forming an 
environment similar to the endosteal niche, which harbours a quiescent OB subset, 
and to which quiescent HSCs locate.  
In the next chapter, this characterised 3D MSC model is extended to include other 
putative niche cells, OBs and ECs, to model the endosteal and vascular areas of 
the BM niche, respectively. The model is also used to examine its effect on HSCs 
and whether proliferation and maturation is affected.   
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Chapter 5 Study of cell behaviour following co-
culture within endosteal and vascular niche 
environments 
5.1 Introduction  
The preceding chapters have dealt with the characterisation of a 3D MSC spheroid 
BM model, and optimisation with a view to introduce HSCs to the culture model. 
In this chapter, the 3D model has been extended to include additional BM—
resident cells in an attempt to model different areas of the BM niche. 
As mentioned previously (Chapter 1), there are two niche ‘zones’ or environments 
within the BM: the vascular niche, around the BM blood vessels; and the endosteal 
niche, populated by quiescent osteoblasts on the bone surface. There are various 
models that have been proposed as to how these environments interact with each 
other; whether signals from the endosteum are in fact diffusing into a vascular 
environment, or whether this area independently comprises a distinct niche with 
a distinct function (Kiel & Morrison 2008, Figure 5.1). In addition to the presence 
of different cells within this areas, the MSCs present in each location may differ: 
nestin+ MSCs are perivascular; and CXCL12-abundant reticular (CAR) cells, which 
are generally considered to include an MSC subset, are located near the 
endosteum (Morrison & Scadden 2014). To further complicate the issue, the 
distinction between the vascular niches, i.e. sinusoidal and arteriolar, is unclear 
and these may themselves serve different niche functions (Kunisaki et al. 2013).  
These subsets may have different behaviours and properties which in turn have 
different influences on haematopoietic cells. For example, the endosteal niche is 
proposed to house quiescent, long-term HSCs maintained in G0 for an extended 
period of time. Injury or other external signals may cause activation and migration 
to the vascular niche, priming them for differentiation. A separate niche at the 
endosteum may accommodate cells undergoing self-renewing divisions (Wilson & 
Trumpp 2006b). Furthermore, these niches feed into haematopoietic 
differentiation. There is evidence to suggest that the vascular niche biases HSC 
differentiation into myeloid and megakaryocytic lineages, due to cues originating 
from BM-ECs (Rafii et al. 1995). In a similar way, early lymphoid progenitors 
appear to occupy a distinct endosteal niche (Ding & Morrison 2013). In this way, 
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the niche environments locally control HSC quiescence and multilineage 
differentiation.  
 
Figure 5.1 Schematic of possible relationships between endosteal and perivascular niches 
with in the BM. Taken from (Kiel & Morrison 2008).  
5.1.1 Objectives  
To evaluate the differences in HSC behaviour when cultured within different 
environments similar to the endosteal and vascular niches respectively, two triple 
culture models were developed. The endosteal niche model comprised OBs and an 
MSC spheroid, and the vascular model comprised ECs and an MSC spheroid. Freshly 
isolated HSPCs (following a CD34+ selection) were subsequently co-cultured within 
both environments. Whilst stromal-HSC co-culture is a decades-old concept, 
efforts to recapitulate these two niche environments by co-culturing HSCs with 
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additional cell types have been limited. The study described in this chapter aims 
to evaluate differences in cellular behaviour when cells are cultured in the model 
compared to when they are cultured in isolation, as follows.  
1. The individual cell populations, i.e., MSCs, OBs, endothelial cells, and HSCs 
will be extracted from the model using methods detailed in earlier 
chapters.  
2. RNA will be extracted from cell samples and expression of genes will be 
analysed in comparison to cell populations cultured in isolation. Categories 
of genes that will be examined are as follows:  
 Cell cycle genes, including cyclins, inhibitors, and promoters.  
 Markers of phenotypes, including those of haematopoietic 
lineages, osteoblastic lineage, endothelial cells, and MSCs.  
 Components of cell-cell signalling pathways including the Notch 
pathway and the Hedgehog pathway.  
 Genes involved in interactions between cells in the niche, including 
integrins, cadherins, cytokines, and their receptors.  
3. The results of this analysis will be evaluated in the context of the niche 
environment and hence functionality of the model in replicating the bone 
marrow. 
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5.2 Materials and methods 
5.2.1 Cell culture 
MSCs and HSCs were obtained and cultured as described previously (section 2.1). 
HUVECs were obtained from Lonza and OBs were obtained from Promocell; cells 
were separately maintained in their respective optimal medium (EBM and 
osteogenic DMEM). Following the introduction of HSCs into the model, the 
resultant triple-cultured models were maintained in SFM (IMDM + 5GFs, section 
2.1).  
5.2.2 Generation of co-cultured endosteal and vascular bone 
marrow models 
The co-culture models were established using a Transwell tissue culture insert 
(Figure 5.2, 12-well insert, 0.4 µm pore size, translucent, Greiner Bio-One 
International GmbH, Stonehouse, UK). ECs or OBs were seeded onto the membrane 
at 1 x 104 cells membrane-1. MSC spheroids were then formed as previously 
described (section 2.2). At day 0 of the experiment, spheroids were implanted 
into a collagen gel within the Transwell insert. This MSC/OB or MSC/HUVEC co-
culture was maintained for 7 days, with either OB medium (osteogenic media) or 
HUVEC medium (EBM) underneath the Transwell, and DMEM above the gel within 
the Transwell.  
 
Figure 5.2 Schematic of the triple-culture endosteal and vascular BM models, indicating 
MSC spheroids cultured within a collagen gel directly above OB/HUVEC monolayers. HSCs 
are subsequently introduced on top of the gel. 
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Following 7 days of co-culture, freshly isolated BM CD34+ cells were seeded onto 
the gel in SFM at a concentration of 15,000 cells well-1. After a further 7 days, the 
gel was digested with collagenase and the cell populations were extracted for 
downstream analysis. The timescale for the entire culture period is depicted in 
Figure 5.3.  
 
Figure 5.3 Experimental schedule with time points of events indicated.  
5.2.3 Cell sample extraction 
Suspensions obtained following digestion by collagenase were centrifuged at 400 
x g to pellet the cells, and washed in PBS twice using the same parameters. If 
appropriate, cell populations were prepared and separated using FACS as 
described in section 3.3.4.  
5.2.4 Gene expression analysis 
Cell pellets were obtained from the endosteal and vascular niche triple-cultures 
and RNA was extracted and reverse transcribed according to the procedures 
described in sections 2.10 and 2.11. RNA samples were analysed on a BioMark HD 
Fluidigm real-time PCR machine, as described previously (section 2.12). Raw data 
values were normalised by subtracting the average of the 6 housekeeping genes 
(ENOX2, B2M, UBE, ATP, RNF, and CYC1) from each experimental value. These 
were specific for each RNA sample. Technical replicates for each biological sample 
(n = 2 or 3) were then averaged. The averages of the biological control samples 
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were subtracted from each biological experimental value. These values were input 
into the equation: fold change = 2-CT. The mean, SD, and CV were calculated 
from these transformed biological values. Statistical analysis was performed using 
Microsoft Excel or GraphPad Prism. 
5.2.5 Phenotyping 
The endosteal and vascular niche models were cultured according to the timeline 
depicted in Figure 5.3. Freshly isolated BM HSPCs from the sample added to the 
models at day 7, and following a further 7 days of culture in both models and 
under various control conditions (see below), HSPCs were subsequently stained 
and analysed using a flow cytometer according to the procedure described in 
section 2.13.2. The culture conditions for HSPCs and samples run on the cytometer 
are as follows:  
1. Unstained control sample containing all cell types (HSPCs, MSCs, ECs, OBs).  
2. HSPCs cultured in suspension in SFM.  
3. HSPCs cultured in suspension in SFM, treated with collagenase on day 7.  
4. HSPCs seeded onto a collagen gel, extracted with collagenase.  
5. HSPCs cultured in a collagen gel with an MSC spheroid.  
6. HSPCs cultured in collagen gel with an MSC spheroid and OBs.  
7. HSPCs cultured in collagen gel with an MSC spheroid and ECs.  
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5.3 Results 
5.3.1 Fluidigm  
Following retrieval of individual cell populations from the endosteal and vascular 
models, RNA was extracted and samples were run on a Fluidigm BioMark HD 96x96 
RT-PCR chip. Figure 5.4 depicts the heat map of the Fluidigm qPCR chip following 
the run.  
 
Figure 5.4 Heat map generated from gene expression analysis using Fluidigm qPCR.  
The genes are listed along the x-axis and the cell samples are listed along the y-axis. Yellow 
colours indicate high expression (low Ct value) and blue/purple colours indicate low 
expression (high Ct value).  
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# Model  Cell type # Model  Cell type 
1 Single sample OB 21 HUVEC MSC  spheroid 
2 Single sample OB 22 HUVEC MSC spheroid 
3 Single sample OB 23 Endosteal HSC 
4 Single sample HUVEC 24 Endosteal HSC 
5 Single sample HUVEC 25 Endosteal HSC 
6 Single sample HUVEC 26 Endosteal HSC 
7 Single sample MSC monolayer 27 Endosteal HSC 
8 Single sample MSC monolayer 28 Endosteal HSC 
9 Single sample MSC monolayer 29 Endosteal MSC spheroid 
10 Single sample MSC spheroid 30 Endosteal MSC spheroid 
11 Single sample MSC spheroid 31 Endosteal MSC spheroid 
12 Single sample MSC spheroid 32 Endosteal MSC spheroid 
13 Vascular HSC 33 Endosteal OB 
14 Vascular HSC 34 Endosteal OB 
15 Vascular HSC 35 Endosteal OB 
16 Vascular HSC 36 Endosteal OB 
17 Vascular HUVEC 37 Single sample HSC 
18 Vascular HUVEC 38 Single sample HSC 
19 Vascular HUVEC  39 Single sample HSC 
20 Vascular MSC spheroid 40 
Non-template 
control 
Non-template 
control 
Table 5.1 Sample identification for the numbers listed on the y-axis of Figure 5.4. 
From the heat map, it is evident that the majority of the retrieved cell populations 
contained sufficient RNA to be successful. The non-template control (expected to 
fail) is situated at positions 40, 80, and 96, and failed for the majority of the 
primers used, except B2M in all three and MAML in the sample in inlet 40. As the 
former is a housekeeping gene and is expected to indicate high expression, and as 
a signal for MAML only appeared in one of the non-template control samples, the 
negative control sample was deemed valid. Only one primer failed completely 
(BMP7, position 95), with no signal generated in any of the cell samples.  
Additionally, low Ct values were observed in many of the single culture control 
samples. This was expected, as these samples were of the highest quality and 
quantity. These patterns were observed in both the technical and biological 
replicates, indicating that the results were consistent.  
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5.3.1.1 MSC spheroid gene expression within the endosteal and vascular 
niche models 
Gene expression in MSC spheroids within the co-culture models, as compared to 
spheroids cultured alone, was investigated (Figure 5.5). Differences were noted 
depending on whether the MSCs were cultured within a ‘blood vessel’ environment 
(with endothelial HUVEC cells; representing the vascular niche) or within a ‘bone’ 
environment (with osteoblasts; representing the endosteal niche). Cells were 
more quiescent in the endosteal niche model, as expected from the in vivo BM 
environment.  
Cell cycle genes (Figure 5.5A) were generally increased in expression in the 
endothelial HUVEC model but decreased in the OB model. This suggests that the 
models reflect the vascular (active) and endosteal (quiescent) niches, 
respectively. The G1/S transition-related E2F TFs all increased in expression in the 
HUVEC model, as did MCM4. AKT2 decreased in expression in the HUVEC model, 
and AKT1, and MYC did not change compared with spheroids in isolation. No results 
were obtained for cyclin E1, but cyclin D2 increased in expression, although not 
to the same extent as in the OB model spheroids.  
Both environments produced similar levels of MSC stem cell markers (Figure 
5.5B), except for an increase in the CXCL12 receptor (CXCR4) and nestin in the 
endosteal model. Conversely, differentiation markers (Figure 5.5C) were 
decreased in the endosteal model (bar one gene), whilst MSCs appeared to be 
more prone to differentiation in the vascular/sinusoidal model.  
MSC spheroids cultured in both bone and vascular environments had generally 
decreased expression of cell adhesion molecules when compared to single culture 
spheroids (Figure 5.5D). The one exception was ICAM-1, which increased with 
osteoblast co-culture.  
Four key HSC supportive cytokines and receptor genes were analysed. Generally, 
MSCs in the endosteal model demonstrated a decrease in expression. Meanwhile, 
Tie-2 and TPO were both increased in the vascular model (Tie2 expression 
increased by around 32-fold).  
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Finally, notch pathway genes were generally decreased in both co-cultures, 
indicating a decrease in activity of notch signalling. Hedgehog signalling remained 
similar to the control, although HHIP expression increased in both models.  
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Figure 5.5 Fold-change in expression of genes in MSC spheroids in co-culture models 
compared to those in isolation.  
Values presented as mean fold change ± standard error of the mean, n ≥ 2. A, Cell cycle genes; 
B, Stem cell markers; C, MSC differentiation markers; D, Adhesion genes; E, Cytokines and 
receptors; F, Notch signalling genes; G, Hedgehog signalling genes. Statistical significance 
was evaluated using the Kruskal-Wallis test followed by Dunn’s multiple comparisons test 
(three samples) or the Mann-Whitney U test (two samples), *p < 0.05, **p < 0.01. 
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5.3.1.2 Endothelial cell gene expression within a triple-culture model 
Gene expression in ECs at the 14-day time point, following co-culture is compared 
here to the control condition (EC monolayer grown in isolation, Figure 5.6). In 
summary, ECs cultured with the 3D model exhibited decreased proliferation, 
reduced cell signalling and adhesion, and adopted a mature phenotype. 
Expression of genes related to the cell cycle generally decreased in ECs in co-
culture. The one exception was the cell cycle suppressor FOS, which increased in 
expression by 16-fold (Figure 5.6A).  
A mixed picture is presented by genes related to angiogenesis. Positive regulators 
both increased and decreased in co-culture, as did negative regulators. Genes that 
are used to define vascular phenotype also generally decreased, with a large 
decrease noted in nestin expression (Figure 5.6B).  
Expression of genes involved in niche interactions, both directly via adhesive 
molecules and indirectly via cytokines (Figure 5.6C&D), decreased. In particular, 
c-kit was downregulated by the equivalent of over 30-fold.  
Genes involved in the Notch signalling pathway both increased and decreased in 
expression. However, overall the pathway was slightly upregulated, as evidenced 
by the increased expression of the downstream components HES1, HEY1, and HEY2 
(Figure 5.6E). In contrast, the Hedgehog signalling pathway was universally 
downregulated, with the greatest decrease observed in HHIP expression (Figure 
5.6F).  
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Figure 5.6 Fold-change in expression of genes in endothelial cells in the co-culture model 
compared to those in isolation.  
Values presented as mean fold change ± standard error of the mean, n ≥ 2. A, Cell cycle genes; 
B, Angiogenesis-related genes; C, adhesion molecules; D, cytokines and receptors; E, Notch 
signalling genes; F, Hedgehog signalling genes. Statistical significance was evaluated using 
the Mann-Whitney U test, *p < 0.05. 
Chapter 5  175 
 
5.3.1.3 Osteoblast gene expression within a triple-cultured model 
Gene expression was analysed in OBs when cultured in the co-culture model for 
24 days compared to culture in isolation (Figure 5.7). In summary, OBs cultured 
with the 3D model slowed their proliferation and exhibited reduced cell signalling 
and adhesion. With regard to the cell cycle, the general trend in expression of 
genes was very similar to the pattern observed in the MSC spheroids (Figure 5.7A). 
Downregulation of BMI1, E2F TFs, MYC, and MCM4 indicated a slower progression 
through the cell cycle, as did upregulation of the cell cycle suppressor FOS. 
However, the levels of cyclin E1 and cyclin D2 increased or remained the same. 
Similar to the MSC spheroids, FBXW7 and TP53 decreased, giving a contrary 
indication.  
The expression of MSC markers remained similar in the co-culture model 
compared to spheroids alone, although the general trend was towards decreased 
expression (Figure 5.7B). Genes related to differentiation also remained similar, 
and generally decreased, saving GATA1, GATA3, and OPN. Osteogenic markers 
and signalling generally decreased compared to monolayers, although 
osteopontin, found in mature OBs, was increased (Figure 5.7C).  
Expression of niche interaction genes generally decreased in co-culture. Adhesion 
gene expression levels remained similar or have decreased, with a significant 
decrease in VLA-4 levels. However, VCAM1 and ICAM1 levels slightly increased 
(Figure 5.7D). 
Expression of most of the intercellular signalling genes related to niche function 
remained similar in the model compared to monolayer culture. CXCL12 expression 
increased three-fold, and Ang1 expression decreased to less than a quarter of the 
level in monolayers (Figure 5.7E). However, large changes in notch signalling and 
hedgehog signalling were observed: large decreases occurred in many of the 
pathway components (Figure 5.7F&G).  
Chapter 5  176 
 
 
Figure 5.7 Fold-change in expression of genes in osteoblasts in co-culture models compared 
to those in isolation.  
Values presented as mean fold change ± standard error of the mean, n ≥ 2. A, Cell cycle genes; 
B, Stem cell markers; C, MSC differentiation markers; D, Adhesion genes; E, Cytokines and 
receptors; F, Notch signalling genes; G, Hedgehog signalling genes. Statistical significance 
was evaluated using the Mann-Whitney U test, *p < 0.05. 
Chapter 5  177 
 
5.3.1.4 Haematopoietic stem cell gene expression within an endosteal and 
vascular BM niche environment. 
Gene expression in HSCs with an MSC spheroid within an endosteal or vascular 
niche environment for 7 days was compared to expression in HSCs cultured in 
isolation (in suspension, Figure 5.8). A general increase in gene expression was 
observed in all gene categories included in the analysis.  
Genes involved in G1/S transition and global regulators of the cell cycle were all 
increased in the niche models compared to isolated culture (Figure 5.8A). This 
increase was greater in the endosteal model compared to the vascular model for 
all genes.  
All genes involved in the notch signalling pathway increased in expression in both 
models (Figure 5.8B). This increase was greater in the endosteal model, except 
for DLL3 and HEY1. Results were not obtained for components of the Hedgehog 
signalling pathway in HSCs.  
Expression of genes related to niche interactions between cells generally 
increased, as did all cytokine interaction genes in both models (except MPL in the 
endosteal niche model) (Figure 5.8C). Likewise, cell adhesion genes were also 
increased, in particular in the endosteal model HSCs (Figure 5.8D).  
The expression of all genes involved in differentiation into different 
haematopoietic lineages increased (Figure 5.8E). This was true for genes defining 
progenitor characteristics, those involved in erythroid differentiation, lymphoid 
differentiation, and myeloid differentiation. In general, the increase was greater 
in the endosteal model HSCs. With regard to progenitor markers, both models 
exhibited higher levels of marker expression than the corresponding suspension 
cultures; in addition, the expression levels appeared higher in the endosteal model 
as compared to the vascular model. The exceptions within the progenitor related 
genes were GATA2, which was upregulated to the same level in both models, and 
CD34, which was increased to a greater extent in the vascular model. For markers 
of erythroid differentiation, expression in both models was higher than in the 
control, and expression was higher in the endosteal model than in the vascular 
model. Expression of lymphoid lineage markers was increased in both models 
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compared to the corresponding control suspension cultures, with a similar trend, 
although GATA3 and CD79 were increased to a higher level in the vascular model. 
A similar pattern was observed in genes related to myeloid differentiation, with 
general increase in both models, and SMAD7 was the only gene related to myeloid 
differentiation that is increased to a higher level in the vascular model than the 
endosteal model.  
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Figure 5.8 Fold-change in expression of genes in HSCs in co-culture models compared to 
those in isolation.  
Values presented as mean fold change ± standard error of the mean, n ≥ 2. A, Cell cycle genes; 
B, Notch signalling genes; C, cytokine interaction genes; D, adhesion genes; E, 
haematopoietic differentiation related genes. Statistical significance was evaluated using the 
Kruskal-Wallis test followed by Dunn’s multiple comparisons test (three samples) or the 
Mann-Whitney U test (two samples), *p < 0.05. 
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5.3.1.5 Hypoxia (HIF1α) expression in all cell types in the endosteal and 
vascular niche models 
Hypoxia is an important parameter within the BM, as the organ is constitutively 
hypoxic, despite being highly vascularised (Morikawa & Takubo 2016). Cells in the 
BM express high levels of hypoxia-inducible factor alpha (HIF1α). The effect of co-
culture within the endosteal and vascular models on hypoxia in the different cell 
types was therefore investigated by looking at expression of HIF1α (Figure 5.9). 
For MSCs, OBs, and HUVECs, levels remained similar compared to the controls 
(cells cultured in isolation, the same as in preceding sections). However, large 
increases in expression were noted in HSCs when cultured in both the endosteal 
and vascular niche models, compared to when cultured in isolation, with a slightly 
larger increase in the endosteal model.  
 
Figure 5.9 Fold-change in expression of hypoxia-inducible factor (HIF1α) in cell types in the 
endosteal and vascular models compared to the respective controls. 
MSC, mesenchymal stem cell; EC, endothelial cell; OB, osteoblast; HSC, haematopoietic stem 
cell. Statistical significance was evaluated using the Kruskal-Wallis test followed by Dunn’s 
multiple comparisons test (three samples) or the Mann-Whitney U test (two samples). 
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5.3.2 Phenotype analysis  
Following extraction from the model after 7 days of culture, HSCs were analysed 
in terms of their surface markers to ascertain the extent of differentiation into 
various haematopoietic lineages.  
5.3.2.1 Progenitor subsets 
Using expression of several cell surface markers as described in section 2.13.2, 
populations of individual lineage progenitors were identified after 7 days of 
culture within the endosteal and vascular models or under various control 
conditions (Figure 5.10). As a control in the phenotyping experiment, a suspension 
sample treated with collagenase was included to ascertain the effect that the 
enzyme has on cell surface markers; as it has been documented to affect some 
lymphocyte surface markers (Abuzakouk et al. 1996).  
Following culture, the percentage of CD34+ cells decreased dramatically in all cell 
populations (from 84% immediately following isolation). This suggests that the 
majority of cells in culture were differentiating. HSCs cultured with ECs retained 
CD34 expression to the greatest extent, followed by cells in suspension (both 
treated and untreated with collagenase). When looking at the HSC fraction, 
freshly isolated cells contained approximately 10% HSCs, which was reduced 7 days 
post-culture; cells in 3D gel culture yielded a higher percentage of HSCs than those 
in suspension culture and the vascular and endosteal models. Multipotent 
progenitors (MMPs) decreased in a similar manner, with a decrease from 
approximately 10% in freshly isolated cells to below 1% in all culture conditions.  
With regard to the oligoprogenitor subsets CMPs & GMPs, numbers retrieved post-
culture were similar to those of freshly isolated cells, suggesting that these cells 
were not increased in number following time in culture. However, MEPs were 
clearly reduced in all culture conditions compared to freshly isolated cells, with 
small populations remaining particularly in the HSCs in gel and HSCs with a 
spheroid. Finally, the lymphoid lineage progenitors (MLPs & CLPs) were below 1% 
in all conditions, but remained at the highest levels in suspension culture.  
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Figure 5.10 Percentage composition of different haematopoietic progenitor subsets following 
extraction from co-culture models or under various control conditions.  
HSC, haematopoietic stem cell; MPP, multipotent progenitor; CMP, common myeloid 
progenitor; MEP, megakaryocyte-erythroid progenitor; GMP, granulocyte-monocyte 
progenitor; MLP, multi-lymphoid progenitor; CLP, common lymphoid progenitor.  
5.3.2.2 Lineage marker expression 
Expression of several lineage markers indicating differentiation into mature 
haematopoietic cells was investigated (Figure 5.11). CD7 expression was initially 
low and remained so in all samples at day 7. CD10 was initially expressed in 
approximately a quarter of cells, but disappeared from the population in all 
samples by day 7. CD13 was expressed in approximately a quarter of cells in the 
majority of samples after 7 days of culture. However, this percentage was 
decreased by about half in the endosteal model, and was slightly increased by 
culture within a gel. CD14 was essentially absent from all samples at day 7. CD34 
was expressed by approximately 20% of cells in all samples, save for HSCs cultured 
with OBs, in which the marker was essentially absent. The cells cultured with ECs 
had slightly increased CD34 expression over the suspension cells. CD36 was initially 
expressed in just above 20% of cells in most samples. In HSCs cultured with OBs, 
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this proportion was slightly lower. However, in HSCs extracted from the vascular 
model, there was a large increase in CD36 expression, to over 50% positive. CD41a 
was initially expressed at a low level, which was maintained in all experimental 
samples, except for HSPCs from the OB model, in which there was no expression 
remaining. Overlaid fluorescence profiles for each antibody in each sample are 
provided in Appendix A (Figure A.1 and Figure A.2) for more information about 
expression by the populations.  
Marker Cell subset/function 
CD34 HSC marker 
CD45 Present on all differentiated haematopoietic cells except erythrocyte 
progenitors and differentiated cells. Not expressed by megakaryocytes 
CD44 HA receptor, expressed ubiquitously 
CD36 Expressed on monocytes/macrophages, platelets, megakaryocytes, 
basophils, and erythrocytes 
CD41a Integrin α chain 2b, important for platelet aggregation (fibronectin 
receptor) 
CD10 PreB cells, preT cells; some T cells, B cells, and granulocytes 
CD7 Thymocytes and mature T cells 
CD13 Aminopeptidase expressed on T cells, monocytes/macrophages, and 
granulocytes (myeloid antigen). 
CD14 Macrophages and neutrophils (to a lesser extent). 
Table 5.2 Function of cell surface markers used to identify subsets of haematopoietic cells 
in experimental samples. 
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Figure 5.11 Percentage of cell population expressing different haematopoietic lineage 
markers.  
5.3.2.2.1 Collagenase treatment does not affect the success of phenotypic 
identification  
The expression of all markers in the collagenase treated sample compared with 
the untreated control suspension was similar (Figure 5.10 and Figure 5.11). 
Therefore, the results obtained from cells extracted from collagen using 
collagenase are reflective of the true expression levels.  
5.3.2.2.2 The proportion of CD34+ cells identified in a sample is dependent 
on the antibody used 
Two separate antibodies against the CD34 marker, each labelled with a different 
fluorophore, were used for phenotyping for two different panels (Figure 5.10 and 
Figure 5.11) on the same samples10 (both freshly isolated cells and those extracted 
from the model). However, the results produced from the two antibodies were 
                                         
10 The different antibodies were used in order to increase the range of fluorophores used for each 
panel.  
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vastly different, as shown in the profile plots for each antibody organised by 
sample (Figure 5.12). From this, it is evident that the separation between positive 
and negative cells was more discernible with the APC antibody. The two 
populations were less easily defined with the PerCP antibody. As APC is inherently 
a brighter fluorophore, the results from this channel are probably more reliable, 
and a better reflection of the true situation. Percentages of CD34+ cells were 
between 96% and 84% at day 1, using the ACP and PerCP antibodies, respectively. 
This equates to a difference of around 10%. However, at day 7 this difference 
increased to around 20%, (under 1% compared with around 20%) although the ratios 
of CD34+ cells to other cells were similar between samples.  
This difference has connotations for the accurate identification of the progenitor 
subsets in the samples, as the initial step of the gating strategy relies on isolating 
CD34+ cells, and all subsequent populations are identified from within this 
population. Hence, the frequency of progenitor subsets may be underestimated 
(Figure 5.10). To resolve this issue in the future, the lineage marker in the panel, 
which currently occupies the FITC channel slot, could be replaced with a brighter 
CD34-FITC antibody.  
 
Figure 5.12 Comparison of signals from APC and PerCP CD34 antibodies, both used in 
different cell phenotypic panels on the same samples (listed). 
  
Unstained	sample
HSPCs	cultured	in	suspension
Collagenase	treated	HSPCs
Endosteal model	HSPCs
Vascular	model	HSPCs
HSPCs	cultured	in	gel
HSPCs	cultured	in	gel	with	spheroid
Day	1	sample
Isotype	control	sample
SAMPLE
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5.4 Discussion 
In this chapter the original MSC spheroid bone marrow niche model has been 
extended to include both osteoblasts or endothelial cells, generating an endosteal 
and vascular niche environment respectively. These models were designed to 
create a HSC-permissive environment, to allow ex vivo culture of freshly isolated 
HSCs. The results from this chapter investigated MSC, osteoblast, endothelial cell, 
and more specifically HSC behaviour in the two models, in terms of gene 
expression changes and HSC phenotype. The results for each cell type are then 
discussed, with comments on the suitability of the two niche models for HSC 
culture. 
5.4.1 MSC spheroids have altered behaviour when co-cultured in 
endosteal and vascular niche models 
As described in Chapter 4, culture of MSCs in a spheroid within a collagen gel 
rather than as a monolayer has a profound influence on cell behaviour and 
phenotype. The cells become more quiescent, express higher levels of stem cell 
markers and nestin, and exhibit decreased inter-cell signalling. Co-culture of MSC 
spheroids with the two bone marrow niche models further influences the 
expression of genes involved in cell signalling, the cell cycle, differentiation, stem 
cell markers, and niche interactions. In order to simplify the results, all changes 
discussed have been collated into a table for each subset of genes.  
5.4.1.1 MSC spheroids are more quiescent in the endosteal model compared 
to the vascular model 
Transcriptome analysis of genes involved in the cell cycle in MSC spheroids 
cultured within the endosteal and vascular niche models has produced interesting 
results, with MSCs appearing to further down-regulate the cell cycle in the 
endosteal model, whereas the vascular model appears to be either similar to 
control (MSC spheroids cultured alone) or re-activating the cell cycle. However, 
some individual results are conflicting, as shown in Table 5.3. The results are 
divided into genes involved in G1/S phase, cyclins, and global regulators of the 
cell cycle.  
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Gene Gene Function 
Gene Expression 
Vascular Endosteal 
G1/S transition genes 
E2F1 
Transcription factor (TF) involved in cell cycle 
regulation and DNA synthesis.  
+ + 
E2F2 TF involved in cell cycle regulation and DNA synthesis. + - 
E2F3 TF involved in cell cycle regulation and DNA synthesis. = = 
MCM4  DNA replication licensing factor = - 
MYC  TF involved in control of DNA replication = - 
AKT2 
Kinase that promotes growth factor mediated cell 
survival and can overcome cell cycle arrest 
- -* 
AKT1 
Kinase that promotes growth factor mediated cell 
survival and can overcome cell cycle arrest 
= - 
Cyclins 
CYCLIN 
E1 
Interacts with cyclin dependent kinase 2, which is 
required for G1/S transition 
 - 
CYCLIN 
D2 
Interacts with cyclin dependent kinase 4 and 6, which 
are required for G1/S transition 
+ + 
Global cell cycle regulators 
FBXW7 
Component of a ubiquitin ligase complex targeting 
cyclins 
+ - 
TP53 Tumour suppressor, can arrest growth = -* 
p38 Stress responsive mitogen activated protein kinase = - 
FOS  Proto-oncogene = = 
BMI1  Oncogene  - - 
Table 5.3 Summary of changes in expression by MSCs of genes involved in cell cycle 
regulation.  
*p < 0.05. -, decreased expression compared to control; =, similar expression to control; +, 
increased expression compared to control.  
In the endosteal model, downregulation of MYC, which is involved in initiating 
DNA replication, supports reduced proliferation (Sato et al. 2016; Leung et al. 
2008). Furthermore, E2F2 transcription factor expression has decreased in the 
endosteal model, as has MCM4, as a key component of the pre-replicative 
complex, which is involved in DNA replication (S phase) (Kuijjer et al. 2008). With 
regards to the cyclins, a decrease in cyclin E1 levels supports a conclusion of 
reduced proliferation. AKT1/2 are also downregulated, as is the global regulator 
BMI1, a regulator of self-renewal (Park et al. 2004).  
In contrast, however, with regard to global regulators, TP53 expression is 
significantly (p < 0.05) downregulated in the endosteal model compared to control 
and to the vascular model. This indicates an increase in proliferation and 
acceleration of differentiation (Velletri et al. 2016; Armesilla-Diaz et al. 2009). 
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Lower p38 levels in the endosteal spheroids is also indicative of higher 
proliferation (Bhandari et al. 2010). Hence, these results suggest that the 
endosteal model is inducing the MSCs to proliferate and differentiate. In addition, 
with regard to cyclins, cyclin D2 expression has increased in both models, which 
indicates increased proliferation in both environments (Kono et al. 2013). 
In the vascular model, during G1/S phase, the majority of genes are either 
increased or remain similar to control. Increases in E2F1 and E2F2 expression 
were observed in the EC model compared to controls and the OB model. The 
liberation of these proteins progresses the cell cycle by activating gene targets 
such as CDK1, DNA polymerase, cyclin E, and CDK2 (Nevins et al. 1997; Iwanaga 
et al. 2006; Timmers et al. 2007; Wu et al. 2001). Hence, the changes in expression 
indicate that vascular model spheroids are proliferative compared to MSC 
spheroids in isolation. Cyclin D2 was increased and most global regulators were 
either unchanged or slightly increased, suggesting an increase in proliferation.  
Of the G1/S phase genes, only AKT1/2 were reduced in the vascular model 
compared to control. No cyclins were reduced and only BMI1 was reduced, 
suggesting reduced global regulation of self-renewal.  
Interestingly, FOS, a cell cycle suppressor (Liu et al. 2016), has remained 
essentially unchanged in both models, when compared to the control and to each 
other. This is very different to the spheroid/monolayer comparison in Chapter 4, 
where FOS was highly increased (by 8-fold, Figure 4.8), so the levels are already 
atypically high in 3D spheroid culture compared to standard culture.  
In conclusion, the vascular model (HUVEC-co-cultured MSC spheroids) exhibited 
fewer changes in gene expression from the control (MSCs in isolation). This may 
reflect the fact that the OBs have a greater influence on the co-cultured MSC cell 
cycle, where the general trend is a reduction in cell cycle and potential 
quiescence.  
5.4.1.2 MSCs in the endosteal model are more primitive than in the vascular 
model 
Evidence from genes related to MSC differentiation and MSC markers suggests 
that the MSC spheroids cultured with OBs have a more primitive phenotype 
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compared to both spheroids in isolation and those cultured with HUVECs, with a 
higher level of potential differentiation within the vascular model. The gene 
changes are summarised in Table 5.4 and discussed below. 
Gene Gene Function 
Gene Expression 
Vascular Endosteal 
Osteogenic markers 
RUNX2 
 Transcription factor (TF) associated with OB 
differentiation  
- - 
BMP2  Potent inducer of osteoblastic differentiation  - - 
OPN 
 Extracellular structural protein with a role in 
biomineralisation and bone remodelling 
- - 
Osteogenic signalling  
PML 
 Tumour suppressor required for assembly of nuclear 
bodies 
= - 
STAT3 
 TF mediating cell response to stimuli via JAK-STAT 
pathway 
= - 
VEGF  Growth factor involved in angiogenesis  - - 
TCF3  TF associated with Notch signalling = - 
TCF4  TF involved in differentiation and apoptosis = - 
NFKB2  TF involved in cell response to stimuli = - 
NFKB1  TF involved in cell response to stimuli = - 
SMAD6  Cell signalling: regulator of TGFβ proteins + - 
Adipogenic marker 
GATA2  TF mainly involved in haematopoiesis + - 
Chondrogenic markers  
LEF1  TF: transcription enhancer   + 
RUNX1  TF involved in haematopoietic differentiation  - - 
SMAD7  Cell signalling: regulator of TGFβ proteins - - 
MSC markers  
CD63 
 Antigen associated with membranes of intercellular 
vesicles  
=   
CD271  Receptor for neurotrophin also identifying MSCs + + 
CD34  Cell surface glycoprotein and cell-cell adhesion factor.  +   
CXCR4  Membrane receptor for CXCL12    + 
Nestin 
 Cytoskeletal protein expressed by nerve cells and 
identifying HSC-supportive MSCs 
  - 
Table 5.4 Summary of changes in expression by MSCs of genes involved in MSC 
differentiation.  
-, decreased expression compared to control; =, similar expression to control; +, increased 
expression compared to control. 
5.4.1.2.1 Osteogenic markers are downregulated in both models 
MSC spheroids cultured in both the endosteal and vascular models have reduced 
levels of osteogenic markers RUNX2, BMP2, and OCN, when compared to controls 
Chapter 5  190 
 
(MSC spheroids cultured alone), indicating reduced osteogenic differentiation. 
The magnitude of the OPN reduction is huge; results may indicate reversal of the 
increase in OB markers observed previously in spheroids when compared to 
monolayers (Figure 4.10). MSC expression of BMP2, another osteogenic 
differentiation regulator (Zhou et al. 2016), has also decreased in both models, in 
particular the endosteal model. In this situation, with co-cultured osteoblasts 
present, BMP2 may no longer be needed, as the surrounding cells are already 
terminally differentiated. In summary, decreased expression of all osteogenic 
regulators supports a lower level of osteogenic differentiation in the MSC 
spheroids when they are in co-culture.  
5.4.1.2.2 Osteogenic signalling is decreased in the endosteal model but is 
maintained in the vascular model 
The expression of genes related to osteogenic signalling have decreased to a 
greater extent in MSCs cultured in the endosteal model (with OBs) compared to 
those cultured in the vascular model (with ECs), further supporting a reduction in 
osteogenesis in MSCs within the endosteal model.  
Osteogenic signalling molecules, TCF4, NFκB1, and PML, have reduced expression 
in MSC spheroids in the endosteal model; a reduction suggests a decrease in 
osteogenesis (Almalki & Agrawal 2016; McCarthy & Centrella 2010; Sun et al. 
2013). Meanwhile, vascular endothelial growth factor (VEGF) may act in a similar 
way to BMP2 in the vascular model. Expression of this gene decreased in both 
models, in particular the endosteal model, in which it was significtly (p < 0.05). 
This indicates a reduction in osteogenesis in both niche environments (Mayer et 
al. 2005), but also that MSCs are not promoting angiogenesis at the 7-day time 
point when cultured with ECs. Accompanying downregulation of STAT3 in a 
corresponding pattern reinforces this conclusion (M. Wang et al. 2007; Nicolaidou 
et al. 2012).  
5.4.1.2.3 Adipogenic differentiation is inhibited to a greater extent in the 
vascular model 
GATA2 expression indicates inhibition of adipogenesis and expression is markedly 
elevated in the vascular model. This suggests lower levels of adipogenesis in MSC 
spheroids when they are co-cultured with ECs. There is some evidence in the 
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literature that angiogenesis and adipogenesis are coupled processes, where 
angiogenesis promotes the production of fat cells (Cao 2007). Therefore, the fact 
that ECs have adopted a mature phenotype in the model may be the reason for 
reduced adipogenesis.  
5.4.1.2.4 Chondrogenic differentiation is not affected by co-culture 
From the three chondrogenic genes assessed, it appears that chondrogenesis is 
greater in the endosteal model, both compared to the vascular model and to 
spheroids in isolation, as demonstrated by a decrease in SMAD7/RUNX1 and an 
increase in LEF1 expression in MSC spheroids (Paik et al. 2012; Iwai et al. 2008; 
Wang et al. 2005). Therefore, signals originating from OBs may be causing this 
increased transcription.  
5.4.1.2.5 MSCs in both co-culture environments maintain their phenotype 
Expression of MSC marker genes are generally higher in 3D MSC spheroid culture 
compared to 2D MSC monolayer culture, as demonstrated in Chapter 4, Figure 
4.10. However, when in 3D co-culture, MSC markers are either maintained at this 
higher level or have increased in both niche environments compared to control 
MSC spheroids, in particular in the endosteal model. A large increase in expression 
of CXCR4, the receptor for CXCL12, in the endosteal model may reflect the 
increased cross-talk between OBs and MSCs (note the increase in CXCL12 in the 
OB data, Figure 5.5E). In addition, CD271, a commonly used MSC marker (Quirici 
et al. 2002), has increased in both models, and to a greater extent in the endosteal 
model, as has nestin (endosteal model only). Meanwhile, levels of CD63 are 
unchanged, indicating a maintenance of stem cell phenotype.  
Results from these marker genes show that the original improved MSC state 
induced by the spheroid culture (section 4.4.6) is maintained, and even enhanced, 
when additional cell types are introduced into the model.  
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5.4.1.3 MSC spheroids in the vascular model may have an increased 
capacity for HSC support 
Evidence from expression of genes involved in niche function and interactions 
between stromal and haematopoietic cells suggests an increased capacity for HSC 
support by MSCs within the vascular model, compared to the endosteal model.  
Gene Gene Function 
Gene Expression 
Vascular Endosteal 
Adhesion molecules 
ICAM1  Cell surface glycoprotein that binds to integrins  + - 
ALCAM 
 Immunoglobulin receptor implicated in cell 
adhesion and migration 
- = 
VLA4 
 Integrin dimer that binds to fibronectin and 
VCAM1 
- = 
VCAM1 
 Cell surface immunoglobulin receptor, ligand for 
VLA4 
- = 
N-cadherin 
 Transmembrane protein involved in cell-cell 
adhesion 
- -* 
CD44 
 Cell surface glycoprotein with multiple ligands, 
involved in cell adhesion  
- -* 
Cytokines and receptors 
CXCL12* 
 Chemokine expressed by many cell types. 
Involved in niche homing and retention 
- - 
TIE2  Cell surface receptor for Ang1 +   
ANG1 
 Vascular growth factor mainly involved in 
angiogenesis 
- - 
TPO 
 Glycoprotein hormone that stimulates production 
and differentiation of megakaryocytes 
+ - 
Table 5.5 Summary of changes in expression by MSCs of genes involved in niche interactions.  
*p < 0.05. -, decreased expression compared to control; =, similar expression to control; +, 
increased expression compared to control. 
5.4.1.3.1 MSC spheroids in co-culture express lower levels of adhesion 
molecules 
The results from Chapter 4, Figure 4.11 indicated a reduction in adhesion-related 
genes in MSC spheroid culture compared to monolayer culture. This was surprising, 
as spheroids are known to employ cell-cell adhesions during spheroid formation 
(notably cadherins). When the MSC spheroids were subsequently co-cultured in 
the endosteal and vascular models, a further decrease in the expression of 
adhesion-related genes was noted (Table 5.5).  
N-cadherin and CD44 have both significantly decreased in expression in both 
models, especially the endosteal model. The former acts in cell-cell adhesion 
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(Zhou et al. 2017). Meanwhile, CD44 recognises hyaluronan (HA) and is involved in 
HSC-MSC adhesion (Wagner et al. 2008). Both of these results are unexpected, as 
is the reduction in expression of the integrin VLA4. 
ALCAM expression can be indicative of the ability of stromal cells to maintain a 
long-term repopulating subset of HSCs (Nakamura et al. 2010). A 0.25-fold change 
in expression compared to the control in the vascular model indicates a potential 
reduction in this ability in these spheroids. Expression of VCAM1, which can also 
be used as a marker for a self-renewing and rapidly proliferating MSC population 
(Mabuchi et al. 2013), has exhibited a decrease equivalent to 16-fold in the 
vascular model, and was slightly decreased in the endosteal model. This may show 
that the MSCs are losing some of the stem cell markers when co-cultured with 
HUVECs, which would correspond with the results in Table 5.4 and support the 
hypothesis that the vascular niche comprises cells that are less quiescent.  
ICAM-1 expression in MSC spheroids, however, has increased nearly 4-fold in the 
vascular model compared to control spheroids (whereas it has again decreased in 
the endosteal model). As this glycoprotein has been shown to play a role in HSC-
MSC adhesion (Romanov et al. 2017), this may reflect interactions between these 
cells in the model. Following on from this, it may show that more HSCs are directly 
interacting with MSCs in the vascular model compared with the endosteal model. 
However, this change is not significant.  
5.4.1.3.2 MSCs express lower levels of cytokines in co-culture 
When compared to MSC spheroids cultured alone, several of the key cytokines 
involved in HSC support and maintenance are decreased in both models. SCF has 
significantly decreased in the endosteal model, a change which is also significantly 
different from the small increase observed in the vascular model. This indicates a 
reduced HSC support function in the endosteal environment. CXCL12 expression 
has decreased in both models, although these changes were not significant. 
However, other cells co-cultured within the model may compensate for this 
decrease, for example CXCL12 expression has increased in OBs (Figure 5.7E). 
Similarly, ANG1 expression has decreased in both models, significantly in the 
vascular model. In contrast, the expression of the ANG1 receptor Tie-2 has 
markedly increased in the vascular model, suggesting that these MSCs may have 
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an increased capacity to respond to ANG1. TPO expression in MSCs has increased 
in the vascular model and decreased in the endosteal model, suggesting that ECs 
stimulate production of this cytokine, whereas interaction with OBs suppresses it. 
In summary, MSCs in the vascular model appear slightly more supportive for HSCs.  
5.4.1.3.3 Hedgehog signalling is decreased in both co-culture models 
Gene Gene Function 
Gene Expression 
Vascular Endosteal 
PTCH1  Receptor for sonic hedgehog + = 
SMO 
 Transmembrane protein that stimulates HH signal 
transduction  
= - 
GLI3  Zinc finger TF; activates PTCH1 expression = = 
GSK3B 
 Serine-threonine kinase involved in multiple 
signalling pathways 
= - 
HHIP  Hedgehog antagonist, interacts with HH ligands + + 
SUFU  Negative regulator of HH pathway = - 
Table 5.6 Summary of changes in expression by MSCs of genes involved in hedgehog 
signalling.  
-, decreased expression compared to control; =, similar expression to control; +, increased 
expression compared to control. 
No data has been obtained for the expression of HH ligands, so the activity of the 
pathway must be inferred from looking at downstream elements. However, 
evidence from the increase in HHIP expression suggests that the pathway may be 
inhibited in both the endosteal and vascular models (Kobune et al. 2012). 
Expression of other members of the pathway has not extensively changed 
compared to the control in either model, with no significant differences (Table 
5.6), although the trend suggests a decrease in Hedgehog signalling in the 
endosteal model and maintenance or small increase in the vascular model.  
5.4.1.3.4 Notch signalling is decreased in the endosteal model 
Generally, notch signalling is decreased in MSC spheroids cultured in the endosteal 
model, whereas it remains similar to control levels in the vascular model (Table 
5.7). 
Gene Gene Function Gene Expression 
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Vascular Endosteal 
NOTCH1  Notch receptor  = - 
NOTCH2*  Notch receptor = - 
NOTCH4  Notch receptor = - 
JAG2  Notch ligand + + 
DLL1  Notch ligand = - 
DLL3  Notch ligand -   
DLL4  Notch ligand - - 
MAML 
 Transcriptional co-activator (enhancer) in 
Notch pathway 
= - 
NUMB  Inhibitor of notch signalling = - 
LFNG  Inhibitor of notch signalling - - 
ADAM10 
 Cleavage protein essential for Notch 
signalling 
= - 
ADAM17 
 Cleavage protein essential for Notch 
signalling 
= - 
HES1  TF induced by Notch signalling  + - 
Table 5.7 Summary of changes in expression by MSCs of genes involved in notch signalling.  
-, decreased expression compared to control; =, similar expression to control; +, increased 
expression compared to control. 
The expression of Notch receptors (Notch 1, 2, and 4) have decreased in the 
endosteal model, with a significant decrease in Notch2 expression. This 
contradicts evidence from the differentiation genes, as Notch signalling typically 
inhibits osteogenesis (noted as reduced in endosteal model spheroids). In addition 
to the notch receptors, other genes have reduced expression in the endosteal 
model, including DLL1, MAML, and ADAM10/17. LFNG has significantly decreased 
in the endosteal model. Collectively, this supports a reduction in notch signalling 
in the endosteal model. 
Conversely, most genes remain unchanged when compared to control spheroids in 
the vascular model, with some exceptions (notch 4, JAG2, and HES1), which are 
all increased.  
Finally, HES1 expression (important for MSC maintenance (Dong et al. 2010)), as 
a target gene of the notch pathway, is different between the two niche models; 
it is increased in the vascular and decreased in the endosteal. As the main 
indicator of notch activity, this result is the strongest indication that notch 
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signalling may be increased in the vascular model, and decreased in the endosteal 
model. 
In conclusion, as depicted in Figure 5.13, the endosteal model is associated with 
decreased expression of genes involved in the cell cycle, differentiation, 
signalling, and adhesion, and an increase in MSC phenotype genes. In contrast, the 
gene expression patterns in MSCs cultured in the vascular model are more similar 
to the control, with an increase in cell signalling. This corresponds to the 
hypothesised situation in the BM, wherein the endosteal niche is quiescent and 
the vascular niche is more active.  
 
Figure 5.13 Summary schematic of changes in gene expression in MSC spheroids cultured in 
the two niche model environments compared to the control (spheroid alone). 
5.4.2 Endothelial cells are more mature in co-culture 
ECs have been included in this study as there is strong evidence for them 
participating in both arteriolar and sinusoidal niches, releasing SCF and CXCL12, 
as well as directly interacting with haematopoietic cells (Ding et al. 2012). Their 
inclusion in the 3D model is an attempt to simulate these vascular niches in co-
culture. The capacity of ECs to form rudimentary vasculature when cultured in 
collagen gel ex vivo is well documented (Yamamura et al. 2007; Korff & Augustin 
1999). Therefore, a secondary aim of this part of the analysis is to investigate 
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whether the HUVECs are angiogenic in the niche model, which may impact on their 
ability to support the HSCs directly or indirectly.  
5.4.2.1 Endothelial cells in co-culture are more quiescent 
A unique property of vascular endothelial cells (ECs) is the ‘contact inhibition’ 
they exhibit, i.e. they exit from the cell cycle, ensuring that cells that line the 
blood vessels are quiescent, protecting against thrombosis and neointima 
development. Therefore, in the monolayer culture system in which cells are in 
close contact (which in this study is the control), the cells are expected to be 
quiescent and non-proliferative. However, evidence here suggests that the 
HUVECs become even more quiescent in the co-culture model compared to when 
they are in isolation (Table 5.8).  
Gene Gene expression Gene Gene expression 
G1/S transition Cyclins  
E2F1 - CYCLIN E1 - 
E2F3 = CYCLIN D2 - 
E2F4 - Global cell cycle regulators 
MYC - FBXW7 = 
MCM4 - FOS + 
AKT2 = p53 - 
AKT1 = p38 - 
 BMI1 = 
Table 5.8 Summary of changes in expression by ECs of genes involved in cell cycle 
regulation. 
Refer to Table 5.3 for gene functions. -, decreased expression compared to control; =, similar 
expression to control; +, increased expression compared to control. 
The significant downregulation of MYC is a strong indicator of cell cycle 
downregulation, as MYC is essential for maintaining a normal endothelial 
phenotype (Baudino et al. 2002), and knockdown leads to senescence (Florea et 
al. 2013).All other G1/S phase genes analysed either indicate a downwards trend 
or no change from control ECs, including the E2F TFs, for which repression is well 
documented in quiescent ECs (Spyridopoulos et al. 1998).  
There is also a downregulation trend or no change compared to control ECs noted 
in the master regulators of the cell cycle in co-culture, aside from FOS which has 
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increased in expression, indicating maintained or improved angiogenesis (Mar et 
al. 2015). The significant downregulation of p53 suggests an increase in cell cycle 
progression, but in endothelial cells it has also been shown to have a role in 
endothelial dysfunction (Kumar et al. 2011), so this decrease may conversely 
indicate a maintenance of endothelial function.  
The evidence from this part of the analysis suggests that the co-culture model is 
providing signals enhancing quiescence, or increasing the interaction of HUVECs 
with each other to promote contact inhibition. It has previously been observed 
that co-culture with stromal cells in a collagen gel inhibits EC proliferation (Stahl 
et al. 2005). Several of the gene changes are also associated with maintained or 
enhanced angiogenesis. 
5.4.2.2 Endothelial cells adopt a mature bone marrow vasculature 
phenotype in the model 
The angiogenic activities of ECs overlaid with a collagen gel are important, as 
these structures may be more relevant for HSC niche function than a standard 
monolayer. Hence, examining the process of angiogenesis, and expression of 
related genes, is useful for evaluating the model in this regard.  
Angiogenesis is the remodelling of existing ECs to form mature vasculature, and 
proceeds through a series of stages, summarised in Figure 5.14. These can be 
divided into destabilisation, proliferation, and maturation. One of these early 
events involves degradation of the vascular basement membrane and ECM 
remodelling (Tabruyn & Griffioen 2007). Early transcriptional activation of 
angiogenic factors, such as VEGF and angiopoietins, is required to activate 
quiescent ECs, causing vessel sprouting and maturation. Proteases digest ECM, 
allowing the cells to invade and migrate towards the angiogenic factor. They 
proliferate behind the front of migration. Once lumen formation and sprouting 
have occurred, the stabilisation phase proceeds; different growth factors are 
involved in the stabilisation phase such as VEGF (Vailhé et al. 2001).  
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Figure 5.14 Schematic of the processes involved in angiogenesis.  
Adapted from (Romero 2015).  
With regards to positive regulators of angiogenesis, increases were observed in 
both RUNX2 and BMP2, with no change or decreases in the other genes compared 
to control ECs. When analysing negative regulators of angiogenesis, no significant 
changes were noted compared to control ECs. When considering EC phenotype, 
the only notable gene change is a decrease in nestin, although this change is not 
significant. Evidence from several genes discussed here indicate lower angiogenic 
activity, but a more mature phenotype, similar to that observed in the BM. This 
may suggest that ECs in the model have entered the stabilisation phase of mature 
vasculature. However, conclusions cannot be drawn as none of these changes are 
significant.  
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Gene Gene Expression Gene Gene Expression 
Positive regulators Phenotype 
VEGF = MEIS1 - 
STAT3 - Nestin - 
RUNX1 - GATA2 - 
RUNX2 + GATA3 - 
BMP2 + PML - 
HIF1α -  
 
Negative regulators 
NFκB2 = 
NFκB1 - 
SMAD6 + 
SMAD7 + 
CD63 - 
Table 5.9 Summary of changes in expression by ECs of genes involved in angiogenesis.  
-, decreased expression compared to control; =, similar expression to control; +, increased 
expression compared to control. 
5.4.2.3 Endothelial notch signalling increases in co-culture  
Notch signalling is relevant to niche function in ECs for several reasons. Firstly, 
expression of notch ligands equates to the ability of ECs to influence HSCs. 
Secondly, expression of notch and downstream genes indicates the ability of ECs 
themselves to respond to notch signals from other cells. Notch signalling 
influences ECs by promoting angiogenesis and/or contact inhibition, depending on 
the context. Changes in expression of genes involved in the notch pathway are 
summarised in Table 5.10.  
5.4.2.3.1 Notch pathway signalling within endothelial cells may decrease in 
co-culture 
The expression of Notch receptors has remained constant. This suggests that 
receptiveness to Notch signalling, and hence downstream effects, in ECs has 
remained similar to the control. The JAG ligands have also remained at similar 
levels. DLL ligands are inhibitors of endothelial sprouting. The significant 
downregulation of DLL1 may therefore indicate a reduction in this inhibition 
(Benedito et al. 2009), as well as a general decrease in Notch signalling. 
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Accompanying significant decreases in ADAM10 and MAML also indicate a decrease 
in the activity of this pathway. Expression of the end products of Notch signalling, 
HES1 and HEY1 has increased, which is an indication of increased Notch signalling. 
However, this trend is not significant, and so it is more likely that Notch signalling 
has decreased.  
Gene Gene Expression Gene Gene Expression 
NOTCH1 = ADAM17 - 
NOTCH2 + LFNG = 
NOTCH4 + MFNG - 
JAG1 = MAML - 
JAG2 = HES1 + 
DLL1 - HEY1 + 
DLL4 = HEY2 = 
ADAM10 -   
Table 5.10 Summary of changes in expression by ECs of genes involved in notch signalling.  
-, decreased expression compared to control; =, similar expression to control; +, increased 
expression compared to control. 
5.4.2.4 Hedgehog signalling may increase in co-culture  
HH signalling has a role in both angiogenesis and vasculogenesis, by targeting both 
ECs directly, or vessel-supportive cells. The direct effect of HH signalling is to 
allow tubulogenesis (Byrd & Grabel 2004). Unfortunately, insufficient data was 
obtained for the HH ligands. The majority of genes analysed indicated no change 
compared to the control ECs, aside from a decrease in HHIP and SUFU. HHIP, a 
natural HH ligand antagonist, is highly expressed in normal ECs (Nagase et al. 
2008). The significant decrease of SUFU indicates that HH signalling may be more 
active in co-culture, as it is a negative regulator of the pathway (Lee et al. 2007). 
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Gene Gene Expression 
PTCH1 = 
SMO = 
GLI3 = 
HHIP - 
SUFU - 
GSK3β - 
Table 5.11 Summary of changes in expression by ECs of genes involved in hedgehog 
signalling.  
Refer to Table 5.6 for gene functions. -, decreased expression compared to control; =, similar 
expression to control; +, increased expression compared to control. 
5.4.2.5 Endothelial cells are less supportive towards HSCs in co-culture  
Evidence from increased Notch signalling, as well as adhesion molecules and 
cytokines, suggests that the HUVECs in co-culture do not particularly generate a 
HSC supportive environment.  
5.4.2.5.1 Expression of Notch ligands is decreased in co-culture: endothelial 
cells have lower direct control of HSCs in co-culture 
Expression of Notch ligands is an indication of the ability of ECs to interact with 
Notch receptors in HSCs/other niche cells and hence trigger signalling within those 
cells. For the ECs in the co-culture model, the expression of the DLL ligands has 
decreased, and expression of JAG ligands has remained constant or decreased, 
indicating a corresponding reduction in their direct HSC-supportive capacity.  
JAG ligands are constitutively expressed by BM ECs, but DLL ligands are generally 
undetectable; the reduction in DLL1 observed in EC co-culture may indicate a 
move towards a more BM-like phenotype (Fernandez et al. 2008). In murine foetal 
arteries, DLL1 is required for maintenance of arterial identity (Sörensen et al. 
2009). A large reduction in expression here may suggest that the ECs are no longer 
maintaining arterial identity, being more akin to microvasculature.  
Expression of DLL and JAG family members enhances the ability to support HSCs 
in vitro: notch activation by these ligands delays myeloid differentiation and 
increases colony-forming potential of HSCs. JAG2 is specifically expressed by ECs 
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in the BM (Fernandez et al. 2008). The levels of JAG1 and JAG2 ligands have 
remained constant, suggesting a maintenance of HSC-supporting ability. 
5.4.2.5.2 Endothelial cells in co-culture express similar levels of adhesion 
molecules compared to control 
As mentioned previously, adhesion molecules mediate cell-cell adhesion and cell-
ECM interactions. Therefore, they are relevant in both angiogenesis and in niche 
functionality of ECs. The changes in expression in spheroids compared to 
monolayers are summarised in Table 5.12.  
Gene Gene Expression Gene Gene Expression 
Adhesion molecules Cytokine molecules 
VLA4 = c-kit - 
VCAM1 - SCF - 
ICAM1 = TIE2 - 
E-selectin = ANG1 - 
CD44 - TPO = 
ALCAM -  
Table 5.12 Summary of changes in expression by ECs of genes involved in niche interactions.  
Refer to Table 5.5 for gene functions. -, decreased expression compared to control; =, similar 
expression to control; +, increased expression compared to control. 
All genes indicated a downwards trend, in particular ALCAM, which has a role in 
endothelial junction formation and in transendothelial trafficking of leukocytes. 
It is expressed by several niche cell types, including ECs. It most likely acts through 
homotypic adhesion to anchor haematopoietic cells (Chitteti et al. 2015). 
Reduction in the expression of ALCAM in ECs suggests a reduced capacity to retain 
HSCs or haematopoietic lineage cells in the model. CD44 has also been 
significantly downregulated. As interaction between CD44 and hyaluronan is 
involved in tubulogenesis (Olofsson et al. 2014), this downregulation may 
represent impared tubulogenic behaviour.  
5.4.2.5.3 Endothelial cells in co-culture express similar levels of HSC-
supportive cytokines compared to control 
Expression of all genes involved in cytokine interactions in the niche have been 
downregulated by at least 0.5-fold in HUVECs, excepting TPO, which has 
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maintained a constant level. This may suggest that the cells are not directly 
supporting HSCs, at least via the mechanisms examined here. However, some 
angiogenic pathways can also be examined by looking at these genes. The receptor 
for SCF, c-kit, is expressed by mature ECs (Suzuki et al. 2014): the significant 
decrease in expression noted in co-culture may therefore indicate that the HUVECs 
have become more mature, supporting previous conclusions. C-kit’s downstream 
signalling pathways promote EC survival, migration, and capillary tube formation; 
supporting this, SCF dose-dependently promotes these angiogenic features (Matsui 
et al. 2004).  
Results from analysis of cytokine genes cannot determine whether the ECs are 
more conducive to interaction with HSCs in co-culture, but give some evidence 
that they are more mature. 
 
Figure 5.15 Summary diagram of gene expression changes in ECs when in co-culture 
compared to control. 
In summary, evidence from gene expression analysis in ECs shows that they are 
more quiescent in co-culture, expressing lower levels of signalling related genes 
and adhesion molecules. Genes related to angiogenesis remain similar or are 
slightly decreased in co-culture. This evidence suggests that the cells may be 
adopting a mature vasculature phenotype in the model. However, it would be 
interesting to further investigate these changes by looking at earlier time points 
during the experiment.  
Endothelial+cells
. cell+cycle
. adhesion
./=+angiogenesis
. signalling
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5.4.2.6 HUVECs may not be optimal for the model 
As a final note, the suitability of HUVECs for developing this co-culture method is 
in question. Firstly, BM-derived ECs compared to HUVECs have a greater ability to 
support adhesion and migration of HSCs than HUVECs or ECs from other organs 
(Yun & Jo 2003). Furthermore, the specificity of the pro-angiogenic effect of notch 
in the BM means that HUVECs may respond differently to BM ECs. Depending on 
the perspective taken, the increased notch signalling could be taken to indicate 
either contact inhibition and hence quiescence, or promotion of angiogenesis in 
the BM-like environment (Fernandez et al. 2008). Although results from transcript 
analyses suggest that HUVECs are adopting a mature phenotype in the model, 
these points suggest that using BM-derived ECs in the model may replicate the BM 
environment more efficiently, and may be more supportive for HSCs.  
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5.4.3 Osteoblasts adopt an endosteal phenotype in co-culture 
OBs are a major component of the BM HSC niche, as components of the endosteum 
environment. The endosteum comprises a flattened, quiescent OB subset. Results 
from the RNA analysis show that co-culture within a 3D model influences 
osteoblast phenotype, encouraging them to adopt these endosteal characteristics. 
5.4.3.1 Osteoblasts may be slightly more quiescent in co-culture 
Whilst changes are not significant, as shown in Table 5.13, there is a general trend 
for reduced expression of almost all genes analysed related to the cell cycle 
although none of these genes have changed significantly from the control  
Gene Gene expression Gene Gene expression 
G1/S transition Cyclins 
E2F1 - CYCLIN E1 + 
E2F2 - CYCLIN D2 = 
E2F3 - Global cell cycle regulators 
MCM4 - FBXW7 - 
MYC - TP53 - 
AKT2 - p38 - 
AKT1 - FOS + 
 BMI1 - 
Table 5.13 Summary of changes in expression by OBs of genes involved in cell cycle 
regulation.  
Refer to Table 5.3 for gene functions. -, decreased expression compared to control; =, similar 
expression to control; +, increased expression compared to control. 
5.4.3.2 Osteoblasts are more mature in co-culture 
Examining the expression of genes involved in osteogenic regulation and cell 
markers suggests that the OBs have a more mature phenotype in the model. This 
conclusion is based on a general trend for reduced early osteoblast markers with 
no changes (or a downwards trend) noted in MSC marker genes, as shown in Table 
5.14.  
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Gene Gene Expression Gene Gene Expression 
Osteogenic markers Adipogenic markers 
RUNX2 - GATA1 + 
BMP2 = GATA3 + 
OPN +  
Osteogenic signalling Chondrogenic markers 
PML = LEF1 = 
STAT3 = RUNX1 - 
VEGF =  
TCF3 = Stem cell markers 
TCF4 - CD63 - 
NFκB1 = CD271 = 
NFκB2 = CD34 - 
SMAD6 -  
SMAD7 = 
Table 5.14 Summary of changes in expression by OBs of genes involved in osteoblastic 
differentiation.  
Refer to Table 5.4 for gene functions. -, decreased expression compared to control; =, similar 
expression to control; +, increased expression compared to control. 
5.4.3.2.1 Expression of osteogenic regulators and signalling decreases in 
co-culture 
In co-culture, osteoblasts exhibited increased expression of OPN, a late osteoblast 
marker, and decreased expression of early osteogenesis regulator RUNX2 and 
BMP2. However, these changes are not significant and so the differentiation state 
of the cells cannot be determined.  TCF4, however, activates RUNX2 (McCarthy & 
Centrella 2010) and was significantly downregulated, which may explain the 
decrease RUNX2 expression and may correspond to lower levels of osteogenic 
signalling. SMAD6 is activated by BMP2 (Q. Wang et al. 2007), and so the significant 
decrease in its expression may reflect lower levels of osteogenic activity.  
5.4.3.3 HSC support capacity of osteoblasts remains similar in co-culture 
Examination of expression patterns of genes involved in HSC interactions with OBs, 
both cytokines and adhesion molecules, suggests that support capacity remains 
similar in the co-culture model as to OBs cultured in monolayer isolation.  
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5.4.3.3.1 Expression of adhesion molecules slightly decreases in co-culture 
Similar to the trend observed with MSCs when cultured within the 3D model, there 
is a downwards trend in gene expression of adhesion molecules in OBs in co-culture 
compared to control (Table 5.15). Again, this may be simply because these 
molecules are in a different conformation in the 3D model compared to standard 
tissue culture.  
The significant decrease in expression of VLA-4 may reflect the fact that this gene 
is not typically expressed by OBs and is present at a very low level in both control 
cells and in the model. N-cadherin has also significantly decreased in expression. 
N-cadherin has been shown to be a negative regulator of OB proliferation and 
survival (Haÿ et al. 2009). Therefore, the decreased expression may encourage 
increased survival of OBs in the model compared to in isolation. It is also highly 
expressed in endosteal lining OBs (Ferrari et al. 2000), suggesting that the OBs in 
co-culture are not exactly reflecting the nature of the endosteal OB subset.  
Gene Gene Expression Gene Gene Expression 
Adhesion molecules Cytokine molecules 
ALCAM - CXCL12 + 
VLA4 - TIE2 = 
VCAM1 = ANG1 - 
ICAM1 = TPO = 
N-cadherin -  
CD44 - 
Table 5.15 Summary of changes in expression in OBs of genes involved in niche 
intercellular interactions.  
Refer to Table 5.5 for gene functions. -, decreased expression compared to control; =, similar 
expression to control; +, increased expression compared to control. 
5.4.3.3.2 Expression of niche cytokines by osteoblasts remains similar in co-
culture 
Tie-2, CXCL12, SCF, and TPO expression levels remain similar to control OBs. 
These are key niche molecules, which are required for HSC maintenance, 
indicating that co-culture has no effect on the capacity of OBs to produce these 
molecules. Ang1 is expressed by OBs, although in the co-culture its expression was 
significantly downregulated. Overexpression of Ang1 increases bone mass and 
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increases ALP activity, whilst also encouraging angiogenesis, thus the lower levels 
of Ang1 expression do not support osteogenic activity in co-culture (Suzuki et al. 
2007). Overall, very few changes in gene expression were observed, and the 
changes that are seen are of low magnitude. Therefore, it appears that OB co-
culture in the model does not change niche signalling.  
5.4.3.4 Notch signalling in osteoblasts remains similar in co-culture 
In general, whilst most changes were not significant, a downwards trend was noted 
in the expression of notch receptors and ligands when compared to control OBs 
(Figure 5.7F). As notch signalling has a general inhibitory effect on 
osteoblastogenesis (Canalis 2008), the fact that the pathway is maintained or 
slightly decreased suggests that osteoblastogenesis is slightly enhanced in co-
culture, maintaining OB phenotype. The significant downregulation of GSK3 also 
suggests that the Notch signalling activity is decreased in co-culture.  
5.4.3.5 Hedgehog signalling in osteoblasts decreases in co-culture 
HH signalling is required for OB differentiation from progenitors. However, HH 
signalling progressively decreases during OB maturation, and is constitutively low 
in mature OBs (Mak et al. 2008). Whilst data has not been obtained for HH ligands, 
and several other members of the pathway, the trend is again for reduced gene 
expression (Figure 5.7G).  
 
Figure 5.16 Summary of gene expression changes in OBs when in co-culture compared to 
control. 
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In summary, changes in gene expression in OBs indicate that they are more 
quiescent and adopt many characteristics of endosteal OBs in co-culture. This is 
promising for the success of the model, as they may provide specific signals that 
are not supplied by the MSC spheroid alone.  
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5.4.4 Haematopoietic stem cells have altered behaviour when 
they are cultured in vascular and endosteal niche models 
Freshly isolated HSCs were co-cultured in either the endosteal niche model (with 
MSC spheroids and osteoblasts) or the vascular niche model (with MSC spheroids 
and endothelial cells). The subsequent analysis of HSC gene expression in both 
models compared to control HSCs cultured in suspension may provide evidence of 
their differentiation state, and hence whether the two niche models have 
different effects on the lineage specification, cell cycle, and cell signalling of 
HSCs.  
5.4.4.1 HSC cell cycle genes have increased in both niche models 
The expression of all the analysed genes involved in the cell cycle are shown in 
Table 5.16. The expression of genes involved in the progression of the cell cycle 
from G1 to S phase (E2F1-2, MYC, MCM4, AKT1-2, and cyclin D2) have increased 
in both the endosteal and vascular models when compared to control HSCs, 
indicating increased proliferation. Interestingly, in almost all of these genes, 
expression is greater in the endosteal model as compared to the vascular model. 
However, none of these changes are significant. 
Gene 
Gene Expression 
Gene 
Gene Expression 
Vascular Endosteal Vascular Endosteal 
G1/S transition Global cell cycle regulators 
E2F1 + ++ p38 + ++ 
E2F3 + ++ FOS + ++ 
MYC + ++ FBXW7 + ++ 
MCM4 + ++ p53 + ++ 
AKT2 + ++ BMI1 + ++ 
AKT1 + ++  
CYCLIN D2 + + 
Table 5.16 Summary of changes in expression by HSPCs of genes involved in cell cycle 
regulation.  
Refer to Table 5.3 for gene functions. +, increased compared to control; ++, increased 
compared to control and other model.  
An increase in MYC was noted in both niche models. The role of MYC in HSC 
function is manifold. Exogenous application of MYC to murine HSPCs in culture has 
been shown to enable proliferation whilst maintaining a progenitor phenotype for 
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up to 28 days: suggesting that MYC supports HSC self-renewal (Satoh et al. 2004). 
In progenitors, it is essential for initiating differentiation but in lineage 
progenitors, its role in cell cycle progression and expansion becomes apparent 
(Wilson et al. 2004). MYC also has a role in interaction of HSCs with the niche: it 
represses integrin and N-cadherin expression (both of which are decreased in the 
niche models) and hence modulates migration and adhesion in the niche.  
Expression of several general cell cycle modulators has also increased, although 
not necessarily in support of proliferation. For example, the increased expression 
of p38 indicates that the HSC lifespan is limited in culture, as inactivation of p38 
maintains their self-renewal capacity (Ito et al. 2006; Wang et al. 2011). In 
addition, p38 activation in CD34+ progenitors prevents differentiation (Oeztuerk-
Winder & Ventura 2012).  
In contrast, FOS is a negative regulator of the cell cycle in HSCs, maintaining them 
in G1/G0 phase following prolonged expression (Okada et al. 1999). The large 
increased fold-change in expression over control in both models suggests a 
downregulation of the cell cycle, particularly in the endosteal model.  
5.4.4.2 Haematopoietic lineage bias depends on culture conditions: 
comparison of RNA data and phenotypic flow cytometry data 
From analysis of the expression of multiple genes involved in haematopoietic 
lineage determination (Figure 5.8E), it is evident that multiple lineages have 
arisen within the population, with differentiation into erythroid, lymphoid, and 
myeloid cells occurring. However, there is also evidence to suggest the continued 
existence of an early progenitor population. In contrast, evidence from expression 
of cell surface markers (Figure 5.10 and Figure 5.11) indicates a large decrease, 
and essentially non-existence of progenitors following a period of culture.  
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Gene 
Gene Expression 
Gene 
Gene Expression 
Vascular Endosteal Vascular Endosteal 
Progenitor Lymphoid 
VEGF + ++ TCF3 + ++ 
LEF1   + NFKB1 + ++ 
GATA2 + + GATA3 ++ + 
PML + ++ CD79 ++ + 
CD34 ++ +  
Erythroid  Myeloid 
SPI1 + ++ TCF4 + ++ 
RUNX1 + ++ MEIS1 + ++ 
SMAD6 + ++ MPO + ++ 
BMP2   + NFKB2 + ++ 
 
GATA1 + ++ 
SMAD7 ++ + 
OPN + ++ 
Table 5.17 Summary of changes in expression by HSPCs of genes involved in HSPC 
differentiation.  
+, increased compared to control; ++, increased compared to control and other model. 
5.4.4.2.1 A haematopoietic progenitor population may persist in the niche 
models  
RNA analysis: Firstly, when considering HSC phenotype and characteristics such 
as quiescence and survival, all genes increased in expression in the co-culture 
models (Table 5.17).  
Flow analysis: In contrast, results from phenotypic analysis (Figure 5.11) indicates 
a large reduction in the proportion of cells expressing the CD34 marker (under 
1%), after 7 days of culture within the niche models. Interestingly, the level of 
CD34+ cells remains similar whether or not collagen gel or MSCs are present. 
However, the extent of this decrease is difficult to ascertain due to technical 
issues, as discussed in section 5.3.2.2.2 (page 184). In particular, the antibody 
used in detection may be underestimating the frequency of progenitors. 
Regardless, the percentage of CD34+ cells in the sample has decreased, indicating 
a loss of both HSCs and progenitor cells, with differentiation in all samples.  
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In the vascular model, lymphoid progenitor (MLP, CLP) frequency has decreased 
to a greater extent compared to the endosteal model. However, myeloid 
progenitors (CMPs) and granulocyte-monocyte progenitors (GMPs) are not present, 
and erythrocytic progenitors (MEPs) have decreased to a greater extent than the 
lymphoid progenitors. This may indicate that most haematopoietic cells in the 
vascular model are terminally differentiated. 
Meanwhile, in the endosteal niche model, the percentages of all progenitors are 
greater than observed in the vascular model. Therefore, there may be less 
differentiation in this model, as expected considering the in vivo role of the 
endosteum (Acar et al. 2015).  
5.4.4.2.2 Erythropoiesis may be increased in the vascular model compared 
to the endosteal model 
RNA analysis: Genes that are involved in erythropoiesis have generally increased 
in both niche co-culture models. Several of these genes are downregulators of 
erythropoiesis; hence, evidence from these genes suggests a downregulation of 
erythropoiesis in comparison to other lineages, despite an increase in BMP2. 
However, none of these increases are significant changes. As hypoxia is relevant 
to erythropoiesis (Morikawa & Takubo 2016), culture of the model in a hypoxic 
incubator may allow replication of physiological proportions of erythroid cells.  
Flow analysis: Evidence from cell surface markers also shows that erythrocytic 
differentiation may be highest in the vascular niche model. In particular, CD36 is 
expressed on the earliest megakaryocyte/erythroid progenitors (MEPs, Ward et al. 
2016). Its expression is greatly increased in the vascular niche model, showing a 
strong bias towards these lineages. This is supported by the changes in expression 
of SPI1. CD41a is expressed on progenitors, with persistent expression in MEPs and 
subsequent mature cells, and is integral to platelet function (Choi et al. 2009). 
Expression of CD41a in the endosteal model is almost non-existent, compared to 
the remainder of the experimental samples, in which expression has been 
maintained at a similar level. This supports the conclusion that the OB model 
reduces megakaryocytic/erythroid differentiation, whilst the vascular model 
remains permissive.  
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5.4.4.2.3 Transcriptomic and phenotypic analyses give conflicting results 
regarding lymphoid differentiation  
RNA analysis: Again, genes involved in production of lymphocytes have been 
upregulated in the co-culture models. Evidence from lymphoid related genes 
suggests a bias towards lymphoid development in the vascular niche model 
compared to the endosteal niche model. This conflicts with in vivo evidence from 
the BM, which suggests that the endosteal BM environment favours lymphoid 
differentiation (Ding & Morrison 2013). As before, as these changes are not 
significant, conclusions cannot be drawn from this data.  
Flow analysis: The expression profiles of some lymphoid lineage markers suggest 
a complete lack of these cells in any of the models. CD10 is a general lymphoid 
marker that arises at an early stage of development. Progenitor cells that express 
CD10 tend to be biased towards B-cell production. A high proportion of CD10+ 
lymphoid lineage progenitors are present in the day 1 samples. However, by day 
7, CD10 is not observed in any of the experimental samples, reflecting a lack of 
both lymphoid progenitors and of mature lymphoid cells. CD7 is expressed by pro-
T cells and mature T cells, therefore being a lymphoid marker (Shukla et al. 2017). 
CD7 expression is initially low, and remains so after culture for 7 days, with the 
lowest levels observed in the cells cultured with collagen. Hence, it can be 
concluded that there are virtually no T-cell lineage cells in any of these samples, 
and lymphoid differentiation is not occurring, contradicting the RNA analysis.  
5.4.4.2.4 Myelopoiesis may be increased to a greater extent in the endosteal 
model 
RNA analysis: The expression of several genes involved in myeloid differentiation 
was examined, all of which were increased in both niche models. MEIS1 was the 
only gene to exhibit a significant difference in expression between the endosteal 
and vascular models. It is fundamentally linked to several stem cell functions 
including quiescence and self-renewal, protecting and preserving HSCs in mice 
(Unnisa et al. 2012) and is also instrumental in erythropoiesis and myelopoiesis 
(M. Cai et al. 2012; Ariki et al. 2014). The significantly increased expression in the 
endosteal model compared to the vascular model suggests a bias towards the 
myelopoiesis lineages.  
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Flow analysis: Evidence from expression of surface markers suggests a lower level 
of myeloid differentiation in the endosteal niche model, with about 12% of cells 
expressing the marker, compared with 20% in the vascular model. CD13 is 
expressed by early as well as differentiated myeloid cells (Winnicka et al. 2010). 
Expression is at around 25% in the baseline sample, and expression is maintained 
at a slightly lower level in the majority of samples. However, expression has 
increased in the presence of a collagen gel alone: suggesting that it promotes 
myeloid differentiation. On the other hand, this effect is offset by the addition of 
an MSC spheroid. CD13 has decreased to a lower level in the endosteal niche 
model: again, implying a lower level of myeloid differentiation in this model.  
In vivo, the vascular niche is a proposed niche for myeloid progenitors and the 
early stages of myelopoiesis (Rafii et al. 1995). Although an increase was observed 
in myeloid-lineage related gene expression in the vascular model, as expected, a 
greater increase occurred in the endosteal model. This conclusion conflicts with 
the expectations from looking at the in vivo BM environment. In contrast, evidence 
from cell surface markers shows that there is a slightly higher level of myeloid 
differentiation in the vascular model. Therefore, no firm conclusions can be drawn 
as to whether the different cell combinations promote differentiation into 
different lineages.  
5.4.4.3 Expression of genes related to niche cell interactions is increased in 
co-culture  
Genes involved in indirect cytokine interactions and direct cell-cell adhesion in 
the BM niche were included in the analysis. These genes have increased in 
expression in both co-culture models, although the increase is slightly greater in 
the endosteal model.  
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Gene 
Gene Expression 
Gene 
Gene Expression 
Vascular Endosteal Vascular Endosteal 
Adhesion molecules Cytokine interaction molecules 
ALCAM + ++ CXCL12   + 
VLA4 + ++ c-KIT + ++ 
VCAM1   + ANG1 + ++ 
LFA1 + + TPO + ++ 
ICAM1   + MPL   - 
CD44   + CXCR4 + ++ 
Table 5.18 Summary of changes in expression by HSPCs of genes involved in niche 
interactions.  
Refer to Table 5.5 for gene functions. -, decreased compared to control; +, increased 
compared to control; ++, increased compared to control and other model. 
5.4.4.3.1 Cytokine interactions may have increased in co-culture  
With regards to cytokine receptors, CXCR4 and c-kit have increased in both 
models, whereas MPL has decreased in the endosteal model and no results were 
obtained for the vascular model. The cytokines TPO and Ang-1 have increased in 
both models and CXCL12 has increased in the endosteal model. These results 
indicate a general increase In inter-cell communication through cytokines and 
their receptors, although as none of these results are significant no firm 
conclusions can be drawn.   
5.4.4.3.2 Direct adhesion interactions have increased in co-culture 
Unlike the other cell types included in the model, the expression of cellular 
adhesion genes has increased in HSCs when in co-culture, particularly in the 
endosteal model. As the HSCs were added to the model in suspension, this may 
reflect an increase in migration, more so in the endosteal model, as the cells 
penetrate the collagen gel model and migrate during the 7-day culture period. 
However, none of these increases are significant.  
5.4.4.4 Notch signalling is increased in co-culture  
Expression of genes involved in Notch signalling has increased in both the vascular 
and the endosteal model. Aside from the expression of the notch ligand DLL3 and 
the target TF HEY1, all genes have increased to a greater extent in the endosteal 
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model. The increase in expression of the Notch ligand DLL indicates that the HSCs 
may initiate higher levels of notch signalling in the vascular model. In addition, 
the increased levels of HEY1 suggest that HSCs have a stronger response to notch 
signalling in the vascular model. In contrast, the HSCs are more receptive to notch 
signals in the endosteal model. This aligns with evidence that OBs are a major 
source of notch signals in the niche (Gu et al. 2016).  
Gene 
Gene Expression 
Vascular Endosteal 
NOTCH1 + ++ 
DLL3 ++ + 
MAML + ++ 
NUMB + ++ 
LFNG + ++ 
MFNG + ++ 
ADAM10 + ++ 
ADAM17 + ++ 
HES1 + + 
HEY1 ++ + 
Table 5.19 Summary of changes in expression by HSPCs of genes involved in notch 
signalling.  
Refer to Table 5.7 for gene functions. +, increased compared to control; ++, increased 
compared to control and other model. 
As discussed previously, notch signals from stromal niche cells, particularly OBs, 
promote proliferation, self-renewal, and maintenance of haematopoiesis (Gu et 
al. 2016). The general increase in components of the pathway indicates increased 
signalling and hence increased stem cell function.  
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Figure 5.17 Summary of gene expression changes in HSCs when in co-culture compared to 
control. 
In summary, HSPCs cultured in the endosteal model appear to be more active than 
those cultured in the vascular model. Conflicting results from flow cytometry and 
RNA analysis make drawing conclusions complicated, but a primitive population 
seems to be preserved within both models, whilst differentiation is occurring.  
5.4.5 Co-culture in 3D collagen gels has differential effects on 
hypoxia depending on cell type 
Hypoxia is a major regulator of the HSC niche. The BM is physiologically hypoxic, 
despite being highly vascularised. This is because the anatomical structure limits 
the abundance of afferent arterioles and haematopoietic cells actively consume 
oxygen (Morikawa & Takubo 2016). In the 3D collagen gel, the diffusion of oxygen 
may be limited and hence it may be a hypoxic environment. This was investigated 
by looking at the expression of HIF1α in the different cell types.  
HSCs: HIF1α is highly expressed in HSCs following activity of the TF MEIS1. It 
mediates hypoxia responses that maintain HSC quiescence. Its presence also 
enhances mobilisation and dynamics of HSCs (Morikawa & Takubo 2016). HIF1α 
expression has markedly increased in HSCs cultured in both the vascular and 
endosteal BM models, reflecting their hypoxic status. Hence, stem cell properties 
such as quiescence are expected to increase in HSCs. The HSCs in the endosteal 
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model are more hypoxic than those from the vascular model, which is accordance 
with the expectation that the endosteum is more hypoxic. However, it should be 
noted that as the model does not simulate blood flow, this difference is due to 
inherent differences in the support cells themselves, rather than a difference in 
oxygenation between the cultures. The increase in HIF1α expression observed in 
HSCs extracted from both co-culture models may also induce the increased VEGF 
expression, which also promotes HSC survival and function (Gerber et al. 2002).  
MSC spheroids: HIF1α expression in MSCs is also relevant to the maintenance of a 
stem cell phenotype, as it is a transcriptional repressor of RUNX2, which initiates 
osteogenesis. It also encourages expression of niche factors including CXCL12 and 
SCF, hence, hypoxia regulates the niche function of MSCs. However, HIF1α 
expression in MSC spheroids is maintained at a similar level to MSC monolayers. In 
fact, a very slight decrease in hypoxia was noted in the endosteal model spheroids; 
this is contrary to the hypothesis that the endosteum environment is more hypoxic 
than the vascular area, and also conflicts with the hypoxia status in the HSCs from 
the two models.  
HUVECs: Evidence as to whether HIF1α expression is relevant to EC niche function 
in the BM is limited, but it may influence the expression of HSC maintenance 
factors in a similar manner to MSCs (Morikawa & Takubo 2016). HIF1α levels have 
decreased to a greater extent in ECs compared to the other cell types when in co-
culture. This is consistent with the vascular area of the niche being less hypoxic.  
OBs: HIF1α levels have not changed extensively between control and co-cultured 
cells. Increased HIF levels in OBs regulates erythropoiesis and HSC population size 
in vivo (Morikawa & Takubo 2016). However, the co-culture has little effect on 
this function.  
Evidence from analysis of expression of HIF1α in all cell types suggests that the 
endosteal model may induce a more hypoxic phenotype in HSCs, consistent with 
the in vivo physiological BM. However, the other model cell types are all less 
hypoxic in the 3D model compared to the control.   
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5.5 Conclusion 
This chapter developed an endosteal 3D model (comprising MSC spheroids and 
monolayer osteoblasts) and a 3D vascular model (comprising MSC spheroids and 
monolayer endothelial cells) to assess whether either provided a HSC-permissive 
environment for HSC culture ex vivo. Detailed RNA analysis of the multiple cell 
types following co-culture within the 3D niche models identified some differences 
compared to the same cell type cultured in isolation, in particular: 
 Endosteal and vascular niche models affect MSC spheroid phenotype in a 
manner that reflects the in vivo characteristics of these niche 
environments: i.e. quiescence at the endosteum and higher activity at the 
vasculature.  
 ECs adopt a mature, quiescent phenotype in the co-culture model, akin to 
mature vasculature.  
 Similarly, OBs have adopted a mature, quiescent phenotype, which may be 
similar to the phenotype of endosteal OBs in vivo.  
 Analysis of HSPCs is harder to draw conclusions from as RNA and cell surface 
markers give conflicting profiles. However, in general extensive 
differentiation and an increase of cell-cell interactions, supporting HSPC 
migration, is observed.  
It is evident that the stromal cell types within the model are behaving as 
hypothesised based on the in vivo niche. However, conditions for the HSCs may 
require further optimisation, for example optimising cell number. As this model is 
being developed with a view towards the co-cultured cells providing an 
environment which encourages HSPC migration and retention, this may negate the 
need for the addition of cytokines and GFs to the media, reducing cost. Therefore, 
adjusting and reducing the concentrations and GF cocktail used in the media may 
have effects on HSPC behaviour that enhance the model functionality.  
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Chapter 6 Discussion  
6.1 Project summary 
As outlined in Chapter 1, this project aimed to recreate the BM niche environment 
in a way that allows maintenance of an HSC population in a stem cell-like state. 
There is a clear research and clinical need for such a system, and this study has 
made progress towards making this goal a reality. Key achievements are described 
below: 
 HSC cell source: in order to carry out the project, a reliable cell source of 
freshly isolated HSPCs needed to be established; this was via a clinical 
collaboration with a local hospital, who donated bone marrow samples from 
which HSPCs were isolated. Following this, BM samples were evaluated and 
determined to be an appropriate HSPC source. 
 Media optimisation: as the model involves a co-culture system, comprising 
MSCs, OBs, and ECs as support cells for the HSCs, the optimisation and 
characterisation of culture conditions capable of maintaining all cell types 
is important. An appropriate media formulation for co-culture, which 
adequately maintained the MSCs and HSCs was idenitifed.  
 Cell retrieval from the 3D model: a procedure for extraction of cell 
populations for downstream analysis was developed and optimised, 
involving collagenase treatment of the type I collagen gel and subsequent 
cell population isolation via flow cytometry.  
 MSC spheroid model characterisation: extensive characterisation of an 
existing MSC spheroid model within a collagen gel was carried out. MSCs 
were shown to be more quiescent, express greater levels of HSC niche-
relevant cytokines, and retain key stem cell characteristics when cultured 
as magnetically labelled spheroids. Hence, this was considered an 
appropriate starting point to introduce further elements of the BM 
microenvironments and support HSCs.  
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 Finally, two further niche cell types (OBs and ECs) were introduced to basic 
MSC spheroid model, to mimic the endosteal and vascular environments of 
the niche respectively. HSCs were subseqeuenlty introduced to the co-
culture niche models. All cell types were cultured for 7 days, retrieved, 
separated, and RNA was isolated to analyse key differences in cell cycle, 
cell markers (self-renewal/differentiation), and cell signalling (cytokine, 
notch and hedgehog). Results indicated that OBs and ECs adopted mature, 
quiescent phenotypes akin to those observed in the BM. Similarly, MSC 
spheroids behaved as expected when separately co-cultured with the cells 
(i.e. quiescent with OBs and active with ECs). HSPCs cultured within these 
two models proliferated and a pool of CD34+ cells was retained, although 
differentiation into more mature cells was observed in both models.  
Therefore, in conclusion, endosteal and vascular BM niche models, capable of 
maintaining MSCs and HSCs in co-culture for up to 7 days, have been developed. 
Both the niche models do contribute key characteristics to allow for an HSC 
permissive environment, although further work is needed in order to produce a 
functional BM model that is able to maintain HSCs in a primitive state for longer 
periods of time.  
6.2 Prospective applications of a bone marrow niche 
model 
A BM niche model has multiple potential applications in investigation of 
haematopoietic processes, pharmaceutical development, modelling disease, and 
providing cells for clinical use. Some of these applications are summarised in the 
following text. 
6.2.1 Probing haematopoiesis 
Although HSCs remain the most studied and clinically relevant adult stem cell, the 
relative lack of success in maintaining them ex vivo means that a deeper 
understanding of their biology is required to improve these processes. Many of the 
signals that cause changes in HSC behaviour have been identified, and are 
discussed in earlier chapters. However, many still remain to be elucidated (Figure 
6.1). The opportunities for studying HSC biology in humans are limited, and using 
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a murine model may not always produce appropriate results, especially given 
differences between the murine and human immune systems. An in vitro HSC 
culture system, such as the one developed in this project, may allow identification 
of such signals, by elimination or subtraction, and hence the development of novel 
methods to control these behaviours.  
For example, the importance of a signal before, during, and after events such as 
self-renewing division, differentiation, and migration can be investigated. One 
such microfluidics system has already been used to show that SCF is not important 
during a first HSC division, but is required for survival afterwards (Choi & Harley 
2016). Another possibility is to set up spatial gradients of cells and growth factors 
in the ECM. This could be used to investigate the importance of gradients for 
migration and locations of progenitor niches. For example, studies have been 
performed using opposing gradients of osteoblasts and HSCs (Mahadik et al. 2014), 
and gradients of SCF covalently linked to a hydrogel (Mahadik et al. 2015). 
 
Figure 6.1 Schematic of HSC behaviours that could be investigated using an in vitro culture 
platform. 
6.2.2 Modelling disease  
In vitro BM models also allow modelling of disease niche states. Many 
haematological disorders involve HSCs: for example, in leukaemias, stem or 
progenitor cells can become damaged so that they overproduce one type of white 
Chapter 6  226 
 
blood cell, fundamentally changing the cellular composition of the bone marrow 
(Bonnet 2005, Figure 6.2). Leukaemic stem cells can migrate into the BM and 
remodel the niche environment to favour themselves at the expense of HSCs (Lane 
et al. 2009). In turn, an abnormal niche microenvironment can alter the behaviour 
of HSCs. As LSCs share quiescent and self-renewing properties with HSCs, and are 
protected from external clinical treatments by the niche environment (Tabe & 
Konopleva 2014), developing treatments that target only LSCs is difficult. An in 
vitro model could therefore be used to study how these interactions occur and 
identify therapeutic targets. Furthermore, as these malignancies are 
heterogeneous in terms of the original mutation and in terms of phenotypic 
changes, an in vitro model can provide a platform to identify the most appropriate 
therapeutic for an individual patient, whilst also taking into account the 
microenvironmental conditions. A co-culture system has already been used to 
identify personalised treatment for multiple myeloma using patient cell samples 
(MSCs and HSCs) (Pak et al. 2015). A new PhD project in CCE, in collaboration with 
the Paul O’Gorman Leukaemia Research Centre, is investigating how LSCs migrate 
into the niche and how they subsequently interact with the resident MSCs and 
HSCs using the system developed here.  
 
Figure 6.2 Schematic of leukaemia development from HSCs. 
6.2.3 Modelling the aging niche 
A further opportunity is to study how aging of both HSCs and the niche affects 
their function. Aged HSCs have lower potential and the prevalence of 
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haematological disorders increases with age (Sharpless & DePinho 2007). This may 
not simply be a cell-intrinsic effect, but may also arise due to aging of niche cells. 
Studies comparing young and aged HSCs have shown that properties such as 
mobilisation ability are dependent on niche age rather than HSC age (Nakamura-
Ishizu & Suda 2014). The mechanisms relating to the aging of HSCs and their niche 
are currently not well understood. They may involve changes in expression of 
adhesion molecules, which reduces with age, as aged HSCs are less adherent to 
stromal cells in culture (Geiger et al. 2007). Metabolic state may also play a role: 
for example, MSC ROS levels increase with age, along with senescence. An in vitro 
model provides a system to study the effects of introducing an aged cell to a young 
system and vice versa. It could also provide a way to analyse specific cell 
behaviours and outputs such as metabolites. This has clinical relevance for 
evaluating and improving transplant procedures between individuals of different 
ages. 
6.2.4 Ex vivo pharmaceutical screening 
Given the importance of HSCs, studying their behaviour and function requires 
them to be studied both in vivo and in vitro. To increase the length of time they 
can be studied, this means co-culture systems and animal models are usually used 
to probe HSC biology. However, these systems often have low applicability to 
humans, due to interspecies differences in immune systems and the lack of 
support in tissue culture. This contributes to the high attrition rate of 
experimental treatments in phases I and II of clinical trials. They are also time 
consuming and expensive. An emerging alternative is developing in vitro model 
systems in a multiwell plate format that suitably mimic organs of the body. These 
systems can be fully humanised with primary human cells. Individual organs and 
combinations of organs have the potential to be much more predictive than 
traditional animal and 2D monolayer cell culture systems. Multiple combinations 
of drugs and personalised therapeutics can also be tested (Dehne et al. 2017). 
However, mimicking organs ex vivo is complicated, models need to combine ECM 
molecules, multiple cell types, and appropriate mechanical and biochemical 
stresses. Nevertheless, there are several examples of organ systems that have 
been developed successfully and are in use (Marx et al. 2016). 
Chapter 6  228 
 
Incorporation of physiological conditions such as shear stress and perfusion by 
using a microfluidic system may enhance the functionality and properties of niche 
models. It would also allow precise temporal and spatial control of growth factors, 
cytokines, and ECM. In particular, the pharmaceutical industry is beginning to 
move towards these systems in a bid to increase the efficiency of pre-clinical 
screening, and reduce failure rate.  
 Animal models Artificial organ models 
Positives  + Well established systems + Potential for standardisation 
and high throughput 
+ Systemic effects can be 
examined  
+ Humanised system 
 + Include increased numbers of 
experimental variables 
Negatives - Time consuming - Difficult to recapitulate systemic 
physiology 
- Expensive - Early stages of development 
- Low predictability of success 
in later trial stages  
 
- Ethical issues   
Table 6.1 Comparison of positive and negative aspects of using animal models versus 
artificial organ models for pharmaceutical screening.  
Only 10 substances out of every 100 that enter clinical trials will be approved for 
market access (DiMasi et al. 2016). The high attrition rate of experimental 
treatments between pre-clinical studies and Phase I/II clinical trials can be at 
least partially attributed to the insufficient predictability of the former. Hence, 
if in vitro models are more predictive than animal models, they have the potential 
to save the pharmaceutical industry millions of pounds on wasted trials, and also 
bring back into contention previously discarded candidates. High throughput 
models would also allow large scale screening of treatments with increased 
numbers of experimental variables, including evaluation of combination 
therapies. Therefore, developing such a system would be economically valuable 
and has the potential to revolutionise the pharmaceutical industry.  
6.2.5 Cell source for research and the clinic 
A major application of this technology is the potential to supply large numbers of 
high-quality cells for both research and for use as cell therapies. Currently, HSCs 
are stored as frozen and thawed at point-of-use. This process, though relatively 
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successful, involves high levels of necrosis and apoptosis (approximately 40% loss 
in umbilical cord blood CD34+ cell samples), and reduces functionailty 
(Hodgkinson et al. 2017; Duchez et al. 2013). A system that can maintain HSCs for 
an extended period of time, and allows expansion of the population on demand, 
could overcome these limitations. In a related way, such a system could be used 
to produce large autologous grafts from a small sample of a patient’s own cells. A 
patient’s cells could be extracted, and then maintained or expanded while the 
patient undergoes myeloablative therapy. This may enable a higher yield and 
negate the need for a donor, avoiding issues of graft-versus-host disease and the 
need to find an HLA match. In vitro organ models may allow this expansion or 
retention.  
6.2.6 Gene editing platform 
Combination of gene editing with artificial organ models provide an ideal vehicle 
for gene therapy strategies (Bredenoord et al. 2017). For example, intestinal stem 
cell organoids have been used as proof of principle for gene correction using 
homologous recombination in primary adult stem cells from patients with cystic 
fibrosis (Schwank et al. 2013). HSCs are particularly a prime target for gene editing 
for experimental therapies, due to their primitive nature and involvement in many 
haematological indications. Gene editing is an area of intensive clinical 
investigation and is expected to grow rapidly in the next decade. If this model 
allows gene editing of HSCs, and subsequent retrieval for use in vivo, its potential 
would be tremendous.  
6.2.7 Personalised medicine 
Incorporating specific patients’ cells into a model could pave the way for 
personalised treatments. This could include engineering disease models using 
induced pluripotent stem cells from a donor. Any treatment screened on such a 
platform would then be tailored to the patient’s specific genetic profile. As 
mentioned previously, a co-culture system using patient cells has already been 
used to screen treatment for multiple myeloma (Pak et al. 2015).  
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6.3 Limitations of the model 
Although the model system presented here has included a greater number of niche 
components than many other bone marrow models, several key parameters have 
not been included. There remain many challenges to creating a truly functional 
bone marrow model. Firstly, there are many types of cells that reside in the bone 
marrow and feed into the HSC support and regulation network, including 
megakaryocytes and components of the sympathetic nervous system. Omitting 
some of these cell types may compromise the functionality of the system and its 
ability to maintain HSCs. Using multiple cell types with different requirements in 
traditional cell culture requires extensive optimisation of the system, balancing 
conflicting priorities. Furthermore, replicating the complex architecture of the 
bone marrow, including vessels, bone, and trabecular structures has not yet been 
achieved. With the help of advanced scaffold technologies this may be possible in 
the future. In particular, this study has only included collagen in the ECM; the 
addition of molecules such as fibronectin could increase the relevance of the 
system.  
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6.5 Conclusion 
In this project, an HSC-permissive BM niche model has been optimised, developed, 
and characterised. The stromal cell types, MSCs, ECs, and OBs adopt phenotypes 
akin to those observed in vivo. HSCs proliferate in co-culture and a pool of CD34+ 
progenitors is maintained, although the results do not align exactly with behaviour 
in the BM. Therefore, further optimisation of the model is required before it can 
be taken forward for applications discussed in this chapter.  
6.5.1 Recommendations for future work  
 Increase the number of biological replicates for phenotypic 
characterisation to investigate repeatability of results.  
 Optimise cell numbers for the model, particularly for HSCs. At present, the 
HSC cell numbers were limited by BM availability, however freezing 
techniques (section 3.3.1.1) have been developed that allow for good 
retrieval levels. This allows us to bank down cells for future use. 
 Characterise the levels of growth factors and cytokines released by 
spheroids (I identified CXCL12 levels, but need to look at TPO and other key 
GFs/cytokines involved in HSC maintenance).  
 Remove growth factors from the media formulation to ascertain whether 
they are redundant for HSC support functions.  
 Examine gene expression at the protein level (proteomics), as a follow up 
to the changes noted in the RNA study.  
 Investigate cell signalling, quiescence, and differentiation when cultured 
for longer time points.  
 As a long-term goal, introduce LSCs into the model to investigate 
remodelling of the niche in a disease environment; a study which is 
currently underway.  
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Appendix A   
Figure A.1 and Figure A.2 show overlapping signal profiles for the different 
markers used in phenotyping experiments described in section 2.13.2 and 2.13.3, 
organised by antibody. This gives an overview of the separation of the positive 
and negative populations present in the different samples: for some of the markers 
this distinction is not obvious. For several of the markers, however, there is a 
clear difference in the number of cells expressing the marker at day 1, compared 
to all the other samples.  
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Figure A.1 Overlaid profiles of signals from lineage markers used to identify progenitor 
subsets in different samples. 
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Figure A.2 Overlaid profiles of signals from lineage markers in different samples. 
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